Steroid biogenesis in testicular tumours by Pierrepoint, Colin G
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
STEROID BIOGENESIS IN TESTICULAR TUMOURS
by
Colin G, Pierrepoint ^ B.V.Sc,^ M.R.C.y.S
Thesis submitted for the Degree of 
Doctor of Philosophy 
of the University of Glasgow^ Scotland,
May, 1967.
ProQuest Number: 10646174
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10646174
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
I . Acknowledgments.
I wish to thank Professor Sir William L. Weipers 
and Dr. J.K. Grant for their expert direction and 
continued encouragement throughout this project.
The British Empire Cancer Campaign for Research 
have financed the work reported and I am grateful 
for their generosity.
I am indebted to Mr. A. Finnic for photographing 
the tissue-sections, Tables, Text-figures and Graphs 
included in this Thesis.
The descriptions of the histological sections 
were kindly provided by Dr. L.J. Anderson, Dr. H.M. 
Pirie, Dr. G.S. Spilg and Dr. R.S, Cowdell.
I am grateful to Miss M. Ogilvie for typing the 
manuscript and to the members of the Department of 
Surgery, Veterinary Hospital, Glasgow, for their 
expert assistance and allowing me the use of their 
operating theatre facilities.
I extend my appreciation to the members of the
University Department of Steroid Biochemistry, Royal
Infirmary, Glasgow, for their assistance throughout^
and to Dr, K. Griffiths for his invaluable advice 
and co-operation.
List of contents.
I. Acknowledgments.
II. Abbreviations used.
III. Introduction.
IV. Experimental
(a ) Source of tissues,
(B) Preparation of tissues.
(i) Method (l)
(ii) Method (2)
(iii) Method (3)
(C) Methods of incubation.
(D) Methods of extraction of steroids,
(i) Extraction procedure I,
(ii) Extraction procedure II,
(E) Preparation of chromatograms.
(F) Detection of steroids on chromatograms,
(G) Elution of steroids from chromatograms.
(H) Preparation of derivatives.
(i) Oxidation.
(ii) Acétylation.
1
xiv
1
41
41
41
41
42 
42
42
43 
43
45
46
47
48
49 
49 
49
Page No 
r-
(iii) Saponification. 50
(iv) Reduction. 50
(v) Solvolysis. 51
(vi) Méthylation. 51
(I) (Quantitation of steroids. 52
(i) A ^ “3"03costeroids. 52
(ii) ^  -3 (3-hydroxysteroids. 53
(iii) Phenolic steroids, 54
(iv) / \ ^ - 3 3"Sulphoxysteroids. 56
(J) Measurement of radioactivity in extracts, 57
(K) Thin-layer chromatographic separation of
steroid sulphates. 58
(L) Tissue incubations. 67
(i) An interstitial cell tumour. 67
An investigation of the 
metabolism, in vitro, of 7a- H 
pregnenolone and 4-^^c DHA by 
an interstitial cell tumour of
the testis from a man with 
gynaecomastia.
Page No.
(a) Clinical data. 67
(b) Histological description 69
(c) Preparation of tissue and
conditions of incubation. 71
(d) Extraction and fractionation
of steroids. 72
(e) Investigation of the fractions
containing conjugated steroids. 72
(f) Investigation of the fractions
containing phenolic steroids. 79
(g) Results. 80
(h) Discussion. 80
(ii) Normal testicular tissue (1).
An investigation of the effect 
of time on the metabolism, in vitro, 
of 4- c  DHA and 7a-^H DHA sulphate 
by normal canine testicular tissue.
97
(a) ,Preparation of tissue, incuba­
tion procedure and method of 
extraction of steroids.
(b) Investigation of the fractions 
containing neutral steroids.
97
98
Page No.
(c) Investigation of the fractions
containing conjugated steroids. 100
(d) Results and discussion. 102
(iii) Sertoli cell tumour (l). 114
An investigation of the 
metabolism of H pregnenolone,
4-^^C DHA and 4-^^C testosterone 
by a Sertoli cell tumour of the 
testis from a dog showing signs 
of feminization and alopecia.
(a) Clinical data. 114
(b) Histological description. 115
(c) Preparation of tissue and
conditions of incubation. 115
(d) Investigation of the fractions
containing neutral steroids. 118
(e) Investigation of the fractions
containing phenolic steroids. 121
(f) Investigation of the fractions
containing conjugated steroids. 122
(g) Results. 123
vx
An investigation of the
Page No.
(iv) Normal testicular tissue (2). 132
metabolism, in vitro, of 7a,- H 
pregnenolone and DHA by
normal canine testicular tissue.
(a) Preparation of tissue, 
incubation procedure and 
method of extraction of
steroids, 132
(b) Results. 133
(c) Discussion, 133
(v) Sertoli cell tumour (2). 151
An investigation of the 
metabolism, in vitro, of 4-^^C 
DHA and 7o,-^H DHA sulphate by 
a Sertoli cell tumour of the 
testis from a dog with alopecia 
and apparent pruritis but with 
no signs of feminization.
(a) Clinical data. 151
(b) Histological description, 152
(c) Preparation of tissue and
conditions of incubation. 154
Page No
(d) Investigation of the
various steroid fractions. 155
(e) Results. 156
(f) Discussion. 156
(vi) * Sertoli cell tumour (3). 171
An investigation of the 
metabolism, in vitro, of 
DHA and 7<x-^H DHA sulphate by 
a Sertoli cell tumour of the 
testis from a dog with signs of 
feminization but no alopecia.
(a) Clinical data. 171
(b) Histological description. 172
(c) Preparation of tissue and
conditions of incubation. 174
(d) Investigation of the various
steroid fractions. 175
(e) Results. 175
(f) Discussion. 179
V. Summary and concluding remarks. 189
VXX]
Page No.
VI. Appendices. , 194
1. Preparation of Krebs-Ringer bicarbonate
glucose medium. 194
2. Sources of chemicals. 195
3. To achieve a reasonable extraction 
of neutral steroid sulphates and
phenolic steroids from incubation media. 197
4. To achieve a reasonable separation of
neutral and phenolic steroids after 
extraction from incubation media. 204
5. To assess the effect of an eluate from
an ecteola-coated plate pre-run in the 
solvent system 4M.Urea in 3N*NH^0H on 
the quantitation of DHA sulphate using 
methylene blue. 208
6. To assess the efficiency of elution of 
testosterone from a silica gel-coated
plate using ethyl acetate. 212
7. To assess the efficiency of elution of 
DHA sulphate from ecteola with ethyl
acetate and saturated NaCl solution, 214
8. To assess the efficiency of saponification
of testosterone acetate and the recovery 
of testosterone after thin-layer chromato­
graphy. 218
Page No
9, To investigate the counting efficiency
of 7a-^H DHA sulphate after ^^quenching” 
with methanol and also the degree of 
glass-sticking^: with lower levels of 
steroids used in this investigation. 220
10, Investigation of the loss of radio-
activity when 7cx- H androst-5-ene-diol 
is subjected to an oxidation reaction. 224
VII. References. 226
List of Plates.
1. Human interstitial cell tumour. 70
2. Sertoli cell tumour (1). 116
3. Sertoli cell tumour (2), 153
4. Sertoli cell tumour (3). 173
5 . Atrophic testis contralateral to
Sertoli cell tumour (3)• l8l
6. Atrophic testis from dog on
oestrogen therapy. 182
Page No,
List of Text-figures.
1. The conversion of cholesterol to
pregnenolone. 5
2. Biosynthesis of androgens in the
canine testis. 7
3 . Steroid sulphates as biosynthetic
intermediates. 12
4 . Formation of oestriol via 16a,-
-hydroxylated neutral steroids. 84
5 . Biosynthesis of steroid sulphates, 9I
6. Possible pathways to the formation
of oestriol via steroid sulphates. 95
7 . Possible pathways for steroid
biosynthesis in the dog testis. I30
8. Possible pathways to the formation 
of testosterone sulphate from DHA
sulphate. 166
List of Graphs,
1. The formation of testosterone, androst- 
enedione and androst-5-ene-diol from 
4„14c with time. 105
Classified list of Tables.
Incidence of testicular tumours
Table
Page No.
2. The formation of testosterone, 
androstenedione and androst~5™ 
-ene-diol from DHA
sulphate with time. 106
3 . The rate of transformation of 
4-^^C DHA and 7a-^H DHA 
sulphate,
4. The quantitation of DHA sulphate 
using methylene blue.
107
210
Human
Canine
1
2
25
29
Solvent systems employed. 
Steroid sulphates 
All steroids investigated
3
4
60
73
X X X
Table Page No.
Radioactivity assocxated with the various 
steroid fractions and individual steroids.
Interstitial cell tumour 5 & 6
Normal testicular tissue (l) 8
Sertoli cell tumour (1) 10
Normal testicular tissue (2) 12
Sertoli cell tumour (2) 15
Sertoli cell tumour (3) 18
75 & 81 
103 
124
134
157
176
Evidence for identification of steroids.
Interstitial cell tumour 
Normal testicular tissue (l) 
Sertoli cell tumour (l)
Normal testicular tissue (2) 
Sertoli cell tumour (2)
Sertoli cell tumour (3)
7
9
11
13
16
19
82
104
125
135
158
177
Comparative tables of conversion figures.
Sertoli cell tumour (l)/normal 
testicular tissue (2) 14 143
Table Page No.
Sertoli cell tumour (2)/normal
testicular tissue (1) 17 160
Sertoli cell tumours (1), (2) b*
(3)/normal testicular tissues
(1) b- (2) 20 178
Sertoli cell tumours (2) & (3)/
/normal testicular tissue (1) 21 186
II, Abbreviations used.
Trivial name Systematic name.
cholesterol: cholest-5-en-3p-ol.
cortisol: lip,17a,21-trihydroxypregn- 
-4-ene-3;20-dione.
pregnenolone : 3 p-hydroxypregn-5-en-20-one.
pregnenolone acetate: 3 p-acetoxypregn-5-en-20-one.
11-oxopregnanetriol; 3a,17a,20a-trihydroxy-5 p- 
-pregnan-ll-o^e.
17a-hydroxypregnenolone: 3 p,17a-dihydroxypregn-5-en-
-20-one.
17a-hydroxypregnenolone 
acetate:
3 p-acetoxy-17a-hydroxypregn- 
-5-61^ -20-one.
l6a-hydroxypregnenolone: 3 P,l6a-dihydroxypregn-5-en
-20-one.
progesterone : pregn-4-ene-3,20-dione.
17a-hydroxyprogesterone 17a-hydroxypregn-4-ene-3,20 
-dione..
X . V
Trivial name. Systematic name.
16a-hydroxyprogesterone: l6a-hydroxypregn-4-ene-3,20'
-dione.
DHA. 3 p-hydroxyandrost-5-en-17“One.
DHA acetate: 3 p-acetoxyandrost-5-en-17-one.
androst-5-ene-diol: androst-5-ene-3 17p-diol
androst“5-ene-diol 
diacetate :
androst "5-ene--3 p, 17p-
"diacetate.
androst-4-ene-diol: androst-4-ene-3 p,17p-diol
androstenedione androst-4-ene-3,17-dione.
testosterone : ,17p-hydroxyandrost-4-en-3-one.
testosterone acetate: 17 p-acetoxyandrost-4-en-3-one.
llp-hydroxyandrostenedione: llp-hydroxyandrost-4-ene-
-3,17-dione.
adrenosterone: androst-4-ene-3 j H ,17-trione.
11p-hydroxyandrosterone: 3a,llp-dihydroxy-Sa-androstan-
-17-one.
XVI
Trivial name. Systematic name.
11"Oxotestosterone: 17 p-hydroxyandrost-4-ene- 
“3,ll“dione.
11-oxotestosterone 
acetate ;
17 p-acetoxyandrost-4-en.e- 
-3,11-dione.
oestrone: 3-hydroxyoestra-l,3,5(10) 
-trien-17-one.
oestrone acetate; 3-acetoxyoestra-l,3,5(10)- 
-trien-17-one,
oestrone-3-methyl ether: 3-methoxyoestra-l,3,5(10)
-trien-17-one,
oestradiol-17p: oestra-1,3,5(10)-triene 
“3,17 p—diol.
oestradiol-17 p-diacetate: oestra-1,3,5(10)-triene
“3,17 p-diacetate.
oestradiol“17 p-3 
-methyl ether :
3-methoxyoestra-l,3,5(10) 
-trien-17 p-ol,
oestradiol-17a: oestra-1,3,5(10)-triene- 
— 3,17a—diol.
X V X l
Trivial name. Systematic name.
oestradiol-iya-diacetate: oestra-1,3,5(10)-triene-
“3,17a-diacetate.
oestriol: oestra-1, 3 , 5 (lO) -triene- 
-3,16a,17 p-triol.
oestriol triacetate: oestra-1,3,5(10)-triene 
-3,16a,17 p-triacetate.
oestriol-3-methyl ether: 3’-iïi©bhoxyoestra-l, 3, 5 (lO)
-triene-16a,17 p-diol.
equilenin: 3-hydroxyoestra-l, 3, 5 (10),- 
6 , 8 (9 ) -pentaen-17-one,
diethylstilboestrol: 3,4-bis(p-hydroxyphenyl) 
—3™hexene.
cholesterol sulphate: cholest-5-ene-3 p-sulphate.
pregnenolone sulphate: 3p-sulphoxypregn-5-en-
— 20 — one «
17a-hydroxypregnenolone
sulphate:
3 p-sulphoxy-17a-hydroxypregn- 
— 5 — en—20—one.
16a-hydroxypregnenolone 
sulphate :
3 p-sulphoxy-16 a-hydroxypregn 
— 5 — en—20—one .
xvii
Trivial name. Systematic name.
16a,17a“dihydroxypregnen- 3 p-sulphoxy-l6a ,17a-dihydroxy- 
clone sulphate: pregn-S-en-20-one.
DHA sulphat e: 3 p-sulphoxyandrost-5-en- 
-17-one.
16a-hydroxy-DHA sulphate 3 p-sulphoxy-l6a-hydroxy- 
androst-5-en-17-one.
androst-4-ene-diol 
sulphate:
one or more of the sulphated 
forms of androst-4-ene-diol.
androst-5-ene-diol 
sulphate:
one or more of the sulphated 
forms of androst-5-ene-diol.
androst-5-ene-diol-3
-sulphate:
3 p-sulphoxyandrost-5-en-
—17 p—ol•
testosterone sulphate 17 p-sulphoxyandrost-4-en- 
-3-one.
oestrone sulphate: 3-sulphoxyoestra-l,3,5(10) 
-trien-17-one.
oestriol-3--sulphate 3-sulphoxyoestra-l,3,5(10) 
-triene-l6a,17 p-diol.
Trivial name Systematic name.
I.G.S.H,: Interstitial cell stimulating 
hormone.
F.S.H.: 
A.C.T.H.:
Follicle stimulating hornone.
Adrenocorticotrophic hormone.
Testicular Tumour Panel: Testicular Tumour Panel and 
Registry of the Pathological 
Society of Great Britain and 
Ireland in association with 
the British Empire Cancer 
Campaign for Research.
ATP: adenosine 5^-triphosphate.
NADP: nicotinamide-adenine 
dinucleotide phosphate.
dpm: disintegrations per minute.
B.C. : Enzyme Commission number (see 
"Enzyme Nomenclature" Elsevier 
Publ. Co., Amsterdam, 1965).
Ill. Introduction.
Tumours arising in mammalian endocrine tissues 
provide the endocrinologist with material that may help 
to throw further light on the metabolism of the cancer 
cell and on the enzymic activity of a particular cell 
type which would otherwise prove very difficult to 
isolate in the pure state owing to the particularly 
close association that dissimilar cells often have 
with each other. Such is the case with Sertoli cells, 
the spermatogenic epithelial elements and Leydig cells 
in the mammalian testis. In addition, if a particular 
tumour arises in more than one species of animal a 
unique comparative study is thus made available.
Such a situation presents itself in the case of 
testicular tumours occurring in man and dog where 
neoplasms of one particular cell type do occur and are 
histologically so similar in the two species as to 
provide difficulty in their differentiation.
Certain of these testicular tumours are associated 
with obvious clinical signs of hormonal imbalance in 
the host indicating a probable derangement of testicular
enzyme systems. It was thus considered a worthy 
project to investigate the steroidogenic ability of 
those tumours of the testis that were associated with, 
in particular, feminization in man and dog.
An outline is presented below of the Imowledge 
accrued since early times of testicular function in 
relation to its endocrine status and of the pertinent 
data on testicular tumours in man and dog where signs 
of hormonal dysfunction are clinically manifest.
The testis has been associated with "maleness" 
since ancient times as indicated by the castration of 
men (St. Matthew, Ch.19, v.l2) and his domestic 
animals (Aristotle, c. 344 B.C., a) and the changes 
observed in appearance and behaviour thereafter 
(Aristotle, c. 344 B.C., b) .
John Hunter (1794) was probably the first to 
demonstrate experimentally the hormonal activity of 
the testis by grafting a rudimentary spur from a hen 
on to the leg of a cock and noting its development into 
a strong masculine appendage. The small spur from a 
young cock, however, underwent a very much slower 
development when implanted into a hen^s leg.
Berthold (1849) showed that comb-shrinkage following
castration could be counteracted by testicular trans­
plantation into other parts of the body. Other workers 
(Loewy, I903; Walker, I9O8,a,b; Pezard, I9II) have 
also demonstrated the masculinizing properties of 
testicular extracts in poultry.
The isolation of an androgenic substance from 
bulls’ testes (McGee, 1927) started the investigations 
into the chemical nature of testicular hormones and 
the process of their biosynthesis. Testosterone was 
identified by David, Dingemanse, Freud & Laqueur (1935) 
while evidence was provided by the early perfusion 
studies of Danby (1937, 1938, 1940) that this was the 
main androgen secreted by the testis of the bull. She 
postulated that it could be formed from DHA, androstene­
dione and androst-5-ene-diol. Testosterone was 
eventually shown to be a secretory product of the 
testis of the dog (West, Hollander, Kritchevsky & 
Dobriner, 1952) and of man (Lucas, Whitmore & West, 1957).
The idea that cholesterol might be a precursor of 
the steroid hormones developed as the chemical structures 
of the hormones isolated from the steroid producing 
glands were found to be perhydrocyclopentenophenanthrene 
derivatives bearing an obvious chemical relationship to
cholesterol. The work of Werbin & LeRoy (1954),
Zaffaroni, Hechter & Pincus (1951), Werbin, Plotz,
LeRoy & Davis (1957), Ungar Dorfman (1953), Bloch 
(1945) and others has shown that cholesterol is a 
common precursor of virtually all of the known steroid 
hormones. Enzymic cleavage of its side-chain yields 
isocaproic acid and pregnenolone (Staple, Lynn & Gurin,
1956) (Text-fig. 1). Pregnenolone had previously been 
isolated from testicular tissue by Ruzicka & Prelog (1943)*
The advent of isotopically-labelled steroids in the 
1950’s allowed for more intimate investigations into the 
biosynthesis of testicular hormones. Carbon-labelled 
acetate was shown to be converted to cholesterol when 
incubated with rat testicular tissue in vitro (Srere,
Chaikoff, Treitman & Burstein, 1950). Brady in the 
following year reported the ability of this same tissue 
to synthesize testosterone from acetate
and suggested that cholesterol may not be an obligatory 
precursor of testosterone. Hall (19^3, 1966), on the other 
hand, has provided evidence that cholesterol is an intermediate 
in the biosynthesis of testosterone by rabbit testicular 
tissue and that interstitial cell stimulating hormone
T e x t - f  i g u i ' e  1 .
CHC h o l e s t e r o l
CH
CH
H O
CH
c=o
Pregneno lo ne
4-
isocaproic acid
COOHlCHglgCH^
/ C H g
CH
acts between cholesterol and pregnenolone formation.
The enzyme system 3 p-hydroxysteroid dehydrogenase- 
-isomerase^ necessary to convert pregnenolone to 
progesterone (Text-fig. 2^  reaction 1) has been 
demonstrated in rat testicular tissue by Samuels, 
Helmreich, Lasater & Reich (1951). The further 
conversion of this compound was shown to be possible 
by the enzyme studies of steroid oxidations (Lynn &
Brown, 1956). These authors showed the presence of 
17a-hydroxylase, 17a-hydroxypregnene C^^-C^Qlyase and 
17(3-hydroxysteroid dehydrogenase enzymes in rat 
testicular particles. Slaunwhite & Samuels (1956)
formulated a biosynthetic pathway for the production 
of testosterone by testicular tissue. Progesterone 
is converted to 17o.-hydroxyprogesterone (reaction 2), 
side-chain cleavage forms androstenedione (reaction 3) 
and then the reduction of this compound to testosterone.
A second pathway was proposed by Kahnt, Neher, Schmid 
& Wettstein (1961) after the suggestion by Glen &
Heftman (1951) and Savard & Lorfman (1954) that DHA 
might be an intermediate in the synthesis of testosterone. 
They postulated that pregnenolone was converted to 
17a”hydroxypregnenolone (reaction 5 ) ,  and the side-chain
T e x t - f i g u p e  2 .
B I O S Y N T H E S I S  OF A N D R O G E N S  
I N  T H E  C A N I N E  T E S T I S .
P r o g e s t e r o n ePreg n e n o l o n e O
HO
CHÇH3
1 7oi O H  Pregnenolone q- q 1 7ol OH Progesterone C—O
- O H- O H
HO
D H A O
HO
Androst-S-ene-d io l OH
HO
M/
Androstenedione
O
10
Vi/
Testosterone oH
was then removed to form DHA which is then converted 
to androstenedione (reactions 6 & 10) and finally to 
testosterone by reaction 4.
The existence of these pathways has been 
substantiated by the in vivo and in vitro studies of 
Eik-Nes and his co-workers, Eik-Nes & Kekre (1963) 
suggested that the conversion of pregnenolone to 
17a-hydroxypregnenolone might be more important in th*^  
dog testis than the formation of progesterone^ a steroid 
hormone^ from pregnenolone^ and then use the route from 
17a-hydroxypregnenolone to 17a-hydroxyprogesterone 
(reaction 9) both of which steroids have low biological 
activities. Hagen & Eik-Nes (1963  ^ 1964a) reported 
the conversion of 17a-hydroxypregnenolone to 17a- 
-hydroxyprogesterone with the formation also of DHA, 
androstenedione and testosterone. These same authors 
(1964b) showed that DHA was metabolized at a faster 
rate than 17a-hydroxyprogesterone to androstenedione 
and suggested that the latter steroid was not an 
obligatory intermediate in the formation of testosterone 
Rosner, Hosita & Forscham (I964) suggested androst-5- 
-ene-diol as an intermediate. This steroid has been 
shown to be converted to testosterone by placental and
adrenal tissue (Baulieu, Wallace & Lieberman, 19^3)
and recently by Slaunwhite & Burgett (1965) using
rat testicular homogenates. These authors suggested
that DHA is not an important intermediate in testosterone
biosynthesis being rapidly converted to androstenedione
which, in this particular preparation, does not rapidly
form testosterone. Equilibrium between androstenedione 
and testosterone was not achieved in this tissue even
after 3 hr. incubation and at that time the former
was found to be present in greater amounts. They also
suggested that 17a-hydroxypregnenolone may be converted
to androst-5-Gne-diol without the intermediation of DHA.
Fevold and Eik-Nes (I963) have demonstrated the 
presence of 20a and 20p hydroxysteroid-dehydrogenases 
in testicular tissue and were able to isolate the 20a 
and 20p reduction products of progesterone and 17a- 
-hydroxyprogesterone from their incubations with 
testicular tissue, Ellis & Berliner (I965) also 
reported the isolation of 17a,20a-dihydroxypregn-4- 
-en-3-one and the transformation of this steroid into 
testosterone.
The studies of Kase, Forchielli & Dorfman (quoted 
by Dorfman, I963) indicate a pathway from progesterone
to testosterone via testosterone acetate. These
o
authors found that the incubation of 7a- H proge­
sterone and 17a-hydroxyprogesterone with a
homogenate prepared from human polycystic ovaries 
yielded testosterone containing a higher ratio of 
than that found for the androstenedione 
simultaneously formed. This strongly suggests that 
testosterone could be formed from progesterone without 
the intermediation of either 17a-hydroxyprogesterone 
or androstenedione. Fonken, Murray & Reineke (I96O) 
established this supposition by isolating 21-^^C testo­
sterone acetate during the transformation of 
21-^^C progesterone to testosterone by Cladosporium 
resinae. Had the pathway involved 17a-hydroxylation 
of progesterone and side-chain splitting the testosterone 
acetate isolated would not have borne the ^^C-label. 
Testosterone incubated with the microorganism did not 
give testosterone acetate. Forchielli, Gut & Dorfman 
(1961) described the direct conversion of progesterone 
to testosterone acetate by the formation of an epoxy 
bridge between carbons 17 and 20 of progesterone and 
the simultaneous rupture of the direct linkage between 
these two carbons. To examine the possibility that
17 a,-hydr oxyprogest er one might not be an obligatory 
intermediate in the formation of testosterone from ‘ 
progesterone, Forchielli et al. (I96I) incubated
progesterone containing tritium in the 17a-position 
with homogenates of rat testes and found that the 
testosterone isolated was in fact tritiated. The 
isotope was in the 17a,-position to indicate, by its 
disappearance or otherwise from the steroid molecule, 
whether oxidation to androstenedione had occurred 
prior to testosterone formation.
The demonstration of sulphation of steroids in 
endocrine tissues (Baulieu, 1962; Sneddon & Marrian,
1963; Wallace & Lieberman, I963); suggested the possibility 
of new pathways for steroid hormone biosynthesis via these 
conjugates. That biosynthesis could proceed via the 
intact steroid sulphates was demonstrated by Calvin, 
VandeWiele & Lieberman (I963); Calvin & Lieberman (I963); 
and Roberts, Bandi, Calvin, Drucker & Lieberman (1964a,b) 
(Text-fig. 3)• It has been demonstrated moreover, that 
the dog testis is able to convert DHA sulphate to testo­
sterone and androstenedione in vivo (Aakvaag, Hagen &
Eik-Nes, I963).
Calvin et al. (I963) have pointed out that the 
regulatory processes determining end-product formation 
and their amounts are, as yet, not understood. The
T e y t - f i g i i r e  3 .
S t e r o i d  s u l p h a t e s  as b i o s y n t h e t i c  i n t e r m e d i a t e s .
c = o
HO
HO
HO
Cholesterol sulphate
Pregnenolone sulphate
] 7o<—hydroxypregnenolone 
sulphate
D H A  su lphate
enzyme systems responsible for the various conversions 
indicated above are intimately involved with this control. 
Derangement of any one, or more, of these systems may 
provide for the non-production of a particular inter­
mediate or in the formation of an abnormal hormone and 
the development of clinical syndromes.
The 3P”Sulphoxysteroids isolated provide for 
further possibilities for consideration as loci where 
derangement can occur.
These steroids and their enzymes will be discussed 
further in the light of the findings from the investi­
gations of steroid biosynthesis in testicular tumours 
presented herein.
The question has inevitably arisen as to which of 
the testicular cells are responsible for the synthesis 
and secretion of these steroid hormones. Histologically 
the testis may be divided into seminiferous tubules and 
the interstitial cells of Leydig. The latter are 
disposed in a connective tissue stroma between the 
tubules and are permeated by a capillary network.
Ancel & Bouin (1903a, 1904a,b) appear to have been
among the first to investigate the problem of the site 
of production of the testicular hormone. They observed
in horses, dogs and pigs the degeneration of seminal 
epithelium of retained testes without immediate 
atrophy of the accessory gential organs and without 
degeneration of the interstitial tissue. Ligation 
of the efferent ducts caused complete disappearance 
of the seminal epithelium without the animals losing 
their masculinity. The work suggested that the 
interstitial cells were responsible for male hormone 
production. Moore (1932) recorded that an abdominal 
testis was secreting twice as much androgen as a 
normal testis and it contained no seminiferous cells. 
Moore & Samuels (1931) working on the converse showed 
involution of the prostate and seminal vesicles when 
atrophy of the interstitium had been induced by a 
deficient diet. The excretion of 17-oxosteroids and 
the development and condition of secondary sex 
characteristics parallel histologic and cytologic 
evidence of secretory activity by the interstitial 
cells (Albert, Underdahl, Greene & Lorenz, 1955) •
Exposure of the testes to x-rays was noted, at the 
turn of the century, to produce sterility, without 
impairing androgenic function. Tandler & Grosz (1912) 
observed that an irradiated roe-deer became infertile
but cast its antlers and subsequently regenerated them 
in the normal way. Nemenov (1916) destroyed the 
germinal epithelium of a dog without affecting the 
development of the prostate. A more quantitative 
investigation by Abbott (1959) showed a very rapid 
drop in weight of the testes of rats exposed to high 
doses of x-rays which was associated with complete 
destruction of the seminal line but with normal 
intertubular tissue and accessory organs. Copulatory 
activity remained normal.
Many other types of destructive procedures have 
been used to remove a particular cellular element 
including so-called "Cadmium-castration^*. Parizek
(i960) showed permanent destruction of the Sertoli and 
germinal cells but the Leydig cells eventually recovered 
along with a rise in androgenic activity. This 
regeneration has been observed biochemically (Favino, 
Baillie & Griffiths, I966).
Spontaneous failure of the seminiferous tubules 
has been recorded as in the syndrome described by 
Klinefelter, Reifenstein &■ Albright (1942) in which the 
patient presents with small testes containing hyalinised 
tubules but abundant Leydig cells, azoospermia and high
gonadotrophin excretion, Heller & Nelson (1945)
stressed the histological normality of the Leydig
cells, the frequent association of complete tubular 
failure and yet normal masculinity of the men.
Histochemical techniques (Kunze, 1922; Pollock, 
1942) applied to investigations of the distribution 
of testis lipids have revealed, in almost every 
instance studied, that the testis cholesterol is 
localized predominantly in the interstitial cells. 
Pollock (1942) suggested a relationship between the 
location of "ketosteroids" in the interstitial cells 
to testosterone content. Pearlman (1950), on the 
other hand, found no apparent relationship between 
changes in testis cholesterol and interstitial cell 
function, but did suggest that the cholesterol might 
be localized predominantly in the seminiferous tubules,
Huggins & Moulton (1948) found a linear correspon­
dence between the esterase activity of the Leydig cells 
and their androgen production. Wattenberg (1958)
localized the 3p-hydroxysteroid dehydrogenase enzyme 
only in the interstitial cells of Leydig after he had
I
incubated testis slices from the albino rat with 
pregnenolone and DHA. This latter work has since been
confirmed many times (Baillie, Niemi & Ikonen, 1965;
Baillie & Griffiths, I964; Niemi & Ikonen, I963;
Steinfoerger, Steinberger & Vilar, I966). Niemi &
Ikonen (I963) related the esterolytic activity with
the activity level and distribution of the 3 p-hydroxy-
steroid dehydrogenase. On a purely histochemical \
basis Niemi, Harkonen & Ikonen (I966) showed that the
esterase (hydrolase) activity of the Sertoli cells
differs markedly from that of the interstitial cells.
The former, an acetic-ester hydrolase (E.G. 3-l»l*6)
has a substrate preference for indoxyl acetate rather 
than naphthyl acetates. The esterase activity of
the interstitial tissue falls into the acetic-ester
hydrolase type (E.G. 3*1*1*6). Hypophysectomy results
in a rapid decrease of some oxidative enzyme activity
including that of 3 p-hydroxysteroid dehydrogenase of
the interstitial tissue (Niemi & Ikonen, I962), whereas
the two types of nonspecific esterase activity responded
quite differently (Niemi et al., I966). The acetic-
-ester hydrolase activity in the interstitial cells
decreased rapidly after cessation of the gonadotrophin
stimulation, whereas the acetic-ester hydrolase activity
occurring in both the Sertoli and interstitial cells
increased. On the basis of their results Niemi et al. 
(1966) concluded that there are two functionally 
different categories of esterases (hydrolases) in the 
testis tissue; one sensitive to gonadotrophin 
stimulation which can be demonstrated chemically with 
p-nitrophenyl propionate as substrate and which is 
related to steroid biosynthesis and another non­
specific hydrolase which utilizes p-naphthyl acetate 
and which is not connected with the endocrine function 
of the testis and hence is not affected by hypo­
physectomy. This latter fraction is dependant upon 
the amount of the interstitial connective tissue and 
Sertoli cells but independant of the number or functional 
state of the Leydig cells or germ cells.
Christensen & Mason (I965) isolated Leydig cells 
and seminiferous tubules from rat testis and incubated 
each with 4-^^C progesterone. They found that both 
tissues were capable of transforming this steroid to 
17a-hydroxyprogesterone, androstenedione and testosterone 
although the interstitial tissue was considerably the 
more active. This work confirmed the histochemical 
findings cited above that the interstitial cells are 
the principle site of androgen production in the testis
but showed also the ability of the seminiferous 
tubules to transform steroids and synthesize 
androgens in vitro probably to the extent of 10^ 
of the total androgen production of the testis.
Oestrogenic activity of testicular extracts 
was shown as early as 1921 by Fellner and shortly 
afterwards in male urine (Lacqueur, Dingemanse,
Hart & de Jongh, 1927). The phenomenally high 
levels of oestrogenic activity in stallions^ urine 
was shown initially by Kust (1932) and two years 
later oestrone was isolated from this source 
(Haussier, 1934; Deulofeu & Ferrari, 1934). The 
involvement of the testis in the production of these 
oestrogens was again emphasised by Zondek (1934) 
who demonstrated a far greater activity in the urine 
from stallions than that from geldings. The actual 
isolation of oestrone and oestradiol-17p in crystalline 
form from horses^ testes was achieved by Beall (1940).
Direct evidence for the testicular formation of 
oestrogens was demonstrated using homogenates in the 
horse (Baggett, Engel, Balderas & Lanman, 1959) and 
by Nyman, Geiger & Goldzieher (1959) who perfused 
testes with acetate-l-^^C and showed the production
of radioactive oestrone and oestradiol-17p.
The site of origin of oestrogens in the testis 
is still in dispute. A tubular origin has been 
suggested by the occurrence of oestrogens in semen 
(Diczfalusy, 1955) whilst preparations of human semen 
were shown to cause an enlargement of the uterus when 
injected into immature rats (Green-Armytage,
Silberstein & Wachtel, 1947).
The production of a hormone, distinct from the 
androgens, by the germinative epithelium was suggested 
by the parabiotic experiments of Martins & Rocha (1931)• 
McCullagh (1932) designated this hormone "inhibin" 
and showed it to have pituitary-inhibiting properties 
quite distinct from the androgens. Klinefelter et al. 
(1942) pronounced a "dual hormone theory of testis 
physiology" there being a second hormone from the 
germinal epithelium which is very similar to an 
oestrogen. Tornblom (1942) demonstrated that in 
castrated rats testosterone would cause growth of 
the prostate yet not prevent pituitary hypertrophy. 
Howard, Sniffen & Simmons (1948) proposed that a 
gonadotrophin, presumably equivalent to FSH, 
stimulates the Sertoli cells which secrete a hormone
that provokes spermatogenesis, inhibits the production 
of FSH and probably influences the secretion of ICSH. 
Lacy (1962) whilst working on the regulation of the 
spermatogenic cycle in the mammalian testis described 
a metabolic cycle of the Sertoli cells which was 
dependant upon spermatogenesis and synchronised with 
it. He studied by light and electron microscopy 
the phagocytosis of "residual bodies", first described 
by Regaud (I90I), by the Sertoli cells followed by an 
increase in their lipid content. This lipid gradually 
disappeared during the next five stages of the 
epithelial cycle, becoming minimal at stage fourteen 
(Leblond & Clermont, 1952). Lacy (1962) considered 
this disappearance to be indicative of hormone-release 
which influenced spermatogenesis. He suggested that 
the "residual bodies" initiate or accelerate steroid 
synthesis by the Sertoli cells. The Sertoli cell 
hormone (SCH) is then utilized during spermatogenesis 
and its synthesis and/or release is dependant upon 
FSH. That spermatogenesis requires androgens has been 
shown (Boccabella, 1963) and that the seminiferous 
tubules are capable of their synthesis (Christensen 
& Mason, I965) may provide for tubular function
indépendant of the biosynthetic products of the 
Leydig cells. Christensen & Mason (1965) were 
unable to demonstrate the formation of either oestrone 
or oestradiol“17P from progesterone, testosterone or 
androstenedione during incubation studies with 
separated seminiferous tubules and Leydig cells from 
rat testes.
Leach, Maddock, Tokuyama, Paulsen & Nelson
(1956) maintain, on the other hand, that oestrogen 
excretion is a better index of Leydig cell function 
than is androgen excretion. Maddock & Nelson (1952) 
administered chorionic gonadotrophin to men and found 
a two-fold increase in urinary 17-oxosteroids as 
compared with an elevation of oestrogen five to sixteen- 
-fold in conjunction with hyperplasia of the Leydig 
cells.
Electron micrograph studies of testicular cells 
have produced equivocal results with regard to 
morphological correlation with endocrine function. 
Christensen & Fawcett (I96I, I966) and Christensen
(1963) postulate that the abundant agranular endo­
plasmic reticulum of the Leydig cells of the opossum, 
mouse and guinea pig testis respectively indicates 
that this is the site of at least part of steroid
hormone production in the light of the findings of 
Lynn & Brown (1958) that the microsomal fraction of 
guinea pig testis homogenates contained at least two 
ribonuclease-stable enzymes involved in androgen 
biosynthesis. The enzymes for the metabolism of 
progesterone in the mouse testis are found mainly in 
the microsome fraction (Murota, Shikita Tamaoki,
1965)• It is agreed that the microsome fraction 
derives predominantly from the endoplasmic reticulum 
of intact cells and thus Christensen & Fawcett (I966) 
conclude that the enzymes necessary to transform 
progesterone to 17a~hydroxyprogesterone, androstenedione 
and finally testosterone are presumably associated with 
the abundant agranular endoplasmic reticulum of mouse 
interstitial cells. The mitochondria of these cells 
contain the tubular cristae that are typical of 
mitochondria in many steroid-secreting cells (Belt & 
Pease, 1956).
Brbkelmann (I963), on the other hand, demonstrated 
that the Sertoli cells of the rat testis also contain 
an agranular endoplasmic reticulum, mitochondria with 
tubular cristae, lipid droplets and/or inclusion 
bodies resembling lysosomes, which picture, he suggests.
fits in well with the cytoplasmic morphology of 
steroid-producing cells.
Signs of abnormal hormonal production are often
associated with testicular tumours in man and dog and
have been hailed by many investigators as indicating 
the steroidogenic ability of the parent cell, with
some equivocy of interpretation.
Neoplasia of the testis in man is rare, occurring 
at a rate of 2.3 per 100,000 males (Collins & Pugh, 
1964) with an annual incidence of 550 to 600 new cases 
in the United Kingdom. Dixon & Moore (1952) 
attributed 0.64^ of all male cancer deaths in the 
United States of America to this cause, while the 
comparable rate for this country in 1938-39 was 
0 .52^ (Harnett, 1952). Signs of hormonal imbalance 
have frequently been found in conjunction with 
interstitial tumours of the testis in man. The 
possible dual role that the Leydig cell may play in 
normal steroid synthesis is indicated by the two 
diametrically opposite forms of endocrine disorder 
with which tumours of this cell type are associated. 
Its occurrence is rare; 1.4^ of the testicular 
tumours examined by the Testicular Tumour Panel
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(Collins & Cameron, I964) were of this type and 
1.2% in the series of Dixon & Moore (1952). The 
Panel reported 43% of this group to be associated 
with gynaecomastia in adults, indicating feminizing 
tendencies (Table 1.). This same growth occurring 
in the juvenile testis would appear to be almost 
invariably associated with precocious sexual develop­
ment . The children generally present with macro­
genitosomia, pubic hair, deepening of the voice,
precocious muscular and skeletal development and 
psychosexual precocity. Acne is sometimes noted.
Bishop, Van Meurs, Willcox & Arnold (I96O) reported
such a case in an 11 yr. old boy and reviewed 25
further cases from the literature. Levels of
urinary 17-oxosteroids in those cases where estimations
were recorded, were found to be elevated. The sexual
precocity has been ascribed to "associated congenital
adrenal hyperplasia" (Abelson, Bulaschenko, Trommer
& Valdes-Dapena, 1966). These authors suggest that
probably the tumour itself results from ACTH stimulation.
In a few instances testicular tumours in children have
been associated with Cushingfs syndrome (Hamwi, Gwinup,
Mostow & Besch, 1963; Crouch, 1958; Engel, McPherson,
Fetter & six others, 1964)•
Endocrine features, if any, arising in the adult 
in association with the interstitial cell tumour are 
gynaecomastia, decreased libido and impotence. It 
has been suggested that androgenic manifestations, as 
occur in children with this type of neoplasm, cannot 
occur in the adult as full virilization is already 
present. It is not clear whether the mammary 
hypertrophy is due to tumour oestrogens, testicular 
androgen stimulated by tumour gonadotrophins 
(Gabrilove, Sharma, Wotiz & Dorfman, I965) or tumour 
androgens acting directly on the breast, In the 
case described by Abelson et al. (1966) the moderate 
rise in urinary oestrogens was not associated with 
gynaecomastia. The levels of urinary 17-oxosteroids 
were, however, abnormally high and fractionation 
revealed that both 11-oxygenated and 11-deoxy steroids 
were increased. The presence of llp-hydroxylase, 
considered previously to be a specific enzyme of the 
adrenal cortex, has been described (Savard et al., I960; 
Dominguez, 1961; Smith, Breuer & Schriefers, I964) in 
testicular tumour tissue, Besch, Watson, Barry,
Hamwi, Mostow & Gwinup (I963) considered the testicular 
tumour they investigated, which was shown to synthesize
cortisol, was of adrenocortical origin.
Sertoli cell tumours of the human testis occur 
less frequently than in the dog; 6 out of 995 
testicular tumours were so described by the Testicular 
Tumour Panel (Collins & Symington, I964) (Table l).
One patient, aged 27 yr., also had enlargement of the 
breasts. Gynaecomastia has been reported previously 
to be associated with this tumour (Ostergaard, 1947; 
Teiluni, 1949 > 1958; Jones b" Friedman, 1950; Lewis 
& Stockard, 195.0; Fuglsand & Ohlsen, 1957) •
The occurrence of testicular tumours in the dog 
is high. Dow (1962) found 16^ of 580 unselected 
dogs examined at the Glasgow University Veterinary 
Hospital to be so affected, whilst Cotchin (1954) 
reported 5.8% of 2,j6l canine tumours to be of the 
male gonad. It is of interest that all testicular 
tumours in the dog are of Sertoli, interstitial or 
spermatogonial cell origin. The absence of teratomas 
has been the striking feature of all published 
surveys of canine testicular tumours. The relative 
incidence, respectively, of these three types of 
tumour in the dog is given as 39^^ 60^ and 48^ by 
Dow (1962) and 49%^ 17% and 34-^  by Cotchin (I96O) .
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Both authors found bilateral and multiple tumour 
involvement of testes to be high. Table 2 summarizes 
their findings ^ and Table 1 indicates the relative 
incidence of some human testicular tumours and the 
frequency of malignancy and endocrine effects.
The frequency with which clinical signs of
hormonal imbalance are associated with testicular
tumours in dogs is an outstanding feature of
testicular cancer. The canine Sertoli cell tumour
has attracted particular attention in this respect
and has been used in evidence for the hypothesis
that the parent cell is the site of elaboration of
oestrogens in the normal gland. The changes that
0 - 1  l J u . c L e _ d L ^
occur in those dogs thus affected have been -eluded 
to many times ('Greulich & Burford, 1936 ; Zuckerman 
& Groome^ 1937 ; Zuckerman & McKeown^ 1938; Innes^ 
1942). The feminization is manifested by enlargement 
of the teats^ with or without mammary hypertrophy^ 
and attractiveness to other male dogs, The glands 
may secrete a serous or milky fluid in extreme cases.
The posture adopted for micturition may change from
the three-legged stance of the male to the squatting
position of the bitch. The animal is generally
presented for professional advice when the owner 
observes abnormal skin and coat changes which are 
common indications of the syndrome. The hair begins 
to fall out from the region of the ventral thorax and 
abdomenj the posterior and lateral aspects of the 
thighs and occasionally where there is friction as in 
the neck and shoulder area. The distribution of 
hair loss may become quite widespread and is bilaterally 
symmetrical. The skin is usually thin and velvetty 
in texture but may^ on the other hand, be thick and 
tough, and show, on histological examination, a great 
increase in collagenous fibres characteristic of 
scleroderma fBrodey & Martin, 1958). A diffuse, 
dusky, purple pigmentation is also noted in these 
areas. Quite often the dog will indicate a general­
ized pruritus by scratching excessively. In many 
animals the prepuce becomes flaccid, pendulous and 
oedematous. There are varying degrees of penile 
atrophy and loss of libido and energy. Marked 
deposition of fat of female disposition is often noted. 
The prostate gland varies from being enlarged and 
hyperplastic to distinct atrophy. Cyst and abscess 
formation are not uncommon. Squamous metaplasia of
the prostatic epithelium and of the posterior urethra 
is a common’finding at autopsy.
Mulligan f1944) drew attention to the points of 
similarity in the symptom-complex of feminization 
associated with carcinoma of the testis and the effects 
produced by oestrogens in male dogs. He recorded 
partial atrophy of the thyroid and adrenal cortex as 
well as of the non-tumorous testis with arrest of 
spermatogenesis. Previously, Gardner & De Vita (1940) 
had shown the inhibition of hair growth in dogs after 
the administration of oestrogens, whilst other tissue 
changes and a comprehensive coverage of the literature 
has been provided by Jabara (1962). The conclusions 
drawn from these observations were that Sertoli cell 
tumours of the canine testis may elaborate and secrete 
oestrogens, thus laying the main emphasis on the 
Sertoli cell as the site of oestrogen production in 
the normal testis. Values of up to 70 p.g. of a 
substance, expressed as a-oestradiol, have been 
extracted from 1 Kg, of Sertoli cell tumour tissue 
(Huggins & Moulder, 1945)- These levels were compared 
with the 34 Pg./Kg. of a-oestradiol which was extracted 
from canine ovarian tissue at the time of oestrus.
o o
The findings of Mulligan (1944) and Brodey &
Martin (1958) of thyroid gland atrophy provoked the 
latter authors to suggest that the sluggish behaviour 
observed in these animals may have been caused by the 
effect of excess oestrogens on this gland. The size 
of the tumours found in relation to the development 
of feminization, was commented upon by these authors, 
being 2 - 3  times that of the tumours in non-feminized 
dogs. The incidence of hormonal dyscrasia was also 
found to be higher when the neoplastic testis was ■ 
ectopic (Scully & Coffin, 1952; Dow, 1962).
Interstitial cell tumours of the canine testis 
have also been reported to be associated with 
feminization. Cotchin (1960) found at least 1% of 
the group of tumours he describes under this heading 
as being hormonally active (Table 2). Laufer &
Sulman (1956) reported an oestrogenic Leydig cell 
tumour with multiple métastasés, and discussed the 
problem of bisexual hormone production by gonadal 
cells. Kahan (1955) reported skin troubles, including 
alopecia, in a 7 yr. old Brittany Spaniel which 
developed feminization. The dog was castrated and 
recovery ensued. It appears from the literature that
this particular type of tumour is associated with 
endocrine changes in man far more frequently than in 
the dog; an interesting reversal of the situation 
when compared with the last tumour type.
The correspondence of tumour types in the testes 
of dog and man has suggested to many that the former 
could well be used as a model in the study of 
malignant growths in the latter. Innes (1942)
considered that the serious prognostic outlook 
usually adopted for human cases of testicular tumour 
is not applicable to dogs, most of which survived 
for at least two years after orchidectomy without 
any sign of ill-health. He suggested that a 
carcinoma in the dog which is histologically identical 
with the human variety does not behave in the same 
malignant way. Dow (I962) found métastasés in 9% 
of the canine seminomas he examined, and in 14^ 
of the Sertoli cell tumours (Table 2). Brodey & 
Martin (1958) found 11^ of the latter type to be 
malignant. The corresponding figures provided by 
Cotchin (Table 2) are considerably smaller. Coffin, 
Munson & Scully (1952) considered a malignant Sertoli 
cell tumour from a dog to be of sufficient interest
to be reported.
Malignancies occurring in human cases of 
testicular tumour reported by the Testicular Tumour 
Panel (Pugh & Cameron, I964) are shown in Table 1. 
Interstitial cell tumours in this species are 
generally considered benign but Dalgaard & Hesselberg
(1957) estimated that 10^ may pursue a malignant 
course. The reports of Masson & Sencert (1923)  ^
Venning (1942), Nation, Edmonson & Hannack (1944); 
Gharpure (1950), Tedeschi & Burke (1951) would force 
the conclusion that this type of neoplasm is more 
malignant in man than in the dog. The seminoma is 
also more malignant in man and the Sertoli cell tumour 
less so.
In the experiments described here, all tissues 
were investigated by in vitro techniques using tissue 
homogenates or minces (chopped tissue) suspended in 
solutions containing isotopically-labelled steroids 
as precursors. The use of homogenates assumes that 
any chemical reaction occurring in living cells will 
also occur in a cell-free preparation provided that 
the conditions are right. As the aim of the 
homogenate technique is to isolate tlie reaction
rather than the enzyme, all the tissue must be used 
and not an extract. The use of minced or chopped 
tissue, on the other hand, is an attempt to reduce 
the tissue to such a size not only to permit adequate 
diffusion in and out of oxygen, solutes in the 
suspending medium and steroid substrates, but also 
to provide a uniform tissue suspension of relatively 
high concentration. Moreover, the use of intact 
cells assumes that the various cofactors required 
by the biosynthetic processes under investigation will 
be produced in the required amounts by the cells them­
selves. In the case of homogenates, cofactors must 
be added. A mince does not supply such an organized 
preparation as does a slice, but the metabolism is 
nonetheless considered to be that of surviving tissue 
and reflects qualitatively if not quantitatively that 
of the original tissue. A further factor for 
consideration in the case of an intact cell prepara­
tion is the permeability barrier that may be offered 
by the cell membranes.
It is appreciated that the in vitro system is a 
"closed-system" and thus will not allow the escape of
end-products of metabolism as would occur into the
systemic circulation in vivo. There is therefore
a risk of accumulation of products and the inhibition
of enzyme-systems by them. The "profile*^ of
substances formed may thus be distorted. This is
less likely to occur, however, with the tracer
amounts of substances used, and where precursors
are employed with low specific activities
(e.g. -labelled steroids) particular attention is
paid to keeping the tissue : steroid ratio as high as
possible. The in vitro technique, nonetheless, gives,
probably, the best indications, of the methods at
present available, of tissue enzyme activity and
inactivity and thus provides an excellent tool for
the comparative study of normal and neoplastic cell
metabolism as described here.
The determination of metabolites from the
incubations has been achieved, in general, by methods 
similar to those first described by Berliner &
Salhanick (1956). These procedures enable the 
identification of "invisible" quantities of radio­
active labelled steroids by indirect methods. In 
essence the reaction is stopped by organic solvent 
(acetone) and freezing, followed by the addition of
a Imown amount (300 pg.) of those steroids to be 
investigated. Purification of these steroids, 
which are now "visible" is achieved by chromato­
graphy, Proof of identity and radiochemical purity 
are established by derivative formation, purification 
and specific activity determination. When the "cold" 
carrier steroids are added at the outset of extraction, 
any losses occurring in the radioactive metabolites 
are reflected exactly in the carriers, and thus 
percentage conversions may be calculated. For 
example, if x pc. of radioactive substrate A are 
incubated and after the reaction has been stopped 
y mpmoles of product B are added as "cold" carrier, 
and the mean of three agreeing (within 10^) specific 
activities of B and two derivatives is z pc./mp,mole, 
then the total radioactivity associated with product B 
is yz, and the percentage conversion of A to B is
yz.100.
X
It is appreciated that the term "conversion" 
only indicates the amount of radioactivity isolated 
in a particular compound at that moment in time when 
the reaction is stopped and that more or less
radioactivity may have been isolated with this 
product depending upon the time in the sequence of 
biosynthesis that analysis was made. Only a few 
of the metabolites isolated are end-products in 
themselves but rather intermediates in biosynthetic 
chains, but their formation or non-formation, 
accumulation or non-accumulation provides useful 
information into the enzyme systems prevailing in a 
tissue,
In the procedure outlined above one must guess 
which "carrier" steroids to add and if the precursor 
were to be converted to a completely unexpected 
product it could be missed. This product might be 
picked up by running the total lipid extract of the 
incubation products on a paper or thin-layer 
chromatogram and scanning. Again,one must guess the 
identity of the unlmown product giving the peak of 
radioactivity and one is, of course, limited by the 
supply of pure carrier steroids available.
The lay-out of this thesis may appear not to 
conform with the generally accepted form in that 
there has not been set-aside a section for Results 
and one for Discussion but rather was it preferred
to present the findings of each investigation in 
that same section and to discuss their significance 
at that point. Each investigation thus receives 
its own debate, in general, while reference to 
foregoing results ensures continuity.
IV. Experimental.
(a ) Source of tissues.
The human tumour was obtained from Mr. .T.S.S. 
Stewart, Surgeon at the Radcliffe Infirmary, Oxford.
The dogs with testicular tumours were referred 
to me by Miss D.G. Campbell, M.R.C.V.S. and by the 
Surgery Department, Glasgow Veterinary School,
Normal dog testicular tissue was obtained from 
an experimental animal and from a dog being destroyed 
after a road accident.
All tissue was chilled to-about 0° after removal 
from the subject and transferred at this temperature 
to the laboratory. The time interval from extirpation 
to incubation was approximately 20 - 30 min, for the 
dog tissues and 8 hr, for the human,
(B) Preparation of tissues.
Method (1). A mince. The tissue was chopped 
using the Mcllwain & Buddie (1953) apparatus and 1 g, 
suspended in 13 ml. Krebs-Ringer bicarbonate-glucose 
medium (see appendix 1.).
(ii) Method (2). An homogenate. The tissue (1 g . )  
was homogenized at about 0^ in 8.0 ml. 0.25M. sucrose 
containing 0.12M. nicotinamide in a Potter-Elvehjem 
homogenizer. The homogenate was added to 4*8 ml.
of a solution containing the following: 362 pmoles
2-amino-2-hydroxymethyl-1,3-propanediol (TRIS buffer 
pH 7 .4); 360 pmoles KCl, 26.5 pmoles MgSO^,
7.9 pmoles ATP., 72 pmoles potassium fumarate,
1,6 pmoles NADP., 1.6 pmoles NAD., 120 pmoles 
glucose-6-phosphate and 6.4 Kornberg units glucose- 
-6-phosphate dehydrogenase.
(iii) Method (3)* The tissue was chopped at about 
0^ by hand using a safety razor blade, A known 
quantity (2 g.) was then suspended in a measured 
volume (24 ml.) of Krebs-Ringer bicarbonate-glucose 
solution.
fC) Methods of incubation.
Radioactive steroids (see appendix 2), stored 
at -15° in benzene:methanol (9:1 v/v), were added to 
the incubation vessels along with 100 pi. propylene
glycol. The benzene and methanol were evaporated in 
a stream of air at about 40° leaving the steroids 
dissolved in a film of propylene glycol. The tissue
preparations in their incubation media were added to 
the flask and, after gassing with 95^ 0^, 5% CO^ in 
the case of the chopped tissues, placed in a water 
bath at the requisite physiological temperature and 
incubated, with shaking for a imown length of time 
from 0,5 to 2,5 hr.
At the end of the incubation period the reactions
were stopped by the addition of either 10 ml. benzene; 
: chloroform (6:1 v/v) or acetone and refrigerating
at -15°. The unlabelled carrier steroids were 
usually added at this stage in a small volume of 
ethanol.
(D) Methods of extraction of steroids.
(i) Extraction procedure I . The incubation mixtures 
were homogenised in a Silverson Mixer (Silverson 
Machines Ltd., London) with 3 x 5  vol. benzene: chloro­
form (6:1 v/v) followed by 3 x 5  vol. chloroform and 
finally by 2 x 1 . 5  vol. ethyl acetate. The combined
‘+M-
extracts were evaporated to dryness under reduced 
pressure and the residue partitioned between equal 
volumes of light petroleum (40 - 60°) and 90^ 
methanol in water. The dry residue from the aqueous 
methanolic extract was taken up in 1 ml, toluene and 
shaken with 15 ml. N.NaOH. It is appreciated that 
exposure to this concentration of alkali will 
decompose some steroids, notably 19-hydroxy 
compounds and oestrogens with Ketol structures, but 
these were not investigated in the present experiments 
The alkali was then extracted with 6 x 1 5  ml, benzene 
(Griffiths, Grant & Whyte, I963). The aqueous phase 
was adjusted to pH 8 with concentrated HCl and 
extracted 4 x with equal volumes of ether. The 
pooled ether extracts were used for the chromato­
graphic investigation of phenolic steroids. . The 
benzene fraction contained the neutral steroids. The 
aqueous residue from the benzene : chloroform:ethyl 
acetate extraction was saturated with NaCl and the 
conjugated steroids extracted with an equal volume of 
ethyl acetate.. This conjugated steroid extract was 
filtered and evaporated to dryness under reduced 
pressure,
(ii) Extraction procedure II. The incubation 
mixtures were homogenized in a Silverson Mixer with 
3 X 100 ml. acetone and again with 100 ml. ether:
: ethanol (3:1 v/v). After filtering through a 
scinter glass funnel, the acetone : ether : ethanol 
mixture was taken to dryness under reduced pressure 
and the residue partitioned between 10% aqueous 
methanol and light petroleum (60 - 80°). The 
alcoholic fraction was reduced to the water phase 
and the free steroids extracted with 3 x 30 ml. 
ether. The conjugated steroids were extracted by 
saturating the aqueous residue with ammonium 
sulphate and shaking with 3 x 30 ml. ether : ethanol 
(3:1 v/v) (Edwards, Kellie & Wade, 1953) and then 
filtering through No. 12 filter paper. The dried 
ether extract was partitioned between 20 ml. N.NaOH 
and 2 X  20 ml. toluene. The toluene extracts were 
pooled and examined for neutral steroids. The 
NaOH fraction was brought to pH 8 and the phenolic 
steroids extracted with 3 x 30 ml. ether.
This procedure gives a recovery of 90 -, 100^ 
for neutral steroids, 70 - 80^ neutral steroid 
sulphates and 50 - 60^ oestrogens (see appendices 3
\
\
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and 4).
(E) Preparation of chromatograms.
Thin-layers of Merck silica gel ^^254/366  ^
silica gel G and an anion exchange cellulose (MN- 
-3OOG/ECTEOLA of Macherey, Nagel & Co., Duren, 
Germany) were prepared using the Desaga applicator. 
Suspensions of silicagel (25 g. in 65 ml, water) 
and of ecteola cellulose (ion exchange capacity 
0.35 m. equiv./g.; 12 g. in 60 ml. water) were 
used to spread, in each case, 5 (20 x 20 cm.) 
plates. A small amount (100 mg.) of an inorganic 
phosphor (H,913; Levy West Laboratories Ltd., 
Harlow) was added to the silica gel G slurries 
before spreading.
The thin-layer plates were allowed to stand at 
room temperature for 2 hr. in the case of ecteola 
and 30 min, for the silica gel before activating in 
an oven at 50° and 110° respectively. The ecteola- 
-coated plates were found to function equally well 
if they were merely allowed to stand overnight at 
room temperature.
Steroids were applied bo the plates in ethanol
and the chromatograms developed in the solvent 
systems shown in Table 4*
(F) Detection of steroids on chromatograms.
The Z\^-3"Oxosteroids were visualised in light 
of wavelength 254 mp (Universal U.V. Lamp, Camag, 
Muttenz, Switzerland) as dark spots on a green 
background on both types of silica gel.
The /\^-? p-hvdroxv- and phenolic steroids were 
located on silica gel ^^234/366 plates in
light at 350 mp, and on silica gel G by spraying 
standards run at the edges of the plate with a 15^ 
ethanolic solution of phosphomolybdic acid and 
warming.
The Z\^-3 p-sulphoxysteroids show as fluorescent 
white spots on a bluish background silica gel
when exposed to light of wavelength 350 mp. 
Standards run at the same time on the silica gel G 
plates may be located by spraying with the stain 
described by Eberlein (1965)• These conjugates were 
localized on the Ecteola-coated plates by spraying 
standard sulphates run alongside with the methylene 
blue stain of Crepy & Judas (I96O).
Testosterone sulphate absorbs light at wavelength 
254 mp when run on either of the silica gel preparations 
or on Ecteola (without the addition of phosphor).
(G) Elution of steroids from chromatograms.
All steroids were eluted by scraping the
chromatographic material containing the steroid on 
'
to black glazed paper and transferring to a test tube. 
Ethyl acetate (4 ml.) or ether was added and the 
contents thoroughly mixed using a Whirlimixer 
(Scientific Industries, International Inc. (U.K.) Ltd., 
England). Water (2 ml.) in the case of free steroids 
or saturated NaCl solution (steroid sulphates) was 
added and the tube shaken for several seconds before 
centrifuging. The upper layer was removed and the 
aqueous fraction subjected to a second extraction.
The extracts were pooled and dried in a stream of 
air at a temperature not exceeding 50°. The steroid 
sulphates from the incubation with the interstitial 
cell tumour (see Section IV, L i) were eluted with 
methanol which necessitated the use of a correction 
factor after quantitation with methylene blue (see
4-y
appendix 5).
Recovery of steroids by this method is generally 
of the order of 90 - 100^ (see appendices 6 and 7)*
(H) Preparation of derivatives.
(i) Oxidation, A chromic acid oxidizing reagent
was prepared by the method of Kiliani & Merk (1901)
as modified by Griffiths et al. (I963) • Concentrated
H SO (28 ml.) was added to 92 ml. water and the L 4
mixture stirred into a solution of 32.2 g . Na^Cr^O^.2H^0 
in 70 ml. water and washed in with a further 10 ml. 
water. The reagent (100 pi.) was stirred into 10 ml. 
acetone and, after allowing the precipitate to settle, 
500 pi. of the resulting mixture were added to the 
dry steroid and the reaction allowed to proceed for 
20 minutes at room temperature. The reaction was 
stopped by the addition of 2 ml, water and the steroids 
extracted with ethyl acetate or ether.
(ii) Acétylation. Steroids were acetylated by the 
procedure of Zaffaroni & Burton (19 51). Re-distilled 
acetic anhydride and pyridine (4 drops of each) were 
added to the dried steroid and the reaction allowed to
proceed overnight at room temperature in a tightly 
stoppered test tube. The reaction mixture was then 
diluted with methanol (1 ml.) and the solvents 
evaporated completely to dryness in a stream of air.
(iii) Saponification. Steroid acetates were
saponified by using a modification (Ward & Grant,
/
1963) of the method described by Neher, Desaulles, 
Vischer, Wieland & Wettstein (1958). A solution 
(250 pi.) of a 2% aqueous solution of K„CO (w/v) 
was added to the steroid dissolved in 1 ml. methanol 
and the mixture allowed to stand overnight at room 
temperature. Water (2 ml.) was then added and the 
steroids extracted with ethyl acetate. This 
procedure gives a 70 - 90^ recovery of the free 
steroid (see appendix 8).
(iv) Reduction. The reduction mixture was made up 
by dissolving 5 mg. NaBH^ in 10 ml. methanol at 0°.
An aliquot (200 pi.) of this solution was added to 
the dried steroid residue in a tube standing in 
crushed ice and the mixture maintained at 0^ for
45 minutes. This is a modification of the method of
Southcott, Bandy, Newson & Darrach (1956). The 
reaction was stopped by the addition of one drop of 
glacial acetic acid and the steroids extracted with 
ethyl acetate after the addition of water (2 ml.) or 
saturated NaCl solution in the case of steroid 
sulphates.
(v) Solvolysis. Steroid sulphates were hydrolysed 
by the method of Burstein & Lieberman (1958a). The 
steroids were taken up in 10 ml, water and the pH 
reduced to 1.0 by the addition of 4N.H^S0^. The 
solution was saturated with NaCl and the steroids
extracted with 2 x 10 ml. ethyl acetate. The pooled
o 'extracts were incubated at 50 for 4 h r . and then
washed with 5 ml. 5% NaHCO and 2 x 2  ml. water.
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This procedure cleaves the sulphates of phenolic 
(Sneddon & Marrian, I963) and neutral steroids but 
is without effect on glucosiduronates (Jacobsohn & 
Lieberman, I962) or phosphates (Burstein & Lieberman,
1958b).
(vi) Méthylation. The oestrogens were methylated 
by the method of Brown (1955). The steroids were
taken up in 50 ml, 1.6^ NaOH with the addition of
0.9 g. boric acid to act as a buffer. Dimethyl 
sulphate (1 ml.) was added by safety pipette and 
dissolved by shaking. The mixture was incubated 
for 30 min, at 37° before addition of a further 
1 ml. dimethyl sulphate and 2 ml. 5N.NaOH.
Solution was again achieved by shaking. There was 
a further incubation period of 30 min, at 37° and 
then the mixture was cooled and allowed to stand 
overnight at room temperature.
Extraction of the methylated oestrogens was 
achieved, after the addition of 10 ml. 5N.NaOH to 
the reaction mixture, by shaking with 2 5 ml, benzene 
in the case of oestriol and 2 5 ml. light petroleum 
(40 - 60°) for the other oestrogens. The extracts 
were finally washed with 2 x 5  ml. water.
(l) Quantitation of steroids.
(i) Z\^-3“OXOsteroids, Following purification
by chromatography, the Z\^-3“Oxosteroids 
(including testosterone sulphate) were dissolved 
in 5 ml. ethanol and the optical densities of the
solutions measured at 240 mp against ethanol in 1 cm. 
cells of a Unicam SP500 spectrophotometer. 
Quantitation was achieved by reference to standard 
solutions. Similar amounts of the chromatographic 
material were taken through the elution procedure 
and the optical density readings they gave subtracted 
from those of the equivalent steroid measured.
(ii) ' (3-hydroxysteroids . The^^-3 p-hydroxy-
steroids were subjected to treatment with a sulphuric
acid-ethanol reagent (Oertel & Eik-Nes, 1959)• The
reagent was prepared by carefully adding 2 vol.
concentrated H SO. to 1 vol. ethanol with cooling2 4
and agitation. The reagent (2 ml.) was added to 
the dried steroid and the tubes shaken vigorously in 
a Whirlimixer, Small air-bubbles were allowed to 
escape and the optical densities (O.D.) of the 
mixtures measured with light at wavelength 38O, 4O8 
and 436 mp in 1 cm. cells of a Unicam SP6OO spectro­
photometer against a reagent blank. Standard 
steroid measurements were taken at the same time 
and after Allen correction (see below) the amount of 
steroid present estimated by comparison.
Allen corrected optical densities (Allen, 1950) 
at the above wavelengths.
Allen corrected O.D. at 408 mp
^ °-“ -408 - O-P-380 + °-°-436
2
Blanks from the chromatographic materi’al were 
carried through the same procedure.
(iii) Phenolic steroids. Oestrogens were measured 
by the method of Brown (1955). The Kober (1931) 
reagents were made up as shown below:-
Oestriol. 20 g. quinol/litre of H^SO^ in water (v/v)
Oestrone. 20 g. quinol/litre of 66^ H^SO^ in water (v/v)
Oestradiol-17 (3 and oestradiol-17a. 20 g. quinol/litre
of 60% H^SO^ in water (v/v)
The appropriate quinol-H^SO^ reagent (1.5 ml.) 
for the particular oestrogen was added to the dried 
steroid in stoppered tubes which were then placed in 
boiling water for 20 minutes. The tubes were shaken 
twice during the first 6 minutes of heating. The
tubes were then cooled and water (0.5 ml.) added to
each oestriol tube, 0.25 m l . to each oestrone tube
and 0.1 ml. to the oestradiol-17 P and oestr*adiol“17a. 
A Whirliniixer was used to mix the contents of each 
tube thoroughly after which they were replaced in 
boiling water for a further 10 minutes. After the 
tubes had been cooled the optical densities of the 
mixtures were measured against similarly treated 
reagent blanks in 1 cm. glass micro-cells of a 
Unicam SP600 spectrophotometer at the following wave­
lengths: oestriol and oestrone at 48O, 516 and
552 mp; oestradiol-17p and oestradiol-17a at 480^
518 and 556 mp.
Optical densities were corrected by applying 
the Allen correction, e.g. for oestriol.
Allen corrected O.D. at 516 mp
= 0 D ^ ‘^ -480 ^ ‘^ -552
2
The amount of oestrogen present in each tube was 
found by applying the corrected readings to the 
particular standard calibration curve prepared with 
pure oestrogens measured at the same time with the 
same quinol-H^SO^ reagent.
fiv) A  -3 p-sulphoxysteroids. The A^-3p-sulphoxy-
steroids were determined by the methylene blue method 
of Crepy & Rulleau-Mesiin (I960).
The methylene blue reagent was prepared by 
dissolving 250 mg. of pure methylene blue in 100 ml. 
water containing 50 gm, sodium sulphate and 10 ml. 
cone. sulphuric acid. The resulting solution was 
made up to 1 litre and filtered.
The steroid sulphate was taken up in 0.5 ml, 
water and shaken vigorously with methylene blue 
reagent (0.5 ml.) and chloroform (2.0 ml.) and 
centrifuged. The upper aqueous layer was carefully 
removed and rejected to allow 1 ml. of the lower 
organic phase to be pipetted into a tube containing 
4 ml. 75^ aqueous ethanol. After shaking, the 
optical densities of the solutions were read using a 
Unicam SP600 spectrophotometer at the following 
wavelengths: 625  ^ 650 and 675 mp against a reagent
blank prepared in the same way. The readings were 
Allen-corrected and the amount of steroid present 
found by applying the corrected readings to a 
standard calibration curve drawn up from pure steroid 
sulphates and read at the same time (see appendix 5).
(j) Measurement of radioactivity in extracts.
Portions of steroid residues to be counted were 
placed in glass vials of low potassium content fwiieaton 
Glass Co., Millville, N.J.) and dissolved in 10 ml. 
toluene containing 3 g./litre of 2,5-diphenyl-oxazole 
fPPO) and 0.1 g./litre of 1,4”bis-2(4-methyl-5“ 
-phenyl-oxazolyl)-benzene (dimethyl POPOP). Radio­
activity was determined using a Packard Tri-Garb 
Liquid Scintillation Spectrometer, Model 3214 
(Packard Instrument Co., Inc., La Grange, Illinois). 
Tritium and ^^C were determined simultaneously at 
voltage tap 3*797 with channel I voltage discriminator 
gate of 50 - 210 and amplifier gate of 2S% giving 
efficiencies of counting of approximately 3*8^ for 
^^C and 18^ for ^H. Channel II was set with a
voltage discriminator gate of 190 - 1,000 and 
amplifier gain of S% giving efficiencies of counting 
of approximately 33^ for ^^C and 0% for . Absolute 
quantities of tritium were calculated using a slight 
modification (Packard, 1962) of the standard equations 
of Okita, Kabara, Richardson &■ LeRoy (1957) and of 
^^C from direct readings on channel II since, as 
stated above, no tritium counts appear on this channel
under the conditions specified.
The steroid sulphates were taken up in 1 ml. 
methanol and 9 ml. scintillator solution (described 
above) and quenching determined using internal 
standards (see appendix 9)*
Standard equations.
^  ^I^IR ^2®2R.
^I^IG ^2^2G.
where = counts/min. in the red channel or channel I.
R^ ~ counts/min. in the green channel or channel II
= activity of isotope I (^H).
A2 = activity of isotope II (^^C).
EfR = efficiency of counting for isotope I in channel I.
^IG ~ efficiency of counting for isotope I in channel II.
E^r  = efficiency of counting for isotope II in channel I.
^2G ~ efficiency of counting for isotope II in channel II.
fK) Thin-layer chromatographic separation of steroid 
sulphates.
During these investigations of steroid biosynthesis
Dy
by testicular tumours it has been observed that the 
tissue preparations possessed the enzyme systems 
necessary for the sulphation of certain neutral 
steroids. This observation had not hitherto been 
reported for testicular tissue and it was considered 
of sufficient importance to separate these conjugates 
not only from free steroids and other types of steroid 
conjugates but also as individual compounds before 
cleavage of the sulphate radical. Little work has 
been done on the chromatography of steroid sulphates 
by thin-layer techniques and what has been reported 
brought little success in my hands.
An initial isolation of these conjugates from 
free steroids was achieved using silica gel coated 
plates in solvent system I (Table 3)• At this time 
of the study, only three steroid sulphates were being 
investigated, namely the 3p-sulphoxy derivatives of 
pregnenolone, 17a-hydroxypregnenolone and DHA, which 
in this system, were found to run virtually together 
(Rp 0 .35) whilst free steroids moved with the solvent 
front. This system was slightly modified later 
(solvent system II, Table 3) to one in which the 
above three conjugates as well as testosterone
Table 3 .
Solvent systems used in the separation of steroid sulphates. 
a ) Using silica-gel-coated plates.
I. tert. butanol/ethyl acetate/5N.NH^OH (1:1:1 by vol.).
R f .
DHA sulphate 0.35
Pregnenolone sulphate 0.35
17a-Hydroxypregnenolone sulphate 0.35
II. tert. butanol/ethyl acetate/5N.NH^OH (41:50:20 by vol.).
DHA sulphate 0.32
Pregnenolone sulphate 0.32
17a-Hydroxypregnenolone sulphate 0 .32
Androst-5-ene-diol-3-sulphate 0.32
Testosterone sulphate 0.32
III. Amyl alcohol/cone. NH^OH/H^O (60:30:20 by vol.).
DHA sulphate 0.36
Pregnenolone sulphate 0.12
This is a biphasic system and therefore unreliable.
ÜX
IV, isopropanol/chlorof orm/niethanol/lO N .NH^OH .
(50:50:25:10 by vol.).
DHA sulphate 0.5
Pregnenolone sulphate 0.5
17a-Hydroxypregnenolpne sulphate 0.5
V. n-butanol/toluene/4N.NH^OH/methanol
(68:28:40:56 by vol.).
DHA sulphate 0.63
Pregnenolone sulphate 0.63
17a-Hydroxypregnenolone sulphate 0.63
VI, isopropyl ether/tert. butanol/2N.NH^OH
(18:60:27 by vol.)
DHA sulphate 0.71
Pregnenolone sulphate 0.79
17a-Hydroxypregnenolone sulphate 0.71
B. Using Ecteola-coated plates.
VII. isopropanol/H^O/Formic acid (65:33:2 by vol.)
DHA sulphate 0,00 - 0,07
Pregnenolone sulphate 0,00 - 0.07
17a-Hydroxypregnenolone sulphate 0.00 - 0.07
All three steroids trailed from the source for 
about 1 cm. .
VIII. Methanol/H^O/Acetic acid (75:15:10 by vol.). 
Results as for system VII.
IX. 1,0 M. acetate buffer pH, 4*75-
DHA sulphate 0.00 - 0,19
Pregnenolone sulphate 0.00
17ct“Hydroxypregnenolone sulphate 0.00 ,
X. 0.2 M, NaHCO'^.
DHA sulphate 0.41
Pregnenolone sulphate 0.06 - 0.21
17u-Hydroxypregnenolone sulphate 0.00 - 0.26
XI. H^O.
DHA sulphate O.I3
Pregnenolone sulphate 0,03
17u"Hydroxypregnenolone sulphate 0.00 - O.O8
XII. 0.5 N.NH^OH.
DHA sulphate 0 .27
Pregnenolone sulphate 0.00 - 0,12
17a-Hydroxypregnenolone sulphate 0.00 - 0.17
XIII. 1 N.NH^OH
DHA sulphate 0.24
Pregnenolone sulphate 0.09
17a-Hydroxypregnenolone sulphate 0.00 - 0.16 
Oestrone sulphate 0,15
XIV. 1 M. Urea in 1 N.NH^OH.
DHA sulphate 0 .32
Pregnenolone sulphate 0.14
17a-Hydroxypregnenolone sulphate 0.20 + trail
XV. 2 M. Urea in 2N.NH,0H.
4
DHA sulphate 0.47
Pregnenolone sulphate 0.22
17a-Hydroxypregnenolone sulphate 0.32 t trail
Oestrone sulphate 0.30
XVI. 4 M. Urea in 3N.NH^OH.
Testosterone sulphate _ 0,68
DHA sulphate 0.60
Pregnenolone sulphate 0.45
Androst-5-ene-diol-3-sulphate 0 .45
17a-Hydroxypregnenolone sulphate 0.00 - 0,45
System II with Ecteola.
tert. butanol/ethyl acetate/5 N.NH^OH 
1 (41:50:20 by vol.).
Pregnenolone sulphate 0.63
DHA sulphate
17a-Hydroxypregnenolone sulphate^
0.43 to 0.58
Testosterone sulphate 
Androst-5-ene-diol-3-sulphate
sulphate and androst-5-ene-dlol-3-sulphate (3p-sulphoxy- 
androst-5-en-17p-ol) have a common (0.32). The 
system was prepared by adding, with vigorous shaking, 
just enough tert. butanol to the ethyl acetate and 
SN.NH^OH to permit complete miscibility of the two 
phases. The free steroids still move with the solvent 
front and DHA-glucuronide, at least, is resolved 
(Rp 0.15).
Resolution of the individual steroid sulphates 
still, however, remained a problem and Table 3 shows 
some of the results obtained with silica gel coated 
plates (systems III to VI). System IV was described 
by Wusteman, Dodgson, Lloyd, Rose Tudball (1964).
The report by Oertel, Tornero & Groot (1964) gave 
promise of success but attempts to repeat their work 
proved quite abortive and, in a personal communication. 
Dr. Oertel indicated similar difficulty. The 
material used by these authors, ecteola,, has been 
described more fully previously (see Section IV, E) 
and initially plates were prepared using their 
instructions. Eventually these became modified to 
those described in Section IV, E. Three of the 
systems described by Oertel et al. (I964) are given
in Table 3 and the values obtained (Systems VII to 
IX) .
Ecteola was continued to be used in attempts to
separate the sulphates as shown in Table 3 with
systems X to XIII. It was eventually found that the
addition of urea to NH^OH increased the polarity of
the system considerably and aided in the separation
sought after (systems XIV to XVI). System XVI
proved to be the best but there still remained the
problem of pregnenolone, 17a-hydroxypregnenolone and 
DHA sulphates running more or less together. The
problem was resolved, however, by an initial
chromatographic separation on ecteola-coated plates
in system II by which pregnenolone sulphate (R^ 0.63)
is resolved from the 3p-sulphates of DHA, androst-5™
-ene-diol, and 17a-hydroxypregnenolone and testosterone
sulphate (R^ 0.43 - 0.58). These latter sulphates
are then run on ecteola in system XIII which isolates
testosterone (R^ 0.68) and DHA (R^ 0.60) sulphates.
Separation of androst-5-ene-diol and 17a-hydroxy-
pregnenolone sulphates is achieved by subjecting the
eluted mixture from the previous chromâtopiate-to a
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mild oxidation reaction (see Section IV, H i) which 
converts 3p-sulphoxyandrost-S-en-17(3-ol to DHA sulphate 
which is easily separable from 17a-hydroxypregnenolone 
sulphate on ecteola in system XIII. These techniques 
have been reported (Pierrepoint, 1967).
At a later date it was found that an improved 
resolution and more compact spots could be achieved 
if the ecteola/water slurry was homogenized for 
2 - 3  min. at 6,000 r.p.m. in a 200 ml. Ato-Mix 
Laboratory Blender (M.S.E., Buckingham Gate, London), 
and then after spotting the sulphate mixture, placing 
the plate in a polar lipid solvent system prior to 
running in system J.
L . Tissue incubations.
(i) An interstitial cell tumour. An investigation
o
of the metabolism, in vitro, of 7co- H pregnenolone 
and 4-^^C DHA by an interstitial cell tumour of the 
testis from a man with gynaecomastia.
(a) Clinical data. A 23 yr. old man sought medical 
advice for impotence of two months duration.
Examination revealed bilateral gynaecomastia with 
turgid, tender breasts and hard, erect nipples.
Both testes were abnormal. The left was soft and 
small and 3 cms. in length; the right was tense, 
enlarged and 6 cms. in length, with a hard tender 
nodule, 3 cms. in diameter, at the lower pole. No 
striae were present and the nuclear sex was chromosome 
negative. The daily urinary 17-hydroxycorticosteroid 
and 17-oxosteroid excretions were 10.0 mg. and 8.3 mg. 
respectively.
The patient had first noticed an enlargement of 
the breasts at the age of 17 yr. but his libido and 
coital performance had apparently been unaffected 
until 2 mth. prior to examination. The breast 
enlargement had not regressed after puberty and in 
the previous year further enlargement had taken place.
The right testis was explored through a groin 
incision and the presence of a firm 3 cms. diameter 
spherical nodule was confirmed at the lower pole.
This nodule was easily shelled out by blunt dissection 
together with a thin surrounding layer of normal 
testicular tissue. Following a frozen section
biopsy report the testis was replaced in the scrotum 
and the wound closed.
The specimen was an encapsulated tumour of about 
2.5 cm. diameter. The cut surface revealed a pale 
brown, slightly lobulated appearance but was other™
W jO  T w o
wise homoibogous in colour and consistency. A small 
amount of testicular tissue lay outside the capsule. 
The patient was seen at follow-up clinic 6 weeks 
after the operation. The breasts had decreased in 
size and the left testis was larger than before.
After a further 6 weeks, the breasts were no longer 
turgid or tender and were considered, by the patient, 
to be normal. He was seen 2 yr. after his operation 
when normal libido was reported to have returned.
He had been having intercourse regularly for 18 mth. 
and his woman friend was pregnant with what he 
believed to be his child. Estimations of 17-hydroxy- 
corticosteroids and 17-oxosteroids in a 34 hr. urine 
sample at this time were 8.8 mg, and 12.5 mg. 
respectively.
(b) Histological description. The tumour was 
composed of almost uniform polyhedral cells closely 
packed in sheets with a faint trabecular arrangement
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(Plate l). Each cell had one, or occasionally two, 
large, round or slightly ovoid nuclei with clearly 
defined nuclear membranes and conspicuous nucleoli,
The cytoplasm was eosinophilic and faintly granular, 
containing numerous finely divided lipoid droplets 
and brown pignent which did not give the staining 
reactions of iron or melanin. The tumour was 
fairly vascular and most of the reticulin was of a 
perivascular distribution. Mitotic figures were 
rare and there was a well-defined capsule outside of 
which was testicular tissue. The tumour was described 
as an interstitial cell tumour of Leydig cell origin.
In the testicular tissue many of the seminiferous 
tubules showed a moderate degree of atrophy but in 
others spermatogenesis was present. There was some 
thickening of the lamina propria and a moderate 
amount of interstitial fibrosis. No increase of 
interstitial cells was seen.
(c) Preparation of tissue and conditions of incubation.
Two types of tissue preparation were employed 
using Methods (1) and (2) (see Sections IV, B i and 
IV, B ii, respectively).
In each case, 1 g. of the tumour tissue was 
incubated at 37^ for 2 hr. with 59 mpmoles each 
of 7a-^H pregnenolone (I64 pC/pmole) and 4-^'^C DHA 
(36 pC/pmole). The chopped tissue was incubated 
in 0^:CO^ (95: 5) and the homogenate in air (see 
Section IV, C).
(d) Extraction and fractionation of steroids.
After incubation, 10 ml. benzene : chloroform
(6:1 v/v) and 3OO pg. each of oestrone, oestradiol- 
-17(3 and oestriol, in ethanol, were added. Steroid 
fractionation was achieved by extraction procedure I 
(see Section IV, D i).
(e) Investigation of the fractions containing 
conjugated steroids.
The large number of counts that persisted in 
the aqueous residue (Table 5) after exhaustive 
extraction of free steroids from the incubation 
mixtures with lipid solvents prompted the belief 
that the tumour tissue had formed water-soluble 
substances during incubation. The identification 
of neutral steroid sulphates from adrenal tissue
Table 4 . Solvent systems employed in the separation
of steroids investigated.
A. Chloroform:acetone (185:15 v/v).
B. Benzene : ethyl acetate (l80:20 v/v).
C. Chloroform:ethanol (190:10 v/v),
D . Benzene i.ethyl acetate (120:80 v/v).
E. Benzene: methanol (10:1 v/v).
F. Benzene: hexane : ethanol (140:50:10 by vol.).
G. Chloroform:ethanol (10:1 v/v).
H. Cyclohexane : ethyl a cet at_e (1:1 v/v).
I. tert: butanol: ethyl acetate :5N.NH^OH (1:1:1 by vol.).
J. 4M. Urea in gN.NH^OH.
K. Cyclohexane: ethyl acetate (55:45 v/v).
L. Cyclohexane: ethyl acetate : ethanol (45 : 45 :10 by vol.).
M- Cyclohexane: ethyl acetate (140:60 v/v).
N. Cyclohexane:ethyl acetate (150:50 v/v).
0. Ethyl acetate : ether :cyclohexane (40:20:80 by vol.),
P. tert. but an ol: ethyl acetate :5N.NH^OH (41: 50 : 20 by vol.)
Q, Benzene : ethyl acetate (160:40 v/v). 
R. Benzene:methanol (170:30 v/v).
S. Chloroform:acetone (170:30 v/v).
X. Hexane:ethyl acetate (1:1 v/v).
Table 5* Recovery of radioactivity in the various
steroid fractions
The interstitial cell tumour
Steroid fraction Radioactivity 
recovered (dpm.)
14,
% of added 
radioactivity
14,
Homogenate incubation ~
Neutral
Phenolic
Conjugated
11,428,000 1,666,000 53-23 35-57
244,600 86,750 1.14 1.85
3,858,400 2,148,800 17.97 45.87
Mince incubation -
Neutral
Phenolic
Conjugated
13,305,800 . 3,284,300 61.98 70.11
271,400 165,000
875,600 308,600
1.26 3.52
4.08 6.59
(Baulieu, 1Ç62; Wallace & Lieberiiian, I963 ; Adams, 
1963 ; Wieland, Levy, Katz & Hirschmann, I963) and 
of phenolic steroid sulphates from ovarian (Sneddon 
& Marrian, I963) and testicular (Payne & Mason, 
1965a) tissues indicated that a similar situation 
occurring in our experiment might explain the 
residual radioactivity in the aqueous residue,
A small aliquot of the fractions that would 
contain conjugated steroids was chromatographed on 
silica gel G in solvent system I (Table 4) in which 
the 3 p-sulphoxy derivatives of pregnenolone, 
17a-hydroxypregnenolone and DHA are not resolved 
(Rp 0 .35) but in which any free steroids remaining 
move with the solvent front. Standard sulphates 
and free steroids applied at the edges of the plate 
were located by spraying over them with a 15^ 
ethanolic solution of phosphomolybdic acid and 
warming the plate in a hot oven for a few minutes. 
The areas of silica gel corresponding to the 
authentic steroids and steroid sulphates were eluted 
and their radioactive content estimated by liquid 
scintillation counting (see Section IV, J). The
extraction procedure was shown to be efficient in 
that the counts at the solvent front, i.e. with free 
steroids, were negligible whereas those associated 
with the sulphate area were of sufficient magnitude 
to warrant further investigation. The remainder 
of the sulphate band was then subjected to the 
solvolysis procedure of Burstein & Lieberman 
(1963a) (see Section IV, H v) and the products 
formed chromatographed on silica gel in system A 
(Table 4). The radioactive steroids obtained had 
the same mobilities as pregnenolone, 17a,-hydroxy- 
pregnenolone and DHA.
At this stage 200 pg. each, of the sulphates 
of pregnenolone, 17a-hydroxypregnenolone and DHA 
and unconjugated oestrone, oestradiol-17p and 
oestriol, were added to the remainder of the two 
fractions containing conjugated steroids. An 
aliquot of this fraction from the incubation with 
minced tissue was chromatographed on ecteola (see 
in Section IV, B ) in system J (Table 4). In this 
system DHA sulphate is separated from the sulphates 
of pregnenolone and 17a-hydroxypregnenolone which
are, themselves, not resolved. The DHA sulphate, 
located by spraying standards at the edges of the 
plate with methylene blue (Section IV, F) was 
eluted with methanol and its specific activity 
determined. Correction was allowed for the 
effect of ecteola and/or urea on the quantitation 
of the steroid (see appendix 5)•
The remaining portions of both conjugate 
fractions were then solvolysed as before and the 
products partitioned between benzene and N.NaOH. 
Neutral steroids from the benzene phase were 
chromatographed on thin-layers of silica gel G in 
system A (Table 4). Pregnenolone, 17a-hydroxy- 
pregnenolone and DHA, thus separated, were eluted 
and re-run individually again in system A. After 
eluting, the acetates of each steroid were prepared 
(see Section IV, H ii) and chromatographed in 
system B. Specific activities were obtained for 
the recovered steroids which were located, as before, 
with phosphomolybdic acid. Saponification (see 
Section IV, H iii) yielded the parent steroids which 
were purified in system A and specific activities
measured. The reduction products of pregnenolone 
and DHA after chromatography in system A yielded 
further derivatives for specific activity determina­
tions .
Phenolic steroids from the NaOH phase were 
examined along with the free steroid phenolic 
fraction.
(f) Investigation of the fractions containing
phenolic steroids.
Oestrone, oestradiol-17p and oestriol in the 
four phenolic fractions were separated by thin-layer 
chromatography on silica gel G in system K. The 
oestriol was further purified, before derivative 
formation, by chromatography in system L, while the 
other oestrogens were re-run individually in system K. 
Elution of these phenolic steroids was achieved by 
shaking with ether and water (see Section IV, G) 
and their specific activities assessed. Methyl 
ethers were prepared (see Section IV, H vi) and 
purified by thin-layer chromatography, using 
solvent system B for the derivatives of oestrone 
and oestradiol-17p and system L for the oestriol
ether. The specific activities of these derivatives 
were again measured.
(g) Results.
The radioactive content in the various fractions 
of the products of incubation are shown in Table 5* 
The conjugated steroid fractions show considerable 
radioactivity^ notably in the case of the incubation 
with homogenized tissue. Table 6 shows radio­
activities associated with the individual steroid 
sulphates and free steroids investigated. Incuba­
tions of both whole cell or homogenized tissue 
preparations resulted in the formation of radioactive 
neutral steroid sulphates and in free oestradiol-17(3 
and oestriol. Radioactivity was not found in 
association with either oestrone or with the 
solvolysed products of oestrogen sulphates.
Evidence for radiochemical purity and identity of 
steroids investigated is given in Table 7*
(h) Discussion.
In this investigation of oestrogen biosynthesis 
in vitro by a feminizing interstitial cell tumour of
Table 6, Radioactivity associated with steroids isolated from
Steroid
the incubations.
The interstitial cell tumour
Total radioactivity 
associated with the 
steroid in dpm.
14,
% of added 
radioactivit
14,
Homogenate incubation -
Pregnenolone sulphate 
17aOH-pregnenolone sulphate 
DHA sulphate
Oestrone 
Oestradiol-17 P 
Oestriol
Mince incubation - 
Pregnenolone sulphate 
17cüOH-pregnenolone sulphate 
DHA sulphate
Oestrone 
Oestradiol-17 P 
Oestriol
87,800
60,600
10,730
5.400
2.400 
8,400
17,300
56,000
3,100
74,230
0.41
0.28
0.05
0.37
1.20
0
0.j|25
0.01
0.04 0.07
1.58
13,646 0.06
Table 7. Evidence for the identification of steroids isolated from the incubated tissue
from the interstitial cell tumour
Material investigated 
and chemical 
reaction
Chromatographic 
mobility identical 
with that of
Conjugate fraction
(1) Like pregnenolone sulphate
pregnenolone sulphate 
Solvolysis pregnenolone
Acétylation pregnenolone acetate
Reduction• pregn-S-ene-3p,20p-diol
(2) Like 17ft-hydroxypregnenolone sulphate
- l?aOH-pregnenolone sulphate
Solvolysis 17nOH-pregnenolone
Acétylation 17aOH-pregnenolone acetate
(3) Like dehydroepiandrosterone sulphate ^ -
DHA sulphate
Solvolysis 
Acétylation 
Reduction
DHA
DHA acetate 
androst-S-ene-diol
(4) Like oestradiol-17p
Méthylation
(S) Like oestriol
Méthylation
Free steroid - phenolic fraction 
Oestradiol-17 p
Oestradiol-17 p-3-methyl ether
Oestriol
Oestriol-3-methyl ether
Solvent 
system■
Specific activity 
dpm/mpraole
Homogenate
incubation
K
151.8
146,5
142.1
K
102.4 
108.0
9.9
10.6
Mince
incubation
14c ^H
X K X
0 9.1 0
0 8.7 0
0 9.1 0
N X
0 4.25 0
0 4.10 0
X 13.1 4.8
27.13 13.3 5.0
26.15 12.1 4.4
27.51 14.0 5.0
55.5 0 69.1
46.0 0 65.5
0 12.9 0
0 13.2 0
K not measured.
0 no radioactivity,
t satisfactory results not obtained.
the testis from a man, oestriol was found to
o
contain tritium derived from 7a*- H pregnenolone
but no from 4-^^C DHA. Oestradiol-17p, on
14 Qthe other hand, contained C but no H suggesting 
that, in this tissue, oestriol was formed from 
pregnenolone by a pathway not involving DHA or 
oestradiol-17p• Bolte, Mancuso, Eriksson,
Wiqvist & Diczfalusy (1964a) have previously 
indicated that 16-hydroxylation of oestradiol-17p 
is not an important pathway in the formation of 
oestriol by placental tissue in vitro, confirming 
similar observations by Ryan & Engel (1953)• A 
possible precursor of oestriol in the tissue under 
investigation is 16a-hydroxyprogesterone (see Text 
fig. 4) which was first shown to be formed in vitro 
by ovarian tissue (Warren & Salhanick, 1961) and 
which Kadis (1964) has shown to be a precursor of 
oestriol in the sow ovary. Griffiths et al. (1963), 
Colla, Liberti & Ungar (1966), and 8charma, Dorfman 
& Southern (1965) have shown the presence of 
16a,-hydroxylase activity in feminizing abdominal 
testes. Colla et al. (1966) showed a 15^ conversion 
of progesterone to this compound although 16a-
Tfixt-figiire 4.
Foi’ination of oestriol via 16 o^-hydroKylated neutral steroids
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Key to Text figure 4*
I. Pregnenolone,
II. Progesterone
III. 16a-hydroxypregnenolone.
IV. lôa-hydroxyprogesterone.
V . 3 l6a,17a-trihydroxypregn-5“en-20-one,
VI. I6a, 17cx-dihydroxypregn-4-ene-3 , 20-dione
VII. 16a-hydroxy-DHA.
VIII. l6a-hydroxyandrost-4-ene-3,17-dione.
IX. oestriol.
-hydroxylation has not been shown to be prominent 
in normal testicular tissue (Viscelli^ Hudson &
Lombardo, 1965)*
No evidence was found for the formation of oestrone 
or its sulphate by this tissue, nor was it possible to 
demonstrate the sulpho-conjugation of oestradiol-17p 
or oestriol although the free steroids in this case 
were isolated with radioactive labels, Bolte et al. 
(1964b), however, observed conspicuous differences 
in the results they obtained with their studies of 
the foeto-placental unit depending upon which 
solvolysis technique they employed. They indicated 
certain limitations in the use of each of the two 
methods ; thus one, involving hydrolysis with a 
mineral acid gave consistently lower yields of 
phenolic material and also lower values of oestrone, 
oestradiol-17p and oestriol-like radioactive 
material. The other method, involving gel 
filtration followed by enzymic hydrolysis appeared 
to yield less neutral material. In the present 
investigation the mineral acid procedure was used 
and thus the fact that we found no counts remaining
U /
in the solvolysed "conjugated" phenolic fraction 
might be attributable, to some extent, to this 
technique. The absence of H from oestradiol-17p 
that was labelled with indicates that this
oestrogen was formed from DHA and not from 
pregnenolone.
The incorporation of radioactivity into the 
sulphates of pregnenolone, 17o.-hydroxypregnenolone 
and DHA was observed. The sulphation of steroids 
by endocrine tissues is now a well-recognized fact. 
Baulieu (1962) and Wallace & Lieberman (1963) 
provided evidence of neutral steroid sulphation in 
the neoplastic adrenal cortex. Adams (I963) and 
Wieland et al, (I963) reported similar findings 
with the normal human adrenal cortex. The sulphation 
of oestrone in vitro by bovine adrenal tissue has 
been observed (Sneddon & Marrian, I963)• Wallace 
& Silberman (I964) have demonstrated steroid *
sulphation in ovarian tissue, and recently Payne & 
Mason (1965a) showed that testicular tissue could 
sulphate phenolic steroids. A preliminary account 
of the work described here has been published
(Pierrepoint, Griffiths, Grant & Stewart, I965) and 
in the interim, the sulphation of DHA by normal rat 
testis (Payne & Mason, 1965b) and of DHA and 
testosterone by normal human testicular tissue 
(Dixon, Vincent & Kase, 1965) has been reported.
In the experiment with the whole cell
q 14-
preparation, the presence of H as well as C in
the DHA sulphate indicated that the tissue had the
ability to form this conjugated steroid from DHA
itself or from pregnenolone. Whether the latter
reaction involves the sulphates of pregnenolone and
17a-hydroxypregnenolone (Text fig. 3) as was shown
in adrenal tissue (Calvin et al.. I963; Roberts
et al., 1964a,b) or whether the biosynthetic
sequence proceeds by way of the free steroids is
not certain from this investigation. If free 
q
H DHA is formed, however, it would be surprising 
q
if no H appeared in the oestradiol-17p. Thus,
q
probably, H DHA sulphate is formed by way of the 
sulphates. Bolte et al. (1964a) found that free 
DHA is more readily aromatized in the placenta.than 
is DHA sulphate. If a similar situation pertained
to this tumour, it may account for the failure to
q
find H in the oestradiol-17p. The formation of
neutral steroid sulphates was quite unexpected in
f
this investigation of oestrogen synthesis by an 
interstitial cell tumour and thus unlabelled 
carrier steroid sulphates were not added until 
after the initial extraction procedures. The 
percentage conversions for the neutral steroid 
sulphates shown in Table 6 do not, therefore, 
take into account any losses which may have 
occurred in those preliminary mano^res nor the 
losses incurred during initial investigation of 
the conjugate fractions. The percentage conversions 
indicated are thus minimum values. The conversion 
figures for the oestrogens, on the other hand, do 
allow for any such losses and are considered to 
give a true reflection of the ability of this 
tissue to form these steroids under the conditions 
specified.
The experiment with the homogenized tissue 
showed a higher production of steroid sulphates 
than did that with the mince, It has been shown 
by the work of Bernstein & McGilvery (1952a,b), and
De Meio, Wizerkaniuk & Fabiani (1953) that ATP 
could serve as the source of energy for sulphate
activation in the presence of Mg ions. Both
++ATP and Mg ions were added here as co-factors 
to the incubation with homogenized tissue. 
Activation is catalysed by the enzyme ATP: 
sulphate adenylyl-transferase (B.C. 2.7-7»4) 
which causes the displacement of pyrophosphate 
from the ATP molecule by the sulphate (Lipmann, 
1958) (reaction 1, Text fig. 5)• The compound 
formed, adenosine-5’-phosphosulphate (APS) is 
entirely without activity as a sulphate donor in 
enzymatic reactions. The process of sulphate- 
-activation is completed by a second reaction 
catalysed by the enzyme ATP : adenylylsulphate 3^- 
-phosphotransferase (B.C. 2,7-I*25 ) whereby the 
terminal phosphate of a second ATP molecule is 
transferred to the 3 ^ -position of the APS (Robbins 
& Lipmann, 1957) (reaction 2, Text fig. 5)*
Thus ATP + S ----------APS + PP
ATP + APS ------> PAPS + ADP +
The final product, adenosine-3^-phosphate-5^-
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“phosphosulphate (PAPS) appears to be the general 
sulphate donor in biological reactions and carries 
the sulphate in the form of a mixed anhydride.
The transference of sulphate from PAPS to an 
acceptor (steroid) is catalysed by enzymes called 
sulphotransferases, which, for a steroid such as 
DHA would be 3 ^ -phosphoadenylylsulphate:3 p-hydroxy- 
steroid sulphotransferase (B.C. 2, 8.2.2.) (reaction 3 ^ 
Text fig. 5)• The activation of the sulphate is 
catalysed by the same enzymes regardless of the 
type of sulphate acceptor involved, whereas the 
sulphate transfer requires more or less group 
specific or acceptor specific enzymes (Nose &
Lipmann, 1958).
The formation of neutral steroid sulphates by 
this type of tissue is of particular interest in 
that these conjugates have been incriminated in the 
production of both virilizing and feminizing 
hormones. The efficiency of DHA sulphate as a 
precursor of oestrogens has been demonstrated 
in vitro with placental tissue (Morato, Lemus &
Gual, 1965) and in vivo in pregnant women (Baulieu 
& Dray, 1963; Siiteri & MacDonald, I963; Warren
y o
& Timberlake, 1964; Bolte et al., 1964b), and as 
a precursor of testosterone in the dog testis 
(Aakvaag et al. I964)• That steroid sulphates 
are not merely metabolic end-products of steroid 
metabolism is now accepted and Calvin & Lieberman 
(1966) have presented evidence of the complex 
metabolism of pregnenolone sulphate in man. These 
authors indicate that the metabolic function of the 
sulphate ester in the over-all process of oestrogen 
synthesis may be to serve as a biochemical 
protective group, since DHA, androstenedione and 
testosterone, which have considerably shorter 
half-lives (Sandberg & Slaunwhite, 1956 ; Sandberg, 
Gurpide & Lieberman, 1964) than has DHA sulphate, 
are less efficiently converted to oestrogens 
than is the sulphated steroid when administered to 
pregnant women (Baulieu & Dray, I963; Siiteri & 
MacDonald, I963)• Evidence for the formation of 
DHA sulphate from cholesterol sulphate via sulphated 
intermediates (Roberts et al., 1964a,b) has been 
commented upon earlier in an interpretation of the 
H DHA sulphate formed in the present investigation. 
It is worthy of note, however,, that Calvin & Lieberman
(1966) isolated 3p-sulphoxy, l6a-hydroxyandrost-5- 
-en~17-one (l6a-hydroxy DHA sulphate) bearing ^H
9 c
and S in a ratio similar to that of the injected
9 9 C
cholesterol- H sulphate-'^ S, indicating a direct 
transformation without loss of the sulphate group.
A similar sequence occurring in this tissue via 
l6a-hydroxylated neutral steroid sulphates might 
provide an alternative explanation for the 
tritiated oestriol formation (Text fig. 6).
Siiteri & MacDonald (1963) found indications that 
oestriol may be derived from DHA sulphate by a 
biochemical pathway which did not involve oestrone 
or oestradiol-17P but rather via a l6a-hydroxylated 
intermediate. Corpechot &■ Baulieu (1964) 
demonstrated the direct conversion of DHA sulphate-
3 5  9
- S- H in vivo to 3p-sulphoxyandrost-S-ene-lôa,17p- 
-diol-^^S-^H indicating the significance of the 
metabolism of a steroid conjugate for the biosynthesis 
of oestriol.
The presence of sterol sulphatase (E.C. 3-l»6.2.) 
activity in human testicular tissue has been 
established *(Burstein & Dorfman, I963) . It is 
therefore of considerable interest to speculate on
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the part that sulphation may play in the feminization 
of a patient with an interstitial cell tumour of the 
testis,
A communication on these findings has been 
published (Pierrepoint ^ Griffiths Grant & Stewart ^
1966).
V/
(ii) Normal testicular tissue (1),
An investigation of the effect of time on the
metabolism^ in vitro, of DHA and
o
7a- H DHA sulphate by normal canine testicular 
tissue,
(a) Preparation of tissue^ incubation procedure 
and method of extraction of steroids.
A testis was surgically excised from a dog under 
general anaesthesia (intravenous thiopentone Na/ 
/fluothane gas and oxygen). The organ^ weighing 
18.5 g .; was prepared for incubation by Method 3 
(see Section IV, B iii) and three portions of 2 g. 
were each suspended in 24 m l . Krebs-Ringer 
bicarbonate glucose solution and incubated with 
72.7 mp.moles each of 4-^^C DHA (27*5 p.C/|imole) and 
7a-^H DHA sulphate (206.3 p.C/p.mole) at 37° in an 
atmosphere of 0^:CO^ (95:5). After half-an-hour?s 
incubation^ one flask was removed from the water 
bath and the reaction stopped by the addition of 
10 ml. acetone and cooling to -15°. This was
repeated at 1.5 hr. and 2.5 hr. for the second and 
third flasks respectively. The following unlabelled 
carrier steroids, 3OO W-g. of each, were added to 
each of the three flasks ; DHA sulphate, DHA, 
androst-5-ene-diol, androstenedione and testosterone. 
Flask 3 (2.5 hr. incubation time) received in 
addition 3OO p.g. of unlabelled testosterone sulphate. 
The contents of each flask were thoroughly mixed. 
Steroids were extracted from the incubation mixtures 
in each case, by Extraction Procedure II (see Section 
IV, D ii) providing three fractions from each, 
containing neutral, phenolic and conjugated steroids 
respectively.
(b) Investigation of the fractions containing
neutral steroids.
These fractions were chromatographed initially 
on plates coated with silica gel ^^254/366 
solvent system A (Table 4). This type of silica 
gel was used from hereon-in unless otherwise stated. 
The steroids eluted from this first run were 
examined as described below.
y 7
The DHA, after elution, was acetylated and 
chromatographed in system B. Elution, saponifica­
tion and chromatography of the original steroid 
again in system A was considered sufficient purifi­
cation prior to the first specific activity 
determination. The acetate was again prepared 
from a part of the product and run in system B, 
whilst the reduction product, androst-5-ene-diol, 
prepared from a further aliquot, was chromatographed 
in system C. Specific activities of these derivatives 
were determined.
The androst-5--Gne-diol was acetylated and the 
products resolved by chromatography in system E, 
Androst-5-ene-diol diacetate was located, eluted 
and saponified to give the original steroid. 
Purification of this was achieved in system C before 
measurement of its specific activity. The diacetate 
was again prepared and run in system E to provide a 
derivative for a second specific activity.
The androstenedione was purified by subjecting 
it to an acétylation reaction and re-running in 
system A. A specific activity was measured on the
JLUU
eluted unchanged compound. Reduction to testosterone 
and subsequent acétylation of this product provided 
two derivatives for specific activity determination 
after each had been chromatographed in system A.
The testosterone was converted to the acetate 
and chromatographed in system A. Elution and 
saponification yielded the original steroid which 
was purified in the same system. The specific 
activity was measured. The acetate and oxidized 
product were prepared and measured after 
chromatographing each in system A.
(c) Investigation of the fractions containing 
conjugated steroids.
The procedure for the handling of steroid 
sulphates has been described (see Section IV, K).
In brief, the three fractions containing 
conjugated steroids were chromatographed on silica 
gel in solvent system I (Table 4).
Three-quarters of the eluted steroid sulphate 
fraction were subjected to the solvolysis procedure 
of Burstein & Lieberman (1958a) (see Section IV, H v)
and the resulting free steroids chromatographed in 
system A after the addition of 200 pg. of non- 
-radioactive androst-4-ene-diol to the fraction 
from the 2.5 hr. incubation, DHA was eluted from 
the chromatograms of incubations (l) and (2) and 
DHA, testosterone and androst-4-ene-diol from that 
of incubation (3)* The androst-4-ene-diol was 
oxidized to androstenedione and purified in 
system A before determining its specific activity. 
The other two steroids were dealt with exactly as 
described above for the same steroids from the 
neutral fractions.
The remaining unsolvolysed portion of each 
fraction was chromatographed on ecteola in system J 
and DHA and testosterone sulphates isolated and 
their specific activities determined.
The phenolic fractions were not examined other 
than assessing the total radioactivity in this 
fraction from the 2.5 hr. incubation (Table 8).
(d) Results and discussion.
The radioactive content of the various fractions 
from the three incubations and the radioactivity 
associated with the individual steroid sulphates and 
free steroids investigated are sho\m in Table 8. 
Evidence for the radiochemical purity and identity 
of the steroids investigated is given in Table 9*
A graphic representation of the formation of testo­
sterone, androst-5-ene-diol and androstenedione 
from DHA and 7a-^H DHA sulphate is provided,
by Graphs 1 and 2 respectively. The rates of 
transformation of DHA and DHA sulphate as indicated 
by loss of radioactivity with time are shown by 
Graph 3.
It may be seen from Graph 3 that DHA is at first 
metabolized rapidly; 20^ of this steroid having been 
transformed in the first 30 min., and after 1.5 hr. 
only half of this substrate remained unchanged.
DHA sulphate, on the other hand, is only very slowly 
metabolized and even after the 2.5 hr. incubation 
period barely 7% of it had been transformed.
The interconversion of these two compounds is
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of interest. It may be seen from Table 8 that the
o
incorporation of H into DHA exceeds by at least 
50 times ^ at any stage of the experiment ^ the 
reciprocal incorporation of into DHA sulphate.
This latter incorporation was^ at 2-5 h r .  ^ only 
0.1^ of the original Despite the low rate
of transformation of the DHA sulphate^ the 
experiment shows for the first time the ability of 
canine testicular tissue to use this conjugate in 
the synthesis of testicular androgens^ in vitro. 
Aakvaag et al. (I964) demonstrated the conversion
of DHA sulphate to testosterone and androstenedione 
by the dog testis in vivo after pretreating the 
animals with human chorionic gonadotropin, and 
declared a minimum conversion figure of 2%. The 
results presented here confirm this work and in 
addition show the production of androst-j-ene-diol 
from DHA sulphate,in slightly greater quantities 
than either testosterone or androstenedione. The 
total production of the three being of the order of 
2 to 2>% of the sulphate presented to the tissue.
The conversion of 4-^^C DHA to 4-^^C testo­
sterone sulphate is noted. The formation of this
conjugate was low (0 *03^) and it is assumed that it 
was formed by the sulphation of testosterone and 
that the H content of this steroid was too low to 
be assessed by the techniques adopted here, Dixon 
et al. (1965) have shown that homogenates of normal
human testes will convert DHA and testosterone to 
their sulphate esters and concluded that' testosterone 
sulphate was formed directly from free testosterone.
The search for an androst-4-'ene-diol sulphate proved 
abortive and no radioactivity was isolated after 
addition of the free steroid to the conjugate fraction, 
solvolysis and subsequent oxidation to androstenedione.
The biotransformation of DHA favours, initially, 
the synthesis of androst-5-ene-diol but after about 
SO min. incubation period, it may be seen from 
Graph 1 that the formation of testosterone exceeds 
that of androst-S-ene-diol. Androstenedione, with 
respect to either precursor, at no time features as 
a major metabolite. It has a steady rate of 
formation from DHA up to 1 hr. at which stage the 
quantity of this steroid present reaches a plateau 
( 3 '4 % ) due either to non-formation, or its production
and further metabolism proceed at equal rates. A 
similar picture is seen in its formation from DHA 
sulphate although the rate of synthesis is much 
less and the level is still increasing after 2.5 hr. 
(0 .18^). It may be argued that the amount of 
this steroid does not reach high levels as it is 
being converted to testosterone as quickly as it 
is formed, and the present experiment casts little 
light on this problem, nor was it designed to do so. 
It is, however, of interest that the production of 
testosterone should parallel almost exactly that 
of androst-5-ene-diol from both precursors. With 
regard to their respective formation from 4-^^C DHA 
it can be seen from Graph 1 that androst-5-ene-diol, 
being formed first by reduction of the 17-0x0 group 
of DHA, is present in excess of testosterone until 
almost 1 hr. of incubation, at which time one could 
assume that its own further metabolism by the enzyme- 
-complex 3 {3-hydroxysteroid dehydrogenase-isomerase 
to testosterone just exceeds its own formation, 
after which point-in-time the rates of production 
and metabolism of androst-5-ene-diol remain constant .
At the 2.5 hr. period almost 22^ of the DHA has 
been converted to testosterone and 17^ to androst- 
-5-ene-diol with less than S% remaining as 
androstenedione. Savard & Dorfman (1954) reported 
in their abstract that androst-5-ene-diol was 
converted to testosterone in vivo by the rat testis.
Slaunwhite Burgett (I965) found that rat
testicular tissue converted DHA to androstenedione 
very quickly and efficiently but that the trans­
formation to androst-5"Cne-diol was trivial.
They suggest that while DHA is oxidised to 
androstenedione, DHA sulphate may be reduced to 
androst-5-ene-diol-3-sulphate which, on hydrolysis, 
and oxidation, forms testosterone. This sequence 
of reactions may well hold also for the dog testis 
but, as the results show, it is of little importance, 
providing, at best, 0 .13^ conversion to testosterone. 
These same authors found that an equilibrium between 
androstenedione and testosterone was not reached 
even after 3 hr . incubating with testicular tissue 
and that the oxidized form predominated.
Thus Testosterone Androstenedione
This is shown not to be the case with dog 
testis, and even though equilibrium had not been 
reached the testosterone production rate was 
greatly in excess of that for androstenedione.
Gower (1966), also working with rat testicular 
tissue in vitro, found that after 1 hr, virtually
T / I  '
all the incubated 4- C DHA had been transformed.
In a 4 hr, incubation he found only a 0.05^ 
conversion to androst-5-ene-diol and concluded that 
little or none of this compound was formed although 
in his discussion he suggests that it is efficiently 
converted to testosterone. He also suggests that 
the high activity he found in androstenedione 
relative to that in the androst-5-erie-diol isolated 
after a 4 hr, incubation period confirms that the 
conversion of DHA to the former is very rapid 
whereas the conversion of DHA to androst-5-ene-diol 
is trivial.
The comparison of these results serves to 
indicate differences in steroid metabolism by the 
testes of two species. The results achieved in 
the present investigation indicate the comparative
a-j.3
ability of dog testicular tissue to metabolize DHA 
and its sulphate.and provide some information on 
the rate of production of some testicular androgens. 
These results will be used later to emphasize the 
abnormal steroid biosynthesis encountered in two 
testicular tumours from dogs showing clinical 
endocrine dysfunction (see Sections L, v and 
L, vi).
(iii) Sertoli cell tumour (1).
An investigation of the metabolism, in vitro, of 
7a-^H pregnenolone, DHA and 4-^^C testo­
sterone by a Sertoli cell tumour of the testis from 
a dog showing signs of feminization and alopecia,
(a) Clinical data.
The patient, an 11 y r. old West Highland White 
terrier, was submitted for veterinary advice because 
of widespread bilateral alopecia. Enlargement of 
the nipples and a large swelling in the scrotum were 
also found at examination. The animal had apparently 
been attracting other male dogs, as does a bitch in 
oestrus, for some months, and had been noticed to 
squat to micturate rather than adopting the usual 
three-legged stance of the male. The dog was subjected 
to surgery (anaesthesia, thiopentone N a , cyclopropane/ 
/O^) and a large tumour weighing 38.5 g. was removed 
from the scrotum and transferred to the laboratory in 
crushed ice. The tumour, occupying the whole of the 
left testis, was very hard and of a homogenous creamy- 
-white colour on section.
(b) Histological description.
Most of the tumour was composed of columns and 
sheets of cells dispersed in an abundant fibro- 
-cellular stroma (Plate 2). In some places, however, 
there were distorted tubular structures lined by 
tumour cells and containing a mixture of tumour cells 
and vacuolated cell debris in their lumina, The 
neoplastic cells had oval reticulated pale nuclei 
similar to those of Sertoli cells. In general, 
their cytoplasm was extremely vacuolated, and the 
presence of large vacuoles often displaced the 
nucleus of the cell and distorted its appearance.
The mitotic rate was low. The dense fibrous stroma, 
the nuclear morphology, especially in the cells 
which are not extremely vacuolated, and the crude 
tubular structures suggest that this is a Sertoli 
cell tumour.
(c) Preparation of tissue and conditions of incubation.
The tissue was chopped as described in Method 3 
(see Section IV, B iii), and incubated with 
isotopically-labelled steroids in two vessels.
fPLATE 2, Sertoli cell tumour (1) . 
(x 500)
The mince, 2 g. in each case, was suspended in 
24 ml. Krebs-Ringer bicarbonate-glucose solution 
and incubated with (1) 59 mpmole each of 
7a-^H pregnenolone (254 M-C/pniole) and 4-^^C DHA 
(34 tiC/pmole) j and with (2) 59 miamoles each
o
of 7cii- H pregnenolone (254 p-C/p,mole) and
4-^^C testosterone (34 pC/p,mole) . Incubation
was allowed to continue, in each case, for 2.5 hr.
at 37^ and was stopped by the addition of 10 ml.
oacetone and cooling to -15 .
The following steroids, 3OO |ig. in each case, 
were added; to incubation (1) pregnenolone, 
17o,-hydroxypregnenolone, progesterone, 17a-hydroxy- 
progesterone, DHA, androst-5-ene-diol, androstene­
dione, testosterone, DHA sulphate, pregnenolone 
sulphate, 17a-hydroxypregnenolone sulphate, oestrone, 
oestradiol-17p and oestriol; and to incubation (2) 
l6a-hydroxypregnenolone, 16u-hydroxyprogesterone,
DHA, androst-5-ene-diol, androstenedione, testosterone, 
oestrone, oestradiol-17P; oestriol and equilenin.
Extraction Procedure II (see Section IV, D ii) 
was used to extract and fractionate the steroids 
from the incubation media.
(d) Investigation of the fractions containing
neutral steroids.
The two fractions obtained containing neutral 
steroids were chromatographed on silica gel
H^254/366 solvent system A (Table 4) and the 
steroids eluted either singly or in pairs depending 
upon the resolution achieved from the other carriers 
added. Pregnenolone and DHA were eluted together 
as were testosterone and 17a-hydroxyprogesterone; 
androst-5-ene-diol and 17a-hydroxypregnenolone; 
and 16a-hydroxyprogesterone and 16a,-hydroxypreg­
nenolone .
Pregnenolone and DHA were resolved by "double- 
-running" in system A which involves removing the 
plate after a single run, allowing it to dry and 
then replacing it in the same solvent system 
without eluting the steroids. The two steroids, 
thus separated, were eluted, acetylated and 
chromatographed in system B. Saponification and 
chromatography, again in system A, were performed 
before determining their specific activities. The 
acetates of each steroid were again prepared and
purified in system B for a second specific activity 
and the reduction products, pregn-5-ene-3p,20p-diol 
and androst-5-Gne-diol provided further specific 
activities after chromatography in systems A and C 
respectively. Testosterone and 17a-hydroxy- 
progesterone were separated in system D and each 
subjected to an acétylation reaction. Testosterone 
acetate was purified in system A, eluted, saponified 
and re-run in the same system before its specific 
activity was determined. Oxidation and acétylation 
provided further derivatives, each of which were run 
in system A for purification. The unaltered 
17<x-hydroxyprogesterone from the acétylation 
reaction was run in system D before its specific 
activity was measured. Reduction to 17a,20p-di- 
hydroxypregn-4-en-j-one (system C) and acétylation 
of this product to 17a-hydroxy-20p-acetoxypregn-4- 
-en-3-one (system F) yielded two further derivatives 
for specific activities.
Androst-5-ene-diol and 17o,-hydroxypregnenolone 
were separated in system C and then acetylated.
The products of acétylation were chromatographed in
system E and then saponified before re-running in 
system C. Specific activities were determined 
before re-acetylating and chromatographing in 
system E. Oxidation of androst-5-ene-diol to 
6- 0 X 0 -androstenedione achieved a third specific 
activity for for this steroid (see appendix lO)
after running in system A. The 16a,-hydroxypreg­
nenolone and 16a-hydroxyprogesterone were resolved 
in system G. Each steroid was eluted separately, 
acetylated and chromatographed again in system G 
before measuring their specific activities. The 
reduced product of 16a,-hydroxyprogesterone, 16a,, 20p- 
-dihydroxypregn-4-en-3-one was run in system G, 
before measuring its specific activity. The acetate 
of 16a-hydroxypregnenolone was purified in system A.
Progesterone, eluted singly, was subjected to 
an acétylation reaction and re-run in system A 
before determining its specific activity. Further 
measurements were made after reduction to 20p-hydroxy- 
pregTL-4-en-3“one and acétylation of this product to 
20p-acetoxypregn-4-en-3-one, both of which derivatives 
were purified in system A. Androstenedione was 
also subjected to an acétylation reaction before
re-running in system A. Reduction to testosterone 
and acétylation of this product to testosterone 
acetate, both of which were chromatographed in system 
A, provided further derivatives for specific activity 
me a sur ement s .
(e) Investigation of the fractions containing
phenolic steroids.
The fractions containing phenolic steroids were 
chromatographed initially in solvent system H and 
all eluted singly except oestrone and equilenin 
from the second incubation which ran so closely 
together that they were removed together,
Oestrone and equilenin were resolved by 
'^double-running^* (see Section IV, L iii, d) in 
system 0 and after elution each steroid was further 
purified by chromatography in system M, A specific 
activity was determined for equilenin at this stage 
and, as no radioactivity was found, no further 
investigations were undertaken with this steroid.
The oestrone was acetylated and chromatographed in 
system M, eluted, saponified and re-run in system H 
before specific activity determination. The methyl
ether was prepared and purified in system M and the 
reduced product (oestradiol-17p) was purified in 
system H prior to measurement of specific activities.
Oestradiol-17p was acetylated and chromatographed 
in system N before saponification and purification in 
system H. The parent steroid was measured and also 
the diacetate. The oxidation product, oestrone, 
was prepared and run in system H and the methyl 
ether in system L to provide further derivatives.
Oestriol was re-run in system L, eluted and 
acetylated. The tri-acetate was purified by 
chromatography in system B and a specific activity 
determined. The free steroid was recovered after 
saponification and chromatographed in system L.
Â methyl-ether was formed from the oestriol from 
the second incubation and purified in system L,
(f) Investigation of the fractions containing 
conjugated steroids.
This fraction was dealt with as described in 
the foregoing experiment (see Section IV. L ii, c),
(g) Results.
The radioactivity isolated in the various 
fractions from the two incubations and associated 
with the individual steroids investigated is given 
in Table 10. The evidence for the radiochemical 
purity and identity of the steroids investigated may 
be found in Table 11.
Oxidation of androst-5-ene-diol by Kiliani 
reagent results in the formation of androst-4-ene- 
-3,6,17-trione (6-oxo-androstenedione). During 
this procedure, 7a-tritium is lost, presumably by 
énolisation at the 6,7 position (see appendix 10). 
Hence, this derivative preparation procedure was not 
employed in the investigation of tritiated androst- 
-5-ene-diol. The carbon level remains constant, 
however, if the compound is pure.
It is noteworthy that during the measurement 
of specific activities of derivatives of oestradiol- 
-1 7 the tritium content remained constant during 
oxidation, acétylation and chromatography, but 
eventually disappeared after méthylation and 
subsequent chromatography. It is thus assumed for
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Toblo 11. Evidonco for tho identity oC the otoroids isolated Ci'om the incubationo with Sertoli coll tumour (l)
Material investigated 
and chemical reaction
Chromatographic mobility 
identical with that ofi-
Solvent
system
SPECTIFIC ACTIVITIES (dpa/miimolc)
incubation (1) 
3., 14,
INCUBATION (2)
14,■'H
Noutral atoroidn 
pregnenolone
acétylation
reduction
17e-01t prognonolono
acétylation 
progoaterone
reduction
acétylation
prognenelono 
prognonolono acetate 
progn-S-eno-3p,20p-diol
17e-011 prognonolono 
17e-0H prognonolono acetate
progoaterono
20p-hydroxyprogn-4-on-3-one
ÎOp-ûcotoxyprogn-4-on~3-ono
34,100
33,100
36,300
310
560
690
680
630
1 7a -011 progesterone
reduction
acétylation
16c-011 pregnenolone
acétylation 
16a-0H progostorone
acétylation
reduction
androst-3-cne-diol
acétylation
oxidation
17a-0H progesterone
17a,20p-dihydroxyprogn-4-on“3-ono
17a-hydroxy-20p-ncotexyprogn-4-on-3-ono
16a-0H prognonolono 
3p,16a-diocotoxyprcgn-S-en-20-ono
16q -0H progoaterono 
16a-acotoxyprogn-4-cno-3,2Q~diono 
16a,20p-dihydroxyprogn-4-en-3-ono
androst-S'Cno-diol 
androst-3-eno-diol discototo 
6-oxo-androstenodiono
364
t
77.2
61.2 
80,8
180.9
183.8
761.5
771.9
acétylation
reduction
androstenodiono
reduction
acétylation
tostoStcrone
acotylation
oxidation
DMA
DMA acotato 
nndroot“3-ono-dlol
androstenedione 
tostoatorono 
testosterone acotato
tostostorono 
tcstosterono acotato 
androstenodiono
0
0
0
17.7
16.1
18.0
2,310
2,510
2,460
2,156
2,202
2,352
370
356
350
13.6
13.8
13.1
0
0
0
2.3
2.2
1.0
659.0
684.0 
702.0
4,354.5'
4,318.5
4,170.7
Tabla 11 fContinued). Sertoli cell tumour fll.
JLiir VJ
Hntarifil invoatigntod 
and cbomical ronction
Phenolic fraction 
oostrono
HCthylation
reduction
acétylation
oeatradiol“17p
acotylation
mutliylation
oxidation
oestriol
raéthylation 
acotylation
equilenin
Steroid sulnhntes 
pregnenolone sulphate
solvolysis
acotylation
17a-01t prognonolono 
sulphate
solvolysis
acotylation
DHA sulphato
solvolysis
acotylation
reduction
Chromatographic mobility 
idontieal with that .ofi-
ooatrono
oostrono-3-mothyl other 
ooatradiol-17p 
oestrone acetate
ocotradiol-17 p
oü3tradiol-17p-diacotato 
oostradiol-17p-3-methyl othor 
oeotrono
oestriol
ocstriol-3-methyl othor 
oestriol triacotato
equilenin
pregnenolone sulphato 
prognonolono 
pregnenolone acetate
17n-0H prognonolono 
sulphate
17a-0H prognonolono
17O.-011 prognonolono acotato
DHA sulphato 
DHA
DHA ocotato 
androst-S-ono-diol
Solvent
system
SPECTIFIC ACTIVITIES (dpm/mumolo)
mcUDATION (1) 
14,-’H
0.24
0.67
34.2
0
12.73
INCUBATION (2) 
14,"H
t
379
386
8.08
8,98
9.45
11.39
9.65
16.24
17.12
18.62
9.62
9.60
8.46
t
15.06
14.80
14.38
45.19
46.02
0
13.53
6.63
6.85
6.72
25.35
24.37
26.44
26.99
N not moaeured. $ unsatisfactory result.
the present from these experimental results that this 
radioactivity is not associated with the oestradiol- 
-17p. There was insufficient material remaining to 
investigate the loss' of radioactivity at the 
méthylation stage. The results for the tritium 
isolated with oestradiol-17p have^ however/ been 
included in Table 11.
It is perhaps worthy of note that in neither 
incubation was tritium from 7n- H pregnenolone 
isolated in the co-incubated C^^-steroidj viz. DHA 
(incubation l) and testosterone (incubation 2).
These two steroids were^ however^ isolated with the 
tritium label when they themselves were not being 
used as substrates. This would suggest a suppressive 
effect of the steroids on their own formation and 
obviating itself, in this instance, because of the 
low level of metabolism of pregnenolone by the tumour 
tissue (i.e. 14%) and the very small conversion to 
these particular steroids that would have been 
realised (DHA - 0.04^ and testosterone - 0.05^) but, 
apparently, for their presence in even small amounts 
(approx. 2 5 M-g*) as isotopically-labelled substrates.
Neher & Kahnfc (1965) during their studies on
the selective inhibition of various steps in the
biosynthesis of steroids by rat testicular tissue
showed that the degradation of 4-^^C 17cc-hydroxy-
progesterone was partially inhibited by inactive
substrate at a steroid to tissue ratio of 3:10,000
and also by progesterone and 20p-hydroxypregn-4-
-en-3-one at ratios of 1:10,000 and 8:100,000
respectively. They found complete inhibition of
3the degradation of 7n- H 17a-hydroxypregnenolone 
by the addition of pregnenolone or progesterone to 
steroid to tissue ratios of 3=10,000. Testosterone, 
however, had no effect at a ratio of up to 3=10,000.
The steroid to tissue ratios of the incubations 
reported here, with respect to DHA and testosterone, 
were, approximately, 8:1,000,000 indicating the 
sensitivity of the enzymes of this neoplasm to even 
very low steroid concentrations.
There have been reports on the inhibition of 
formation of adrenocortical hormones (Birmingham & 
Kurlents, 1958 ; Peron, Moncloa ^ Dorfman, I960 ; 
Fukui, TakeuchiWatanabe, Kumagai, Sano & Nishino,
1961; Fekete & Gorog, I963) by the addition of
various corticosteroids or adrenal extracts to 
incubations of adrenal tissues or by their 
administration to the living animal, providing 
evidence for a "feed-back** mechanism at the adrenal 
level.
It is for consideration whether a similar 
**feed-back" mechanism is operative in the testes, 
and in a neoplasm such as the type described here, 
where certain enzyme systems are functioning at 
levels much lower than normal, the thresholds of 
inhibition are more easily surpassed.
It may be seen from Table 10 that 0.04^ of the 
radioactivity from the incubated 4-^^C testosterone 
is associated with the DHA isolated. It was found 
not possible to lose this label from DHA" after 
several chromatographic procedures and the formation 
of various derivatives, as shown in Table 11. The 
evidence remains, therefore, that a reversal of the 
3p-hydroxysteroid dehydrogenase-isomerase enzyme 
system has taken place (reaction 10, Text fig. 7) 
followed by dehydrogenation of androst-5-ene-diol 
at the 17“position (reaction 7h) to form DHA.
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Conversely with regard to the formation of androstene- 
dione (14^) from testosterone^ reversal of the 3(3- 
-hydroxysteroid dehydrogenase-isomerase indicated by 
reaction 9 would convert this compound directly to 
DHA as described by Ward & Engel (1964; 1966).
Rosner^, Hall & Eik-Nes (1965) have observed the 
analogous reduction of progesterone to pregnenolone 
(reversal of reaction 1^ Text fig. 7) by homogenates 
of rabbit testes. If^ as Ward & Engel (1966) 
suggest/ the displacement of the equilibrium of 
this reversible system can be caused by one of the 
products of the system^ then^ in the presence of DPNH; 
testosterone and androstenedione could be converted 
to their respective homoallylic alcohols.
The other results of these incubations will 
be discussed more fully in the light of the findings 
from the incubations with normal testicular tissue 
described in the next section.
(iv) Normal testicular tissue (2).
An investigation of the metabolism, in vitro, of
Q
7a- H pregnenolone and 4“ 'C DHA by normal 
canine testicular tissue.
(a) Preparation of tissue, incubation procedure
and method of extraction of steroids.
The tissue was obtained from a dog being 
destroyed after a road accident. There were no 
clinical signs of endocrinological abnormalities 
and the histological picture of the tissue was 
normal.
The tissue was prepared and incubated in 
precisely the same manner and with the same amounts 
of radioactive steroids as Incubation (l) of the 
Sertoli cell tumour (1) investigation (see. Section IV, 
L iii), i.e. 2 g . minced tissue in 24 m l . Krebs- 
-Ringer bicarbonate glucose solution for 2.5 hr. 
at 37^ with 59 mpmoles each of 7a~’^H pregnenolone 
(254 pC/pmole) and 4-^^C DHA (34 pC/pmole).
Oestradiol-17a was added in addition to those 
steroids investigated in the previous incubations.
o J
The steroids were extracted, using Procedure II 
(Section IV, D ii), and the various fractions 
examined as for the preceding Sertoli cell tumour 
experiment.
(b) Results.
The radioactive content of the three fractions 
obtained from this incubation and total radioactivity 
associated with each of the steroids investigated are 
given in Table 12. The evidence for the radiochemical 
purity and identity of the steroids isolated is shown 
in Table I3.
In agreement with the last experiment the 
oestradiol-17(3 appeared to be tritiated until 
méthylation. These results are shown in Table I3 .
(c) Discussion.
In order to assess more fully the enzymic 
derangement apparent from the investigations of the 
Sertoli cell tumour of Section IV, L iii, the 
results of that experiment and the one described above 
with normal testicular tissue are discussed together.
±34
Table 12. Normal testicular tissue (2).
Recovery of radioactivity in the various steroid fractions 
(dpm X 10 ^)j and the total radioactivity associated with 
the individual steroids isolated from the incubation (dpm x 10”’^)
Percentages of the radioactivity initially present are shown in parentheses
From 7a-^H pregnenolone From 4-^^C DHA
Neutral steroid fraction 
pregnenolone 
17a-0H pregnenolone 
16a-0H pregnenolone 
progesterone 
17o.-0H progesterone 
I6a-0H progesterone 
DHA
androst”5~ene-diol 
androstenedione 
testosterone
35,142
11,797
1,966.1
110.4
218.5 
435.3
0
382
3,589.7
889.7
3,595.6
(91.9)
(30.9)
(5.14) 
(0.29) 
(0.57)
(1.14)
(1.00)
(9.39) 
(2.33)
(9.40)
3,976.5
0
0
0
0
0
0
2.163.2
1.178.3 
345.4
1,613.1
(64.7)
(35.2)
(19.2)
( 5 .6 2 )
(26.2)
Phenolic steroid fraction 
oestrone 
oestradiol"17 p 
oestradiol-17a 
oestriol
841.8
0
0.45
2.5
0
(2.20)
( <0.01) 
( <0.01)
100.2 (1.63)
0.4 (<0.01) 
. 0.4 ( <0.01)
0 
0
Conjugated steroid fraction 1,029.3
pregnenolone sulphate 30.3
17o,-0H pregnenolone sulphate 0
DHA sulphate 5,9
(2 .69)
(0.08)
(0.02)
58.5
0
0
8.1
(0.95)
(0.13)
Table 1.1. Evidence for the identity of the atoroido iooltttod from the incubation with normal toaticnlar tiaauo (2).
^[atorial invooti g a t e d  
and t ho c hemical react i o n
C h r o m a t o g r a p h i c  mobil i t y  
i d e n t i c a l  w i t h  t h a t  of : -
S o lvent
ay o t o m
S p e c i f i c  a c t i v i t i e s  (dpm/inpmolc)i 
3.T
N entrai steroids
1. pro g n o n o l o n o
ac é t ylation
redu c t i o n
2. 17a - O H  p r e g n e n o l o n e
acétylation
3. 1 6a-0H p r o g n o n o l o n o
a c é t y lation a nd s a p o n i f i c o t i o n
4. pro g o a t e r o n o
reduc t i o n
a c o t y l a t i o n
5. 17a - 0K p r o g o a t e r o n o
r e d u c t i o n
a c o t y l a t i o n
6 > 1 6a-0H p r o g e s t e r o n o
a c o t y lation
redu c t i o n
7. DHA
acotylation
reduc t i o n
pr o g n o n o l o n o  A
pr o g n o n o l o n o  a c otato ü
p r o g n - S - e n o - 3 p , 2 0 ^ - d i o l  A
1 7a-0H p r o g n o n o l o n o  C
1 7 a - 0 H  p r o g n c n o l o n o  acotato E
I6 a - 0 H  p r e g n e n o l o n e  G
I 6 a - 0 H  p r o g n o n o l o n o  G
p r o g o a t e r o n o  A
20 p - h y d r o x y p r o g n - 4 - o n - 3 - o n o  A
20 p - a c o t o x y p r e g n - 4 - e n - 3 ~ o n o  A
1 7 a - 0 H  p r o g e s t e r o n e  D
1 7 a , 2 0 p - d i h y d r a x y p r e g n - 4 " o n ~ 3 “ Ono C
17 a - h y d r o x y - 2 0 p - Q c e t o x y p r e g n - 4 - e n - 3 - o n o  F
I 6 a-0H p r o g e s t e r o n e  G
1 6 a - a c o t o x y p r e g n - 4 - c n O " 3 , 2 0 - d i o n o  G
1 6 a , 2 0 p - d i h y d r o x y p r e g n - 4 - e n - 3 - o n o  G
D H A  A
D H A  a c o tato D
a n d r o o t - S - o n o - d i o l  A
1 2 , 5 5 6 . 4
12,836.1
1 1 , 8 5 5 . 9
2 . 1 33.7
2.217.8
194.8
171.5
223.5 
233.7 
230.0
455.6
495.2
487.9
0
0
0
364.5
385.9
348.7
2 .127.0
2.018.0 
2,085.0
8. a n d r o s t - S - e n e - d i o l
a c o t y lation
9 . a n d r o a t c n c d i o n o
reduction
a c o t y lation
10. t e s t o s t e r o n e
a c o t y lation
o x idation
a n d r o s t - 5 - e n o - d i o l  
androflt-5-ene-diol dincotato
a n d r o a t e n e d i o n o  
t e s t o s t e r o n e 
t e s t o s t e r o n e  acetate
t o a t o s t e r o n o  
t e s t o s t e r o n e  acetate 
a n d r o s t e n e d i o n e
3,530.2
3.410.4
863.7
866.4
814.5
3 ,501.8
3,303.0
3 .550.5
1,161.7
1,116.4
323.3
336.4 
328.1
1.541.4
1 .502.5 
1 ,601,8
Table 13 (Continued). Rormal testicular tissue (2)
Material investigated 
and tho chemical reaction
C h r o m a t o g r a p h i c  mobility  
i den t i c a l  with that of :-
Solvent
sy s t e m
Sp e c i f i c  a c t i v i t i e s  (dpm/mnmolc) 
3,1
Phenolic steroids
1 , oestrone
acotylation
méthylation
2 . oestradiol-17P
acotylation
oxidation
méthylation
3 , oestradiol-17o
acotylation
4 . oestriol
oestrone
oestrone acetate 
o e s t r o n e -3-methyl other
o e s t radiol-17 p 
oe s t r a d i o l - 1 7 p - d i n c e t a t e  
o estrone
o e s t r a d i o l - 1 7 p-3-methyl other
ocst r a d i o ! -17c. 
o e s t r a d i o l - 1 7 a - d i a c o t a t e
7.81
7.38
7.07
0,41
2.46
2.04
0.21
0.39
0.43
0.27
0.50
0.34
0.24
0 
0 .
méthylation o e s t r i o l -3-mothyl ether
Steroid sulnhatea
1. pregnenolone sulphate
solvolysis
acotylation
2. 17 q -0H pregnenolone s ulphate
solvolysis
acotylation
3. DilA sulphate
solvolysis
acotylation
p r e g n e n o l o n e  s ulphate 
p r e g n e n o l o n e  
p r e g n e n o l o n e  acetate
17ft-0H pregnen o l o n e  sulphate 
17 u - 0 H  p r e g n e n o l o n e  
17 a - 0 H  pre g n e n o l o n e  acotato
D)1A sulphate 
D H A
D H A  acotato
42.99
41.50
7.93
t
7.32
10.98
9.89
10.52
H not investigated.
^  uns a t i s f a c t o r y  r e s u l t ,
JL37
The conversion figures from the three incubations have 
been brought together in Table 14 for ease of comparison.
The Sertoli cell tumour of the canine testis 
has aroused considerable interest for many years 
due to the high incidence of feminization and other 
signs of endocrine dysfunction often associated with 
it (see the Introduction^ Section III). A great 
deal of clinical evidence has provided tentative 
support for the hypothesis that this type of tumour 
is a source of oestrogenic hormones, Wooldridge 
(1908) described a Pomeranian/ which for 1 yr. had 
shown a gradual enlargement of the right testis 
with a simultaneous loss of hair. Prominence of 
the penile sheath could be seen from the photographs.
The unusual fact was that Wooldridge considered the 
tumour to have no relationship with the other 
clinical signs.
Testicular tumours associated with mammary^ 
prostatic and other changes in three cryptorchid 
dogs were reported by Greulich & Burford (1936). 
Subsequent communications (Zuckerman & Groome^ 1937; 
Arnold j Hamperl, Holtz ^ Junlnnann & Marx ^ 1937;
Huggins & Clark; 1940; Gardner & Be Vita; 1940;
Mulligan.; 1943) indicated that all the changes 
occurring in the various tissues of dogs affected 
by this type of testicular tumour could be mimicked 
by the administration of oestrogens; oestrone; 
oestradiol benzoate; oestradiol monobenzoate and 
diethylstilboestrol were all used. Mulligan (1944) 
summarised the situation at the time : ”The
similarity between the changes produced by estrogens 
and the several features of this symptom-complex; 
suggests that the carcinoma of the testis elaborates 
estrogenic material or at least a substance 
altered in some metabolic process to a compound having 
a feminizing action’A A more complete list of 
authors working on this subject and the various 
effects evoked by oestrogens is provided by Jabara 
(1962) in her paper on the tissue changes in the 
dog following stilboestrol administration.
The presence of an oestrogenic substance in 
these tumours was demonstrated by Huggins & Moulder 
(1945). They extracted 70 gg. of a substance 
described as a,-oestradiol from 1 Kg. of tumour 
tissue removed from dogs showing clinical evidence 
of feminization. Several years later Brodey &
Martin (1958) provided evidence by bioassay for the 
presence in the urine from affected dogs of 
oestrogenic material; the amount of which dropped 
emphatically after surgical removal of the tumour.
The case reported by Berthrong; Goodwin b* Scott 
(1949) presented with generalized alopecia ;
"V
apparent pruritis and marked pigmentation of the 
abdominal and scrotal skin. The posterior teats 
were enlarged and other dogs found the patient 
sexually attractive. Urine analysis suggested 
high oestrogen and low 17-oxosteroid excretion.
These authors did not describe ; however ; the techniques 
they employed in this analysis and therefore too 
much reliance should not be placed on these results.
The right testis was almost completely replaced by 
a tumour weighing 45 g. and described as bearing 
resemblance to a Sertoli cell tumour. Métastasés 
were found. These authors concluded that the 
testis produced an oestrogenic hormone which 
originated in the Sertoli cells.
Steroid biosynthesis by such a tumour has not; 
hitherto ; been described and the results reported 
here provide interesting information on the steroido­
genic ability of this tissue when compared with 
that of normal testicular tissue from another adult 
dog. During the discussion ; reference will be 
made essentially to Table 14; in which the radio­
activity (as percentages of the radioactivity 
initially incubated) isolated with the steroids 
investigated from the Sertoli cell tumour (1) 
incubations (l) and (2) and the normal testis 
incubation have been drawn together ; and to 
Text figure 7- The numbers in the diagram refer 
to particular enzymes and the reactions they 
catalyze at those particular points in the 
biosynthetic sequence; and will be referred to as 
such in the text.
From the diagram (Text fig. 7) there are at 
least seventeen possible reactions in numerous 
pathways involved in transforming pregnenolone to 
testosterone. Although progesterone and 17a- 
-hydroxypregnenolone were formed by the tumour via 
reactions (1) and (5) respectively; no tritiated 
17a-hydroxyprogesterone was found. A high rate of 
metabolism of this compound would surely have 
resulted in the formation of tritiated androstenedione
and/or testosterone via reactions (3) and (4a) 
but as only a trace of one of these probable 
metabolites (O.05% testosterone) was found; it is 
concluded that defective formation of 17a-hydroxy- 
progesterone rather than its rapid utilization was 
the reason for its absence. This would indicate 
an impairment of amount or activity of progesterone- 
-17a-hydroxylase (reaction 2) and 17a-hydroxy- 
pregnenolone 3 p-hydroxydehydrogenase-isomerase 
(reaction 8). The fact that it was possible to 
demonstrate 17a-hydroxylation of pregnenolone in 
the same experiment (reaction 5) provides some 
evidence to support the view that steroid specific 
17a-hydroxylases exist in testicular tissue. A 
similar observation has been made for ovarian tissue 
(Griffiths; Grant; Browning, Cunningham & Barr, I966). 
It could be argued that 17a-hydroxylation of 
progesterone would have been demonstrated were the 
latter compound produced in greater amounts and that 
the different conversion figures for the two 17a- 
-hydroxylated steroids was due to the greater 
relative amount of pregnenolone to progesterone that 
was presented to the tissue. It may be seen from
Table 14 that the combined conversion figures of 
progesterone and 17a-hydroxyprogesterone in the tumour 
is 1.68^ and in the normal testis 1.71^* The 
difference being that in the former this figure is 
made up solely from the progesterone while in the 
normal testis 1.14^ is due to the 17a-hydroxy- 
progesterone; indicating dysfunction of progesterone- 
-17a-hydroxylase activity in the Sertoli cell tumour.
While the 17a-hydroxypregnenolone-3p-hydroxy- 
dehydrogenase-isomerase (reaction 8) is impaired or 
absent the results from the carbon-labelled steroids 
show that DHA-3 p-hydroxydehydrogenase-isomerase 
(reaction 9) is active in the neoplasm. This 
provides evidence for specific 3 p-hydroxysteroid 
dehydrogenase in the testis. Such specific enzymes 
have already been shown to exist in adrenal tissue 
(Weiiky & Engel; 1963)•
The relative abilities of the normal and 
neoplastic tissues to metabolize the steroid 
precursors with which they were presented show 
interesting differences. DHA is metabolized in 
similar quantitative manner by normal (65^) and 
neoplastic (58^) tissues. Androst-5-ene-diol (19^)
J-4 J
Table 14. To compare the relative amounts of radioactivity isolated with the various steroids
investigated in the incubations with the Sertoli cell tumour and the normal dog testis.
The figures are percentages of the initial radioactivity.
Sertoli cell tumour (l)
From
Pregnenolone
From
DHA
From 
T esto sterone
Normal testis (2)
From From
Pregnenolone DHA
pregnenolone 
17a-0H pregnenolone 
l6a.-0H pregnenolone 
progesterone 
17a-0H progesterone 
l6a-0H progesterone 
DHA
androst-5-ene-diol
androstenedione
testosterone
oestrone
oestradiol-17 p
cestradiol-17a
oestriol
equilenin
pregnenolone sulphate 
17a-0H pregnenolone sulphate 
DHA sulphate
85.8
1.27
0 .29*
1.68
0
0*
o
1.04
0
0.05
0
0
t
0
o'*
0.72
0.02
0.02
0
0
$
0
0
$
42.2 
1.34
38.2 
6 .06 
0.30 
0.17 
$
0
$
0
0
0.18
0.04
o
13.7
85.6
0.14
0.54
t
0
0
30.9
5.14 
0.29
0.57
1.14 
0
1.00
9.39 
2.33
9.40 
0
< 0.01
< 0.01
0
4:
0.08
0
0.02
0
0
0
0
0
0
35.2
19.2 
5.62
26.2 
< 0.01 
< 0.01
0
0
$
0
0
0.13
X formed from 7a-^H pregnenolone in the second incubation 
with tumour tissue.
$ not examined.
and testosterone (26^) are the main metabolites from 
the normal testis, whereas androstenedione (38^) 
predominates in the tumour incubation in which much 
less testosterone (6%) is formed. This points to 
an impairment in reduction at the 17-position 
(reaction 4a), which might be due to decreased 
enzyme synthesis or activity. The testosterone- 
17 p-hydroxydehydrogenase (reaction 4b) was functioning 
well in that 4-^^C testosterone was converted, in 
reasonable yield, to androstenedione (14%) in the 
second tumour incubation, Slaunwhite, Sandberg,
Jackson & Staubitz (I962) demonstrated an inhibition 
of reduction of androstenedione to testosterone in 
homogenates of testicular tissue from men with 
prostatic carcinoma who had been receiving parenteral 
diethyl stilboestrol. The ability of the tumour 
tissue to metabolize pregnenolone (14%) is very much 
less than that of the normal testis (69%). It is 
for consideration whether the oestrogens produced by 
the tumour could have influenced dehydrogenase and 
desmolase activities in this tissue in the light of 
the work of Samuels, Short & Huseby (I964) who 
reported a suppression of steroid 17a-hydroxylase and
pregnene-17; 20-lyase in mouse testicular tissue 
after oestrogen administration.
The decreased 17a-hydroxylation of both 
pregnenolone (reaction 5) and progesterone (reaction 
2) in the tumour may well have resulted from anoxia 
of the tumour tissue related to its size, fibrosity 
and rate of growth. It is well known that steroid 
hydroxylation requires molecular oxygen, and Nakano, 
Sato & Tamaoki (1966) have produced evidence for the 
requirement of molecular oxygen for the conversion 
of 17a-hydroxyprogesterone to androstenedione 
(reaction 3)« It is interesting, therefore, to 
speculate on the possibility that oxygen lack may 
impair the activity or amount of these biosynthetic 
enzymes in vivo, the effects of which persisting 
in vitro.
Evidence is presented for the presence of a 
l6a-hydroxylase by the formation of l6a-hydroxy- 
pregnenolone (0 .29%) in both normal and neoplastic 
tissues although the l6a-hydroxyprogesterone 
isolated was unlabelled. It has been suggested 
already with regard to the formation of oestriol 
from pregnenolone by the human tumour (see Section IV,
L i h) that perhaps an important intermediate could 
be lôa-hydroxyprogesterone. The results from these 
investigations give no indication as to the part 
that l6a-hydroxypregnenolone may play in steroid 
synthesis in the canine testis, as oestriol was not 
formed in any one of the three incubations described 
above with canine testicular tissue. There is 
presented by these results, however, once more, an 
example of steroid specific enzymes; both normal 
and neoplastic tissues possessing the pregnenolone- 
-16a-hydroxylase but not progesterone-l6a-hydroxylase. 
Any question of inability of progesterone to enter 
cells as compared with pregnenolone is discounted 
by the formation of 17a-hydroxyprogesterone in the 
normal testis incubation.
The formation of oestrone and oestradiol-17p 
from both DHA and testosterone by the Sertoli cell 
tumour is of particular interest in that it shows 
for the first time the ability of this tissue to 
form oestrogens. Very little of these two steroids 
was formed from DHA by the normal dog testis; the 
conversions are recorded as less than 0.01%. It
is of interest to speculate on the immediate
precursors of these oestrogens in the tumour.
Oestrone predominated over oestradiol-17p by a ratio 
of 1.8:1 when DHA was incubated and androstenedione 
was the chief metabolite (38%). In the incubation 
with testosterone it was found that oestradiol-
-I7p predominated by a ratio of 3*9:1 over oestrone, 
with androstenedione being, again, the chief 
metabolite but at a much lower conversion (14%).
It is suggested that the tumour tissue is able to 
convert both androstenedione and testosterone to 
oestrone and oestradiol-17p respectively and although 
it is recognised that oestrone and oestradiol-17p 
are freely interconvertible, their relative production 
in this tissue depends upon the immediately 
predominating steroid.
Thus
DHA ' " >  Androstenedione Testosterone
1 i
Oestrone Oestradiol-17P
The sulphates of pregnenolone, 17a-hydroxy- 
pregnenolone and DHA were formed again by the tumour
as in the case of the human interstitial cell tumour. 
Pregnenolone sulphate and DHA sulphate were formed 
by the normal dog testis in slightly less amounts. 
These results do not aid the development of the 
hypothesis formulated after the experiment with the 
human tumour that sulphation of neutral steroids 
may be connected with the synthesis of oestrogens.
It is considered that the results provided by 
this in vitro investigation of a representative 
portion of this neoplasm indicate the steroid 
biosynthetic activity of the tumour as a whole.
It cannot, however, be categorically stated that the 
biosynthesis is the property, wholly or in part, of 
the Sertoli cells. Histological examination 
revealed no Leydig cells, and the interstitial cells 
that were present were considered to be inactive 
fibroblasts having no endocrine function (Professor 
T . Symington, personal communication). If there 
were, however, to be pockets of these cells within 
the tumour mass, and not represented on the histo­
logical section, their metabolic activity could have 
contributed to the biosynthetic pattern observed.
The location of such Leydig cells in the abnormal
environment provided by the neoplastic Sertoli cells 
may so alter their metabolic function that the 
atypical testicular steroid pattern demonstrated 
could result. Camin, Dorfman, McDonald & Rosenthal 
(i960) and Schmidt & Tonutti (1956) commented on the 
effect of virilizing interstitial cell tumours of 
the testis on adjacent testicular tissue and on the 
opposite testis. They suggested a local diffusion 
effect of androgenic substance secreted by the 
tumour on the surrounding testicular substance and 
a systemic effect on the opposite organ. The tumour 
investigated here has been shown to synthesize 
oestrogens and comment has already been made on the 
effect that these substances might have on the 
testicular enzymes.
The evidence remains, however, that the 
biosynthetic pattern observed is due to the metabo­
lism of the radioactive steroid precursors by the 
neoplastic Sertoli cells and thus provides good 
evidence for an endocrine function of these cells 
within the testis.
It is of considerable interest from the comparative 
standpoint that a human Sertoli cell tumour investigated
by Dr, R,S. Stempfel (quoted by Lacy, I962), should 
have synthesized 17a-hydroxyprogesterone and that tne 
metabolite of this steroid, 5p-pT’egnane-3a, 17a, 20a- 
-triol, was secreted in large quantities in the urine. 
Oestrogens were not shown to be elaborated by this 
tissue. Griffiths et al. (I963) reported the
conversion of progesterone to 17a-hydroxyprogesterone 
by a Sertoli cell tumour removed from a human male 
pseudohermaphrodite. Failure to demonstrate 
oestrogen-synthesis was again reported.
It is for consideration whether these differences 
in the steroid-metabolism of canine and human 
neoplastic Sertoli cells may be of significance in 
relation to their relative tendencies to malignancy.
The investigations discussed above have, in 
part, been reported (Pierrepoint, Griffiths & Grant,
1966) .
(v) Sertoli cell tumour (2).
An investigation of the metabolism, in vitro, of 
4“^^C DHA and DHA sulphate by a Sertoli
cell tumour of the testis from a dog with 
alopecia and apparent pruritis but with no 
signs of feminization.
(a) Clinical data.
A Cairn terrier was presented for veterinary 
examination, having suffered mild alopecia and 
apparent pruritis for 6 mth, A swelling had been 
noted in the scrotum for 1 yr. No clinical 
evidence was ascertained for signs of feminization.
A bilateral orchidectomy was performed under 
general anaesthesia (intravenous thiopentone N a ./ 
/cyclopropane/O^)• The neoplastic testis weighed 
70.3 g. and the contralateral organ 3*3 g* The 
normal testis used in the time-controlled experiment 
(see Section IV, L ii) weighed 18.5 g., thus 
indicating the atrophy of the non-neoplastic gland. 
The tumour was transferred to the laboratory in 
crushed ice.
(b) Histological description.
The tumour was composed of tubular formations
of Sertoli cells interspersed in a well developed
fibrous stroma . (Plate 3). The neoplastic cells
were of typical Sertoli appearance, having large
oval reticulated nuclei with clearly defined nuclear
membranes containing one or two prominent nucleoli
and abundant pale-staining cytoplasm with indistinct
borders. The cells were arranged with their long
axes extending radially into the tubules and their
nuclei situated at a distance from the basement
membrane. The structure of the cells was fairly
uniform throughout the tumour, though occasional
bizarre forms were observed. The mitotic rate was
Z.
low. The & ± ^e of the tubules varied considerably. 
Often there was no central lumen, the tumour cells 
being several layers deep. When a cavity was 
present, it frequently contained eosinophilic 
colloid-like material. The tubules were always 
well circumscribed with no evidence of invasive 
activity. The appearance was that of a Sertoli 
cell tumour.
f I
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PLATE 3- Sertoli cell tumour (2).
(x 500)
(c) Preparation of tissue and conditions of 
incubation.
The tissue was prepared as a mince by Method C
(see Section IV, B iii) and incubated in the same
way as described for the previous dog tissue
experiments. In all respects the experimental
procedures are the same as for the 2.5 hr. timed
experiment (see Section IV, L ii), the results of
which will be used for comparative purposes. The
minced or chopped tissue (2 g.) was suspended in
24 ml. Krebs-Ringer bicarbonate-glucose solution
0
and incubated with 72.7 m(imoles each of 7- H DHA 
sulphate (206.3 M,C/pmole) and 4-^^C DHA (27*5 pC/
/(imole) for 2.5 hr. at 37^* The reaction was 
stopped by the addition of 10 ml. acetone and 
cooling to -15^.
The following steroids were added as cold 
carriers, 300 pg. of each; DHA, androst-5-ene-diol, 
androstenedione, testosterone, llp-hydroxyandrostene- 
dione, DHA sulphate, oestrone, oestradiol-17p and 
oestriol. At a later stage 120 pg. testosterone 
sulphate and free androst-5-ene-diol were added to
the sulphate fraction.
Extraction Procedure II (see Section IV^ D ii) 
was used to extract and fractionate the steroids 
from the incubation media.
(d) Investigation of the various steroid fractions.
The steroids from the neutral and conjugated 
steroid fractions were isolated and derivatives 
formed as described for the experiment with normal 
canine testicular tissue (see Section IV, L ii).
The llp-hydroxyandrostenedione, after elution from 
the first chromatographic separation of the neutral 
steroids, was re-run in system C after which it was 
subjected to an acétylation reaction and purified 
in system Q. The eluted steroid was oxidized to 
adrenosterone and chromatographed in system R. A 
specific activity was determined before reduction 
to 1 1 - 0 X 0 -testosterone, purifying in system S and 
then acetylating. The 11-oxo-testosterone acetate 
was run in system T before measuring its radioactive 
content.
The phenolic fraction was dealt with as described
in the Sertoli cell tumour (l) investigation (see 
Section IV, L iii e).
(e) Results.
Table 15 shows the recovery of radioactivity in 
the three fractions achieved by the extraction 
procedure and also the total amount of radioactivity 
associated with each of the steroids investigated. 
Table 16 gives the evidence, on constancy of 
specific activities and chromatographic mobility, of 
the steroids investigated. The percentage 
conversion achieved with this tissue have been 
drawn together with those from the 2.5 hr. incubation 
of normal dog testicular tissue (see Section IV, L ii) 
in Table 17 for comparative purposes. The results 
achieved for the sulphates of androst"5-ene-diol and 
testosterone are uncorrected for losses in extraction 
and purification as these two steroids were added 
later.
(f) Discussion.
With reference to Table 17; it may be seen that
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Table 17
Sertoli cell 'bumour (2)/Normal testicular tissue (l) .
To compare the relative amounts of radioactivity isolated with 
the various steroids investigated in the incubations of tissues 
from a Sertoli cell tumour and from a normal dog testis.
The figures are percentages of the initial radioactivity.
From 
DHA sulphate
Tumour Normal
From 
4-^^C DHA
Tumour Normal
DHA 7.73
androst-5-ene-diol 0.27
androstenedione 0.18
llp-hydroxyandrostenedione 0
testosterone 1.22
oestrone 0
oestradiol-17 p <0.01
oestriol 0
DHA sulphate 87*6
androst-5-ene-diol sulphate <0.17
testosterone sulphate >0.007
5.59
1.30
0.18
22
1.07
12
32
H
93.0
0
81.1
3.75
2.27
0
2.32 
0.01 
0.02 
0 
0 
0 .
O
39.2
17.0
2.77
21.8
22
0.10
22
0.03
32 not investigated.
the tumour tissue shows far less ability to metabolize 
DHA {±9%) when compared with normal testicular tissue 
(61^). The conversion of this steroid to the other 
C^^-steroid metabolites investigated is, therefore, 
considerably less, with the notable exception of 
androstenedione which shows a formation of 2 ,2 ' ]%  
for the tumour and 2.77^ for the normal tissue.
This may be contrasted with the results achieved 
with the Sertoli cell tumour (1) (see Section IV,
L iii) in which DHA was converted to a large degree 
(38^) to androstenedione. In the present experiment 
the conclusion to be drawn is that of relative 
dysfunction of the DHA-3 p-hydroxydehydrogenase- 
-isomerase. It is noteworthy that what is considered 
to be the most important androgenic hormone, testo­
sterone, was formed in the tumour at only about one- 
-tenth the amount of that in the normal tissue and 
invites speculation on the emasculinization that 
this defect may provoke irrespective of a positive 
feminization by any oestrogens produced. That the 
production of oestrogens is also shown to be of a 
very low level complies with the clinical findings 
that the dog was not feminized. The alopecia,
however, is not so easily explained in that the 
evidence already cited (see Sections III and 
IV, L iv c) indicates oestrogens as the cause of 
the hair-loss in affected animals. The formation 
of oestrone and oestradiol-17p from DHA by the 
normal dog testis described in Section IV, L iv 
is, admittedly, slightly less than the production 
found with this tumour but the differences are 
such, that, within experimental error, they cannot 
logically be contrasted, A further factor which 
could be invoked for an explanation is the relative 
size of the two organs. The tumour weighed 70 g.
compared with 10 - 20 g . for the normal testis.
The total production of oestrogenic hormones by 
the tumour may, therefore, exceed that from the 
normal testis by a factor of 5. Using this 
argument we must also conclude that testosterone 
production by the tumour is approximately one-half 
that of the normal dog testis. The author has 
seen several dogs suffering widespread alopecia 
after bilateral orchidectomy and pondered the 
protection that normal testicular secretions 
provide against this condition.
xo s
No detectable counts were found in the DHA
sulphate investigated, indicating inability of this 
tissue to sulphate DHA. This factor, along with 
the lowly production of oestrogens by this tissue, 
lends support to the hypothesis forwarded after the 
human tumour incubation (see Section IV, L i h) 
that sulphation of some neutral steroids may be an 
important factor in the production of oestrogens by 
this type of feminizing tumour. The conversion 
figures of DHA to DHA sulphate in the two investigations 
with normal canine testicular tissue (see Sections 
IV, L ii and IV, L iv) are 0.10 and 0.13^ 
respectively.
The abilities of both normal and neoplastic 
tissues to metabolize DHA sulphate are of comparable 
order. It is of particular interest that this 
conjugate should have been converted to testosterone 
sulphate directly without the intermediation of 
free DHA, androst-5-ene-diol, androstenedione or 
testosterone, all of which steroids were carbon- 
-labelled. Text fig. 8 indicates the possible 
pathways by which this transformation could have 
occurred. Evidence is also provided for the
formation of a tritiated androst-5-ene-diol 
sulphate by this tissue but whether this was the 
3 p-mono, 1? p-mono or the 3 Pj17 p-disulphate cannot 
be deduced from the data.
Lebeau & Baulieu (1963) demonstrated the 
conversion of testosterone to testosterone 
sulphate by an adrenal tumour, while Dixon,
Philips & Kase (1965a) isolated testosterone 
sulphate after incubating progesterone with a 
virilizing adrenal tumour but found no free 
testosterone. Dixon et al. (1965) considered
the possibility of a sulphated intermediate being 
a precursor of testosterone sulphate rather than 
the direct sulphation of testosterone in the light 
of the findings of Wallace & Silberman (1964) of 
androst“5-ene-diol disulphate from an ovarian 
incubation. They concluded that this latter 
compound was not an intermediate and that direct 
sulphation of testosterone had occurred.
Lipsett, Sarfaty, Bardin & Fishman (1966) 
indicated by their in vivo studies of a man with 
a metastatic interstitial cell carcinoma of the 
testis, that testosterone sulphate was formed from
• 0
infused 7a- H DHA sulphate. They also suggested
that the plasma DHA sulphate of their patient was 
the sole precursor of the urinary androst-5-ene- 
-diol sulphate and l6a-hydroxy DHA sulphate, in 
agreement with the findings of Roberts et al. (1964by
The most likely pathway for the transformation 
of DHA sulphate to testosterone sulphate, in the 
light of the results obtained, would seem to be 
by reduction of the 17-oxo-group (reaction 1,
Text fig. 8) to form androst-5-ene-diol-3-sulphate 
and the further conjugation of this compound 
(reaction 2) to give androst-5-ene-diol disulphate. 
Selective hydrolysis (reaction 3) achieves 
androst-5-ene-diol-17-sulphate which is converted 
by a 3 p-hydroxysteroid-dehydrogenase-isomerase 
(reaction 4) to testosterone sulphate.
At any stage the conversion of these 
8 __Æ^^^9&^Sponding 3 p-sulphoxy or
3p-hydroxy steroids (reactions 5, 9, lO) must
be considered a possibility as none of these 
compounds will mix with the pool of Imown ^^C- 
“labelled steroids that were isolated.
A sulphated form of androst-4-ene-diol was
Îext-f igup8 8.
P o s s i b l e p a t h w a y s  to t h o  f o r m a t i o n  of t e s t o s t o p o n e  s o l p h a t o  
f r o m  D H A  s u l p h a t e .
D H A  s u l p h a t e
3 / 3 - s u l p h o x y a n d P O S t - 5 ~ e n - 1 7 / 3 - o l  9^
andP0Sl-5-efle-3^,17(3-ilisulplialc o = s = o
o
V°‘
17p - s u l p h o x y a n i l r o s t -5- 60- 3/3-01
HO
10
3 / 3 - s u i p h o x y a n d p o s t - 4 “ e n - 1 7 - o n e
3 / 3 - s u l p l i o x y a n d r o s t - 4 - e n - 1 7 / 3 - o l
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V
HO \ 8o
OH
0 = 5 = 0
teslost.epone s u l p h a t e
not demonstrated in the experiment with normal 
testicular tissue (see Section IV^ L ii).
Baulieu & Corpechot (1965) described the 
direct conversion in vivo of DHA sulphate to 
androst-5-Gne-diol disulphate without cleavage of 
the sulphate group. Payne & Mason (1965b) 
showed that soluble extracts of rat testis could 
convert DHA sulphate to androst-5-ene-diol-3- 
-sulphate and that this conversion was four times 
more efficient than the similar reaction involving 
the free steroids.
An alternative explanation for the trans­
formation of DHA sulphate to testosterone sulphate 
is via the more orthodox pathway of DHA sulphate —
— .. > DHA > androstenedione (and/or androst-
-5“Gne-diol) —....  ^  testosterone — — testosterone
sulphate but, due to compartmentalization within 
the testicular cells^ these intermediates are not. 
allowed to mix with those metabolites of unconjugated 
4-^^C DHA. This sequence is considered less 
probable than the scheme via sulphated steroids.
Testosterone sulphate was isolated from the 
incubation with the normal testicular tissue (see
Section IV^ L ii d) but possessed only the carbon- 
-label and is considered to be a direct product of 
the sulphation of testosteronej the tritium 
content of which was of such low magnitude that 
the experimental procedure could not detect its 
presence in the conjugate. This finding complies 
with that of Dixon et al. (1965) with normal
human testicular tissue.
14- QThe relative ratios of C to H present in 
the androst-5-ene-diol^ androstenedione and testo­
sterone isolated from the two incubations described 
allow for interesting speculation as corollary 
to the foregoing discussion. " These ratios from 
the normal testis experiment are^ respectively^ 
13:1; 15:1 and 20:1 showing^ as mentioned earlier^ 
a much better utilization of DHA than of its 
sulphate ester. The tumour experiment ^ however^ 
provides respective ratios of 14:1; 13 :i and 2:1 
indicating not only almost identical values for 
androst“5”Gne-diol and androstenedione as those
from normal testis^ but a reduction in the ratio 
14 3of C to H for testosterone by one-tenth.
This is due to the greater tritium content (1.22^)
of the testosterone as compared with 0 . 27%
(androst-5-ene-diol) and 0.18^ (androstenedione)
rather than a lower incorporation of into
its molecule. It is suggested that this tritium
could be derived from hydrolysis of the testosterone
0
sulphate arising directly from 7ct- H DHA sulphate 
as described earlier. If this were to be the case 
it would provide evidence ^ for the first time ^ for 
the presence of a sulphatase enzyme capable of 
hydrolysing a 17p-sulphate, Baulieu^ Corpechot ^ 
Dray, Emiliozzi, Lebeau, Mauvais-Jarvis & Robel 
(1965) and Jarrige (1962) have asserted that all 
experimental evidence indicates, as yet, that the 
ester-sulphates of a 17p- alcohol grouping are not 
hydrolysed.
The llp-hydroxyandrostenedione isolated during 
this investigation was found not to be radio- 
actively labelled indicating its non-pa?eduction by 
this tissue. Androstenedione-llp-hydroxylase has 
been found in abnormal testicular tissue from man 
(Savard et al., I960), although its steroid 
specificity was indicated by its failure to act on 
progesterone. Lipsett et al. (I966) indicated a
similar steroid specificity of this enzyme after 
isolating 11 [3-hydroxyandrosterone from a patientfs 
urine but found no 11-oxopregnanetriol, The 
presence of such an enzyme in the tissue described 
here might then have been missed were it to be 
active on a steroid other than androstenedione 
and which, after hydroxylation, was not further 
metabolized to the particular derivative investigated 
here.
(vi) Sertoli cell tumour (3)«
An investigation of the metabolism, in vitro, of 
4-^^C DHA and 7co-^H DHA sulphate by a Sertoli 
cell tumour of the testis from a dog with signs 
of feminization but no alopecia.
(a) Clinical data.
The patient, a 4 yr . old Shetland collie was 
presented for veterinary advice because of the 
attention paid to it by other male dogs. The 
owner reported that up to half-a-dozen dogs 
would attend the house as if his dog were a bitch 
on heat. Examination revealed a young well-kept 
animal with a good thick coat and a large swelling 
in the right inguinal region. The prepuce was 
somewhat turgid and did not hold the usual 
horizontal position of the normal organ. There 
was some slight enlargement of the teats, particu­
larly those more posteriorly placed. No atrophy 
of the penis was found. The left testis was in 
the scrotum, both of which organs were atrophied.
The dog was submitted for surgery and, under
general anaesthesia (intravenous thiopentone Na/
/cyclopropane/O^), the right testis was removed
from the inguinal region. The left testis was
excised at the same time. The tumour, weighing
31.0 g. and measuring 5 x 4  cms. was hard and
W
fibrous and showed a creamy-shite lobulated 
appearance on section. The left testis was 
atrophic and weighed 2.0 g.
(b) Histological description.
Basically, this tumour was of a tubular 
structure (Plate 4) though the tissue was particu­
larly solid in appearance. In the greater part 
of the section, the tumour was made up of very 
small tubules separated by a finely distributed 
fibrous tissue stroma. The architecture, however, 
varied considerably in different areas. In places 
the cells were arranged in columns and islands, 
and even when tubule formation was more obvious, 
a central lumen was often absent. Usually the 
cells were several layers deep, A number of very
4%
H
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PLATE 4* Sertoli cell tumour (3).
(x 500)
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large tubules were present and some of these were 
cystic, while there was no cavity in others. 
Abundant intra-cytoplasmic Sudanophilic lipid was 
demonstrated in the tumour cells. The mitotic 
rate was moderately high. This was a Sertoli 
cell tumour.
(c) Preparation of the tissue and conditions
of incubation.
The tumour was transferred to the laboratory 
in crushed ice and prepared for incubation (see 
Section IV, B iii). The chopped tissue (2 g.)
was suspended in 24 m l . Krebs Ringer bicarbonate 
glucose solution and incubated, as was the last 
tumour, with 72.7 mpmoles each of 7a-^H DHA
sulphate (206.3 pC/pmole) and 4- C DHA (27.5 pC/
/ (JLmole) for 2.5 h r . The only difference in the
technique adopted for this tissue from that of the 
last tumour and the 2.5 hr. incubation of the time- 
-controlled experiment (see Section IV, L ii a) 
was the temperature of incubation. The tumour 
reported here had been ectopically placed and was 
therefore incubated at body temperature, 38.6*^.
X/ 0
The reaction was stopped by the addition of 10 ml. 
acetone and refrigerating at -15^.
The following steroids were added as cold 
carriers, 300 pg. in each case, DHA, androst-5- 
-ene-diol, androstenedione, testosterone, DHA 
sulphate, testosterone sulphate, oestrone, 
oestradiol-17(3, oestradiol-17co and oestriol.
Extraction Procedure II (see Section IV,
D ii) was employed to extract and fractionate 
the steroids from the incubation medium.
(d) Investigation of the various steroid 
fractions.
The steroids from the neutral and conjugated 
steroid fractions were isolated and measured as 
described for the normal canine testicular tissue 
(1) (see Section IV, L ii b & c). The phenolic 
fraction was dealt with as described for the 
Sertoli cell tumour (l) (see Section IV, L iii e),
(e) Results.
The recovery of radioactivity in the various
1 7 6
Table 18
Recovery of radioactivity in the various fractions and the total 
radioactivity (dmp x 10~^) associated with the steroids isolated
from the incubation of Sertoli cell tumour (3)* 
Percentages of the initial radioactivity are shown in parentheses
From
7a- H DHA sulphate
From 
4-^^C DHA
Neutral steroid fraction 
DHA
androst-5-ene-diol
androstenedione
testosterone
Phenolic steroid fraction 
oestrone 
oestradiol-17 p 
oestradiol-17a 
oestriol
Conjugated steroid fraction 
DHA sulphate 
testosterone sulphate
3,117.17 (10.5) 4,730.2 (86.8)
2,319.1 (7.8) 3,228.6 (59.3)
7.241 (0 .02) ■ 15.73 (0 .29)
505.5 (I.70) 1,186,4 (21.8)
47.92 • (0 .16) 104.58 (1 .92)
31.25 (0.11) 29.73 (0.55)
0 0.8 (0 .01)
0 0.63 (0 .01)
0 0
0 0
20,002 (67.3) 91.81 (1.69)
27,179 (91.5) 5.92 (0.11)
1.95 (0 .007) 0
Table 19. Evidence for tho Identity oC the steroids isolated from^tbo incubation ot' Scrboli cell tumour (3)
Ma t e r i a l  i n v e s t i g a t e d  
and chemical r eaction
C h r o m a t o g r a p h i c  m o b i l i t y  
i d e n t i c a l  w i t h  that of :-
S o l v e n t  S p e c i f i c  a c t i v i t i e s  (dpm/mnmole)
s y s t e m 14,
Ne u t r a l  s t e r o i d s .
1. DHA
a c é t y l a t i o n
reduc t i o n
2. a n d r o s t - S - e n e - d i o l
a c é t y l a t i o n
3. an d r o s t e n e d i o n e
reduc t i o n
a c é t y l a t i o n
4. t e s t o s t e r o n e
a c é t y l a t i o n
oxid a t i o n
D H A
D H A  a c e tate 
a n d r o s t - 5 - e ne-diol
a n d r o s t - 5 - o n e - d i o l  
a n d r o s t - 5 - e n e - d i o l  d i acetate
an d r o s t e n e d i o n e  
t e s t o s t e r o n e  
t e s t o s t e r o n e  a c e tate
t e s t o s t e r o n e  
t e s t o s t e r o n e  acetate 
an d r o s t e n e d i o n e
2.221.9
2.278.9 
2,178.1
7.1
7.0
494.1
466.0
485 . 5
46.5 
47.9
43.5
3. 024.1
3.181.2
3.0 9 3 . 3
15.2
15.2
1 ,167.6
1,159.1
1 .066.3
103. 5 
98.5 
99.1
P h e n o l i c  s t e r o i d s .
1, oestr o n e  
a c é t y l a t i o n 
m é t h y l a t i o n
2. o e s t r a d i o l - 1 7 p
a c é t y l a t i o n
m é t h y l a t i o n
o e s t r o n e  a c etate 
o e s t r o n o - 3 - m e t h y l  ether
o e s t r a d i o l - 1 7  p 
o e s t r a d i o l -17p-diacetate ' 
o e s t r a d i o l - 1 7 p - 3 - methyl eth e r
3 . o o a t r a d i o l - 1 7 a
a c é t y l a t i o n  and s a p o n i f i c a t i o n  o e s t r a d i o l - 1 7 a
4. o e s t r i o l
a c é t y l a t i o n  and s a p o n i f i c a t i o n  o e s t r i o l
0.7 3
0.72
0.50
0.73
0.4 9
Con.iugated s t e r o i d s .
1. D H A  s u l p h a t e
s o l v o l y s i s
acé t y l a t i o n
r e d u c t i o n
2. t e s t o s t e r o n e  s u l p h a t e
s o l v o l y s i s
a c é t y l a t i o n
o x i d a t i o n
D H A  s u l p h a t e  
D H A
D H A  a c etate 
a n d r o a t - 5 - e n o - d i o l
t e s t o s t e r o n e  s u l p h a t e 
t e s t o s t e r o n e  
t e s t o s t e r o n e  ac e t a t e 
a n d r o s t e n e d i o n e
3 3,652
36,968
36,415
34,298
2.06
3.44
2.12
7.82
8.64
6.63
X u n s a t i s f a c t o r y  result.
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Table 20
To compare the metabolism of DHA
by normal and neoplastic testicular tissue
Normal testicular Sertoli cell tumours
tissues
1 . 2. 1. 2. 3.
DHA (unchanged) 39.2 35.2 42.2 81.1 59.3
androst-5-ene-diol 17.0 19.2 1.34 3.75 0.29
androstenedione 2.77 5.62 38.2 2.27 21.8
testosterone 21.8 26.2 6 .08 2.32 1.92
oestrone X <0.01 0.30 0.01 0,01
oestradiol-17 (3 X <0,01 0.17 0.02 0.01
DHA sulphate 0.10 0.13 0,18 0 0.12
testosterone sulphate 0.03 X * 0 0
X not investigated.
-L/y
steroid fractions and the total radioactivity 
associated with steroids investigated are shown 
in Table 18. The evidence for the identification 
of the steroids isolated is given in Table 19 
and two comparative tables (Tables 20 & 21) have 
been drawn up to compare and contrast the results 
from this experiment with those from the 
investigations of the foregoing Sertoli cell 
tumours and the normal testes.
(f) Discussion.
It may be seen from Table 20 that the formation 
of oestrogensj in vitro, by this feminizing tumour 
is of the same order as that for the non-feminizing 
tumour of the last section^ and somewhat greater 
than that provided by the normal testicular tissue 
(see Section IV, L iv b ) . It would be surprising 
if such a low level were responsible for the 
clinical signs observed even with due consideration 
of the total mass (31 g .) of the tumour when it is 
realised that the tumour associated with alopecia 
(see Section IV, L v), producing similar quantities 
of oestrogens, weighed more than twice as much (70 g.)
and yet produced no 'feminizing signs.
It is of particular interest that the trans­
formation of 4"^^C DHA to testosterone and 
androstenedione should again favour the latter 
steroid as with the Sertoli cell tumour (l) 
investigated (see Section IVj L iii). The 
conversion of DHA to androstenedione { 22%) in 
the present investigation greatly exceeds that 
achieved by the two incubations with normal 
testicular tissue (Table 20)  ^ in which reduction 
to testosterone (22 and 26% respectively) would 
appear to have been much more efficient. A 
decrease in amount or efficiency of androstene­
dione -17 -oxo-hydrogenas e is indicated in this 
tumour tissue.
Considering the lowly production of oestrogens 
by this tumour and the efficient conversion^ both 
in this tissue and in the previous feminizing 
tumour (see Section IV, L iii)  ^ of DHA to 
androstenedione^ as compared with the normal 
tissues and the non-feminizing tumour, it would 
suggest that the androstenedione, instead of being 
converted to the potent androgen, testosterone.
fPLATE 5. Atrophic testis contralateral to 
Sertoli cell tumour (3).
(x 800)
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PLATE 6 Atrophic testis from dog 
on oestrogen therapy.
(x 800)
in the testis, is being secreted in the blood stream 
and converted to oestrogens elsewhere in the body. 
West, Damast, Sarro & Pearson (1956) and Braun- 
-Cantilo, La Roche, Novitsky & Lawrence (I96I), 
have shown the production of oestrogens in vivo 
after the injection of androgens into adrenalecto- 
mized and oophorectomized subjects. Recently 
Rase & Cohn (I967) described a patient with absent 
pituitary-ovarian function in whom it was concluded 
that DHA sulphate, secreted by the adrenal gland, was 
being converted to oestradiol-17(3 peripherally.
Histological examination (Plate 5) of the contra­
lateral ^(normal" testis from this dog provides 
further evidence that this animal was suffering a 
hyperoestrogenism. The seminiferous tubules of 
this organ are seen to contain Sertoli cells and 
spermatogonia only, with no evidence of spermato­
genesis. The lumina of the tubules are occupied 
by amorphous basophilic material, interspersed 
among which are scattered pyknotic nuclei. There 
is marked thickening of the tubular basement membrane 
and lamina propria. Few interstitial cells are
±04
seen. The appearance is that of an atrophic 
testis and is considered to be consistent with 
the effects of oestrogen suppression. Similar 
findings have been reported (De La Baize,
Gurtman, Janches, Arrillaga, Alvarez & Segal,
1962) for the human testis after the administation 
of diethylstilboestrol to men with prostatic 
cancer.
Plate 6 shows the histological appearance 
of a testis from a dog that had received 1 mg. 
oestradiol benzoate daily for a period of 3 mth. 
The resulting atrophy demonstrated appears, in 
fact, less severe than in the case of the non- 
-neoplastic organ from the dog described in this 
section indicating the suppressive activity that 
was induced by the Sertoli cell tumour, either by 
direct or indirect means.
This tumour tissue showed a much higher 
metabolic activity with regard to DHA (40^) than 
did the previous tumour (20^) and approached more 
closely that of the normal tissues (60 and 65^ 
respectively). The Sertoli cell tumour (1) also 
had a high metabolic activity with a 5S% trans-
formation of DHA.
In contradistinction to the non-feminizing
tumour, DHA sulphate was formed from DHA although
-labelled testosterone sulphate was not
isolated. Evidence is provided, however, for
the formation of tritiated testosterone sulphate
indicating a similar metabolic pathway from 
q
7a- H DHA sulphate to that described in the 
last section (see Section IV, L v e, and Text 
fig. 8).
q
The metabolism by this tumour,.of 7a- H DHA 
sulphate shows interesting similarities and 
differences to that of the previous tumours. The 
amount of this steroid that was isolated unchanged 
after the 2.5 hr. incubation period was high 
(approx. 90^) in all three investigations- where 
it was employed as a precursor. The two tumours 
provided almost exactly the same conversion to 
DHA (7*7 and 7*8^ respectively, Table 21) which 
was slightly better than the conversion provided 
by the normal tissue ( 5 - 6 % ) ,  The metabolism 
from this stage on, however, differed considerably 
in all three tissues. Androstenedione was again
186
Table 21
To compare the metabolism of 7a- H DHA sulphate 
by normal and neoplastic testicular tissue.
Normal testicular Sertoli cell tumours
tissue (l) (2) (3)
DHA sulphate (unchahged) 93.0 87.6 91.5
DHA .5.59 7.73 7.81
androst-5-ene-diol 1.30 0.27 0.02
androstenedione 0.18 0.18 1.70
testosterone 1.07 1.22 0.16
testosterone sulphate 0 >0.007 0.007
\the predominant product from the feminizing tissue,
as with the previous feminizing Sertoli cell tumour
(see Section IV, L iii), exceeding the equivalent
formation of this steroid by the tumour associated
only with alopecia by a factor of 10 (Tumour 2, Table
20). The formation of testosterone was again very
low. The results also indicate that once hydrolysis 
q
of the 7a- H DHA sulphate has occurred the metabolism 
of the resulting DHA continues as for the unconjugated 
substrate, 4-^^C DHA.
The essential differences between the tumours 
causing feminization and the one unassociated with 
such signs appears to be a greater steroidogenic" 
activity, a DHA-sulphating enzyme system and a higher 
androstenedione: testosterone production in the former 
(Tables 20 & 21).
It is not easy to explain the cause of the 
feminization that was demonstrated in this final 
case nor the reason for apparent oestrogenic- 
-suppression of the contralateral testis although 
hypotheses have been presented. Greater difficulty 
is found in understanding the reason for the atrophy 
observed in the "normal testis" from the Cairn
\
\
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terrier with the Sertoli cell tumour (2) as this 
animal had no signs of feminization-
Why some Sertoli cell tumours cause femini­
zation, others alopecia and 83% (Dow, 1962;
Table 2) or 71^ (Cotchin, I96O; Table 2) are 
associated with no discernible endocrine changes 
at all, may be decided upon by further investiga­
tions ,
JLU y
V. Summary and concluding remarks.
The metabolic activity particular to certain 
testicular cell-types and the changes thereof that 
become apparent with the advent of neoplasia, 
coincident with the species-different systemic 
effects manifested, has prompted the work described 
in this Thesis. The canine Sertoli cell tumour 
and the human interstitial cell tumour are of 
special interest in this respect with regard to 
their providing neoplastic tissue of one cell-type 
and being commonly associated with feminization in 
the host animal.
The metabolism in vitro of certain radioactive 
isotopically-labelled steroids by one human,and three 
canine testicular tumours has been investigated.
It is considered that the results obtained provide 
interesting information concerning the steroidogenic 
activity of these tumours and of the particular 
neoplastic cell-type. Tissue from two normal 
canine testes has been incubated in identical 
manner for comparative purposes. Normal human 
testes are not easily obtained.
j^ y\j
The transformation of 4-^^C DHA to oestradiol- 
-17p and of 7a-'^H pregnenolone to oestriol has been 
demonstrated in tissue from an interstitial cell 
tumour from a man with gynaecomastia. The production 
of oestriol by a pathway not involving DHA or 
oestradiol-17p has prompted the hypothesis that 
l6a-hydroxylated neutral steroids, either free or 
conjugated, may be of some importance in the synthesis 
of this steroid by the neoplastic interstitial cells.
It was also shown that this tumour was capable 
of converting certain neutral steroids to their 
sulphate esters. The role of steroid sulphates has 
assumed greater importance during the past decade 
than hitherto anticipated with regard to their 
further participation in biosynthetic sequences to 
steroid hormone production, It is postulated that 
their formation in this feminizing tissue may play 
some part in the oestrogen synthesis demonstrated.
New methods are also described for the isolation 
and separation of certain neutral steroid sulphates 
using thin-layer chromatographic techniques.
Tissue from a canine Sertoli cell tumour has 
been shown, for the first time, to synthesize oestrone
and oestradiol-17p from 4-^^C DHA. The comparative 
studies made of the metabolism of this tumour type 
and of tissue from normal dog testis has indicated 
relative enzyme inactivity in the tumour, and, in 
particular, has provided evidence for steroid- 
-specific 170,-hydroxylase, 16a,-hydroxylase and 
3P"hydroxysteroid dehydrogenase-isomerase enzyme 
systems in canine testicular tissue.
The Sertoli cell has, in the past, been
of-
discountedj on the whole, being capable of steroid
metabolism and synthesis, yet the results of these 
investigations indicate the presence in this cell of 
several enzyme systems capable of performing these 
functions. Pregnenolone was shown to be converted 
to 17a-hydroxypregnenolone, progesterone, DHA, 
androst-5-ene-diol and testosterone. The sulphation 
of neutral steroids was also demonstrated in this 
tissue, and a suggested pathway to the synthesis of 
testosterone sulphate from DHA sulphate is described.
Recently Woods & Domm (I966), using a fluorescent 
steroid-specific antibody technique, have indicated 
that the Sertoli cells of the rat and fowl testis 
can synthesize androgens,
The ability of normal and neoplastic canine 
testicular tissue to transform DHA sulphate to 
testosterone, androst-5-ene-diol and androstene­
dione in vitro has also been demonstrated.
Differences are noted between the ability of 
a canine Sertoli cell tumour described herein and 
that reported for two similar tumours of human 
origin (Stempfel, quoted by Lacy, 1962; and 
Griffiths et al., I963) to.synthesize 17a-hydroxy- 
progesterone and oestrogens, and the question is 
raised as to the significance these, findings may 
have in relation to the relative tendencies to 
malignancy shown by this tumour in the two species.
It is considered that differences observed in 
the metabolism of DHA by the two feminizing canine 
Sertoli cell tumours as opposed to the tumour 
unassociated with such signs may not only be of 
significance with regard to clinical signs observed 
but also with respect to the degree of malignancy 
of the tumours. Moulton (I96I) concluded that the 
histological appearance of this type of tumour shows 
no constant correlation with malignancy thus 
providing difficulty in classifying benign and
malignant growths. This author does indicate, how­
ever, that malignancy tends to be associated with 
special histological features such as the pleomorphic 
appearance of the Sertoli cells, the possession, by 
them, of larger, more hyperchromatic nuclei and the 
tendency of the neoplastic cells to infiltrate rather 
than to remain in the tubules, These criteria are 
observable in Plates 2 and 4 from the two feminizing . 
tumours in contrast to the benign appearance of the 
tumour associated only with alopecia (Plate 3)• It 
is of interest that the more anaplastic the cells are 
the greater their steroidogenic activity seems to be. 
The biochemical results, such as the androstenedione:
: testosterone production, obtained from an incubation 
of these tissues with a substrate such as 4-^^C DHA 
could be of some ancillary aid in the differential 
diagnosis of benign from malignant growths.
VI. Appendices.
Appendix 1 .
Preparation of Krebs-Ringer bicarbonate-glucose medium.
The method of preparation of this medium is based 
on that described by Cohen (1957)•
NaCl.
KOI.
NaHCO X
glucose
KH2PO4
MgSO^.VHgO
CaCl .ÔH^O
Volume (ml.) 
10 
10 
10 
10 
1
1
57
1
Concentration of solutions 
M. g./lOO ml.
1.16
0.465
0.244
0.116
0.116
6.78
3.47
2.05
1.0
1.573
2.86
Final cone. 
M.
0.116
‘ 0.0465
0.0244
.0.00116 
0.00116
0.242 5.3 0.00242
X
The final volume 100 m l .
'previously gassed for 1 hr. with CO^.
The final mixture is gassed for 10 min. with S% CO^ 
in oxygen, after which the pH is generally found to be 7*4.
Appendix 2.
Sources of chemicals.
Common reagents
Nucleotides
Glucose-6-phosphate- 
-dehydrogenase
British Drug Houses, Ltd., 
Poole, Dorset (ANALar grade 
unless otherwise stated).
Boehringer & Soehne GmbH., 
Mannheim, W. Germany.
Sigma Chemical Co.,
St. Louis, Missouri, U.S.A.
Radioactive steroids.
Radioactive steroids were purchased from the 
Radiochemical Centre, Amersham, Bucks., and were stored
at -15^ at an approximate concentration of 1 pC/ml.
14 q( C-steroids) or 10 p,C/ml. ( H-steroids) in a mixture
of methanol:benzene (1:9 v/v). The purity of these
compounds as claimed by the makers was checked by
thin-layer chromatography and scanning with a Packard
Radiochromatogram Scanner, Model 7200.
Non-labelled steroids.
These steroids were obtained from Koch-Light 
Laboratories, Ltd., Colnbrook, Bucks., Steraloids 
Ltd., Croydon, Surrey, Ikapharm, Ramat-Gan, Israel 
and Mann Resear’ch Laboratories, Inc., New York, U.S.A 
The steroid sulphates were kindly donated by 
Dr. G.F. Woods and Dr, C .L . Hewett, Organon Labora­
tories Ltd.
Solvents.
Ethanol and methanol (Burroughs, A.R. grade) and 
diethyl ether, acetone, petroleum ether and toluene 
were used without further purification. It was 
found necessary to purify the benzene by shaking with 
cone. H^SO^. Traces of acid were then removed by 
washing with water, and after drying over anhydrous 
CaCl^ the benzene was distilled twice. All other 
solvents used were washed with water and redistilled 
before use. These procedures appeared to minimize 
interference with spectrophotometric analysis.
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Appendix 3«
To achieve a reasonable extraction of neutral steroid 
sulphates and phenolic steroids from incubation media.
In this investigation DHA sulphate and oestrone 
were taken as representatives of, respectively, neutral 
steroid sulphates and phenolic steroids.
Unlabelled DHA sulphate and oestrone, 3OO (ig. in
each case, were added to a mixture of 0.5 M-C. each of
q 14
7a- H DHA sulphate and 4~ 'C oestrone in a flask
containing 2 g . minced guinea pig testis in 24 m l .
water and 10 ml. acetone. This was considered to
simulate an incubation medium prior to extraction.
The steroids were extracted using Extraction
Procedure II (see Section IV, D ii). The procedure
for separating neutral and phenolic steroids (20 m l.
N.NaOH/6 X  20 ml. toluene) was performed and the
alkaline residue re-extracted with 3 ^ 20 ml. ether
after adjusting*to pH 8.
The steroid sulphate was extracted from the
aqueous phase by the method of Edwards et al. (1953)
as described earlier (see Section IV, D ii),
lyb
The procedure adopted for assessing the amounts 
of radioactivity in the various fractions was as 
follows:-
1. Alkali fraction.
(a) l/lO volume dried in a vial and taken up in 
10 ml. scintillator solution.
(b) l/lO volume dried and taken up in 1 ml. 
methanol 4 9 ml. scintillator solution.
2. Aqueous fraction.
(a) As for la.
(b) As for lb.
3. Toluene fraction.
(a) As for la.
(b) As for lb.
The radioactivity was measured and assessed for 
both the quenched and unquenched aliquots as described 
in Section IV, J.
xyy
Results.
Total initial radioactivity :-
7 a - D H A  sulphate - 1,959; 100 dpni.
4-^^C oestrone - 1,386,200 dpm.
The total amounts of radioactivity, as assessed by 
the two techniques of counting, in each extract.
Percentages of initial radioactivity are in parenthesis. 
Fraction ^H
la 0 423;6oo (30.6)
lb 0 421,400 (30.4)
2a 1,444;200 (73.7) 3,100 (0.2)
2b 1,485,100 (75.8) 5,000 (0 .4)
3a 30,000 (1 .5) 704,700 (50.8)
3b 13,800 (0 .7) 707,700 (51.1)
It may be seen from the accompanying table that 
only approximately 1l %  of the DHA sulphate was located 
in the toluene or neutral steroid fraction whereas 
SOfo of the oestrone was found there. The recovery 
of DHA sulphate from the aqueous residue was of the
2UÜ
order of 75^ but oestrone counts in the alkaline 
fraction achieved only 30^ of the maximum. The low 
level of contamination (0,2 - 0,4^) of oestrone in 
the aqueous fraction was considered satisfactory.
Recovery of the oestrone from the toluene 
fraction was attempted by back-extracting with 
N.NaOH. The toluene was evaporated and the dry 
residue taken up in 20 ml, toluene and extracted 
with 3 X 20 ml. K.NaOH. These volumes were not 
bulked but extracted individually with 3 x 20 ml. 
ether.
Each ether extract of 3 x 20 ml. and the toluene 
residue were assessed for radioactive content by 
removing a Imown aliquot for scintillation counting 
without the addition of methanol.
The total radioactivity associated with each extract 
and the percentage of the original radioactive in
parenthesis.
Extract
Ether extract (1) 
Ether extract (2) 
Ether extract (3) 
Toluene residue
14C (dpm)
359,300 (25.9)
88.700 (6.4)
21.700 (1.6)
35,000 (2.5)
Percentage of the 
originally in 
the toluene residue
51.0
12,6
3.1
5.0
2 0 1
The results shown in the above table indicate 
that one back-extraction of the toluene fraction with 
20 ml. NaOH will remove 50% of the contained oestrone. 
Subsequent extractions remove 13^ and 5% respectively.
These results indicate that the procedure 
outlined in Extraction Procedure II (Section IV, D ii) 
provides a good, clean recovery of DHA sulphate in the 
aqueous phase. Oestrone, on the other hand, tends to 
be easily extractable from an alkaline medium by 
toluene, Back-extraction of the toluene with 20 ml, 
N.NaOH recovers 50% of this oestrone.
To assess the repeatability of the previous investigation
The "incubation medium" containing labelled and 
non-labelled DHA sulphate and oestrone was prepared as 
before and the steroids extracted as described 
previously.
The toluene extract was reduced to 20 ml. volume 
and back-extracted with 2 x 20 ml. N.NaOH, keeping each 
extract separate. The two soda phases were then 
separately adjusted to pH 8 and the steroids extracted 
with 3 X 30 ml. ether.
The aqueous residue was dealt with, in respect to 
DHA sulphate, as described before.
Aliquots of each fraction were taken for counting 
as before. .
Results.
The table shows the total radioactivity in the 
various fractions. Percentages of the initial radio­
activity are given in parentheses.
ZU3
%
Aqueous fraction 2,019,850 (82.3) 13,740 (0.99)
Residual activity in the 
soda phase after toluene
extraction. 351,880 (25.4)
1st back-extraction of
the toluene. 524,280 (37*8)
2nd back-extraction of
the toluene. 154,730 (11.2)
Residual activity in
the toluene. 23,710 (0.97) 39,090 (2.7)
The accompanying table shows again a good recovery 
(82^) of DHA sulphate but a very poor initial recovery 
{ 25%) of oestrone after extracting the NaOH containing 
this oestrogen with 6 x 20 ml. toluene. Back- 
-extraction of the toluene phase achieved a recovery 
of 50^ giving a total of approximately 75^ of the 
original oestrone.
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Appendix 4 *
To achieve a reasonable separation of neutral and 
phenolic steroids after extraction from the incubation 
media.
In this experiment neutral and phenolic steroids 
were represented, respectively, by DHA and oestrone,.
Unlabelled DHA and oestrone, JOO . in each
q
case, were added to 0-5 each of 7a- H DHA and 
oestrone. The mixture was then divided 
equally into three portions and dried. Toluene 
(l ml.) was added to each tube followed by 20 ml. 
N.NaOH, The steroid mixtures were then subjected 
to three extraction procedures; tube 1. was shaken
with 2 x 20 ml, toluene, tube 2. with 4 x 20 ml.
toluene and tube 3- with 6 x 20 ml, toluene.
The toluene fractions were evaporated to dryness 
and a small aliquot taken from each for counting by 
liquid scintillation counter. The remainder was 
taken up in toluene again (20 ml.) and back-extracted
with 1 X 20 ml. N.NaOH.
The alkali fractions from the initial and 
back-extractions were taken, individually, to pH 8
using conc. HCl and steroids extracted with 3 x 20 ml. 
ether. A known volume from each ether fraction was 
then taken for counting.
Results,
Total initial radioactivity;- 
7 a - h  DHA - 1 ,077,500 dpm.
4- C oestrone - 1,466,000 dpm.
The total amounts of radioactivity (dpm) and; in 
parenthesis; the percentages of initial radioactivity 
in each extract.
Before the back-extraction.
Toluene fraction.
Tube 1. 1,056,800 (98.1) 454,100 (31.0)
Tube 2. 984,500 (91.4) 725,000 (49-5)
Tube 3. 1,026,900 (95-3) 967,000 (66.0)
Alkaline fraction.
Tube 1. 0 761,800 (52.0)
Tube 2. 0 643,400 (43-9)
Tube 3. 0 529,800 (36.1)
3h 14^
After the back-extraction.
Toluene fraction.
Tube 1. 907,000 (84.2) 78,500 ( 5 . 3 5 )
Tube 2. 875,600 (81.3) 118,100 (8.06)
Tube 3 . 868,700 (80.6) .149,000 (10.2)
Alkaline fraction.
Tube 1. 136;200 (12.6) 264,600 (18.1)
Tube 2. 143,900 (13-4) 323,100 (22.0)
Tube 3. ' 216;000 (20.1) 614,300 (41.9)
The accompanying table shows that the DHA is 
equally well extracted by 2 x 2 0  ml. toluene as by 
4 X 20 ml. or even 6 x 2 0  ml. In fact the consequence 
of exceeding that initial procedure is a further 
withdrawal of oestrone from a 31^ to a 66^ extraction. 
The readings obtained with the alkaline fraction 
confirm these findings indicating that 2 x 20 ml. 
toluene is optimum.
Back-extracting the toluene with 20 ml. N.NaOH 
does remove some of the oestrone but also reduces the 
yield of DHA and carries some of this latter compound 
back into the otherwise DHA-free alkaline fraction.
It would seem reasonable; therefore ; either to 
extract the soda phase with 2 x 20 ml. toluene and
not to back-extract; giving the following values :-
Toluene fraction - 98% of the DHA
31/^ of the oestrone.
Phenolic fraction - No DHA
S2% of the oestrone.
or to back-extract the toluene once or even twice 
but not to bulk these fractions with the phenolic 
fraction which is already free of DHA,
The former of these was adopted in order to 
maintain the high recovery of neutral steroids and 
use thin-layer chromatography and derivative formation 
to separate the contaminating phenolic steroids.
ZrUO
Appendix 5.
To assess the effect of an eluate from an ecteola- 
-coated plate pre-run in the solvent system 4M.
Urea in 3N.NH.OH on the quantitation of DHA sulphate 
using methylene blue.
The final purification of DHA sulphate in these 
investigations is by chromatography on ecteola- 
-coated plates in solvent system J. (Table 4)* In 
the investigation of the human tumour (see Section 
IV; L i) the conjugates were eluted with methanol; 
and in subsequent work by ethyl acetate from saturated 
NaCl solution (see Section IV; G). To assess any 
effect that such procedures might have on the 
quantitation of the steroid conjugates by the 
methylene blue method (Crepy b* Rulleau-Meslin; I96O) 
the following investigation was carried out.
An ecteola-spread plate was placed in a tank 
containing the solvent system J. until the solvent 
front had traversed most of the plate. After 
drying; the ecteola was divided into areas of 
approximately 5 sq. cm. being the area that a 
steroid would have covered after chromatography.
ZUV
Four of these areas were subjected to the methanolic 
elution procedure and another four to that of ethyl 
acetate/saturated NaCl solution. Three eluates 
from each group were transferred to tubes containing; 
respectively ; 5, 10 and 20 [ig. DHA sulphate and the 
remaining two eluates were retained as blanks. A 
further set of tubes containing; again; 5, 10 and 
20 pg. DHA sulphate were prepared as standard 
solutions for comparison.
Quantitation was achieved using the method of 
Crepy & Rulleau-Meslin (I960) (see Section IV; I iv). 
The results are shown below and the graphic 
representation of .the Allen corrected optical 
density readings against mass is given in Graph 4.
Blank corrected optical densities 
Mass of steroid / ,.  ^ , \(optical density units)
Standards + Methanolic 
eluate
Ethyl acetate 
eluate
5 Pg. 0.056 0.029 0.047
10 H-g. 0.107 0.054 0.106
20 fg* 0.207 0,110 0.214
From the results above and Graph 4 it is concluded
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that interference by ecteola/urea after elution of 
DHA sulphate with ethyl acetate/saturated NaCl 
solution is negligible whereas after using the 
methanol procedure a correction factor of 1.93 is 
required,
xz
Appendix 6 .
To assess the efficiency of elution of testosterone 
from a silica gel-coated plate using ethyl acetate.
Three aliquots of 10 p.g. testosterone in ethanol 
were applied to a silica gel-coated plate. Without 
chromatography the three areas were scraped from the 
plate and the steroid eluted using ethyl acetate and 
water as described in Section IV^ G. A further three 
similar areas of silica gel were also subjected to 
this elution procedure to provide blanks. Standard, 
solutions^ 3 X 10 ^g.^ were prepared for comparative 
purposes.
The dried steroids and blanks were taken up in 
5 ml, ethanol and the ultra-violet absorbancy 
determined using 1 cm. silica cells of an S.P.500 
Spectrophotometer with light at 240 my..
Results.
(as optical density units).
optical density Corrected for blank
Eluted steroid 1.
2 . 
3.
Blanks
Standards
1 . 
2 . 
3.
1 . 
2 .
3.
0.143
0.142
0.147
0.038
0.030 0.033 
0.032
0.111 
0.112 
0.112
0.110
0.109
0.114
The recovery of testosterone from silica gel by 
eluting with ethyl acetate from water is virtually 100^.
z±4
Appendix 7•
To assess the efficiency of elution of DHA sulphate 
from ecteola with ethyl acetate and saturated NaCl 
solution.
The investigations of metabolism and synthesis 
of steroid sulphates by testicular tissues necessi­
tated the chromatography of these compounds on 
ecteola in the solvent system 4^,Urea in 3N.NH^OH 
(see Section IV^ K). It was therefore important 
to be able to elute these steroids from this 
material efficiently.
A stock solution A was prepared : - 
7a-^H DHA sulphate - 0,5 M-C,
Unlabelled DHA sulphate - 100 y.g.
Ethanol - 10 m l .
Procedure,
(1) Preparation of standard solutions.
Three aliquots of 0,5 ml. of solution A were 
pipettedJ individually^ into vials and blown to 
dryness. Methanol (1.0 ml.) was added to each 
followed by 9 ml. scintillator solution.
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(2) Preparation of standard solutions plus
ecteola eluates.
A plate coated in ecteola was allowed to stand 
in a tank containing the solvent system 4M.Urea in 
3N.NH^0H until the solvent had run several cm.
The plate was removed and dried. Three areas of 
3 sq. cm. of the ecteola that had been traversed 
by the solvent system were scraped off the plate 
and extracted with 2 x 3  m l . ethyl acetate after 
the addition of saturated NaCl solution as in the 
procedure for eluting steroid sulphates (see 
Section IV^ G). The eluates were dried and taken 
up in 2 ml. methanol. Three vials were taken 
containing in each case^ 0.5 ml. solution A 
(evaporated to dryness)^ to which was added 1 ml. 
of the methanolic eluate of the three extractions ^ 
respectively^ described above. Scintillator 
solution (9 ml.) was added to each vial.
(3) Elution of DHA sulphate from ecteola.
Three tubes containing 1 ml. solution A were 
taken and the solvent evaporated. To each were
added 3.0 sq. cm. of ecteola material from the 
pre-run plate. The steroids were extracted with 
2 X 3 m l . ethyl acetate from saturated NaCl 
solution and blown to dryness. Each fraction was 
then dissolved in 2 ml. methanol and 1 ml. of each 
removed to a vial with 9 ml. scintillator solution.
(4) Preparation of blanks.
Three areas of pre-run ecteola (3 sq. cm.) 
were scraped from the plate and subjected to the 
ethyl acetate elution procedure. The dried 
eluates were dissolved in 2 ml. methanol and 1 ml. 
of each removed to a vial containing 9 ml. 
scintillator solution.
All vials were then placed in a Packard 
scintillation counter and radioactive content 
assessed.
Results.
(1) Standard solutions = 13,091 cpm.
(2) Standards + ecteola eluates = 13,490 cpm.
(3) Extracted DHA sulphate = 12^691 cpm.
(4) Ecteola blanks = 36 cpm.
(5) Scintillator blank = 40 cpm.
-Ù3, /
It can foe seen from the results above that 
ecteola eluate does not suppress counting efficiency, 
in fact the counts from these fractions were slightly 
(2 - 3%) higher than the unaffected standards. The 
extracted DHA sulphate accounted for 97% of the 
initial radioactivity indicating a very good recovery 
by this technique, i.e. addition of saturated 
NaCl solution to the ecteola DHA sulphate complex 
and eluting with 2 x 3  ml. ethyl acetate.
Appendix 8 .
To assess the efficiency of saponification of 
testosterone acetate and the recovery of testosterone 
after thin-layer chromatography.
To three tubes, each containing 20 gg. 
testosterone acetate in 1 ml. methanol, were added
0.2 5 ml. of a 2% solution aqueous potassium 
carbonate. The mixtures were allowed to stand 
overnight at room temperature.
The steroids were extracted by 3 ^ 3  ml. 
ethyl acetate after the addition of 3 ml. water 
to each tube, and chromatographed on silica gel 
in solvent system A (Table 4)•
The ultra-violet absorbing spots corresponding 
to testosterone were eluted with ethyl acetate and 
recovery estimated by optical density determinations 
in ethanol.
Results.
Optical density Silica gel Corrected -1. % recoveryof testosterone blank reading
From tube 1. 218 35 183 91.0^
From tube 2. I96 35 161 80.2%
From tube 3 . 17I 35 136 67,3%
The results above indicate that this method of 
saponification and subsequent extraction, chromato­
graphy and elution provides a recovery of between 
70 and 90^ of testosterone from testosterone acetate
2 2 0
Appendix 9 *
To investigate the counting efficiency of 7a- H DHA 
sulphate after ^^quenching^^ with methanol and also the 
degree of glass-sticking'^ with the lower levels of 
steroids used in this investigation.
The steroid sulphates are very polar compounds 
providing difficulties during the measurement of radio­
activity with the toluene-scintillâtor solution used 
in these investigations. The problem may be overcome 
by dissolving the conjugates in 1 ml, methanol in a 
vial prior to the addition of 9 ml. scintillator 
solution. This technique affords solubility of the 
steroid but also results in attenuation of the pulse 
heights (quenching) during the measurement of radio­
activity, This effect may be corrected for by 
employing an external quenched standard.
"Glass-sticking^^ is the term applied to the 
phenomenon of very small amounts of steroid that are 
said to adhere to glass surfaces. The use of 
larger amounts of steroid (e.g. 10 pg.) is thought 
to reduce this effect to a negligible level.
These problems were investigated as follows:
zz±
A known and equal amount of 7n-^H DHA sulphate 
was used for each measurement (approx. 0.2 pg,),
(1) 7cb~^H DHA sulphate was dried in a vial 
and 10 ml. scintillator solutions added.
(2) 7n-^H DHA sulphate was dried in a vial 
+ 1 ml. methanol + 9 m l . scintillator solution.
(3) 7a-^H DHA sulphate, pre-dissolved in
0.5 ml, methanol, was transferred to a vial and a 
further 0.5 ml. methanol and 9 ml. scintillator 
solution added.
o
(4) 7a,- H DHA sulphate was placed in a vial 
and 10 pg. of the unlabelled steroid added in 1 ml. 
methanol followed by 9 ml. scintillator solution.
o
(5) 7a- H DHA sulphate, pre-dissolved in
1.0 ml. methanol, was transferred to a vial and a 
further 1.0 ml. methanol and 8 ml. scintillatorI
solution added.
(6) Carbon-labelled and tritiated toluene 
were measured accurately into 3 vials each. To 
one of each was added 10 ml. scintillator solution
2 2 2
and to the remainder, 1 ml, or 2 nil, methanol and 
the volumes made up to 10 ml. with the requisite 
amount of scintillator. These vials served as 
normal and variably-quenched standards.
Results.
Effect of methanol on the efficiencies of
2 14.counting and C toluene.
(a) Unquenched -labelled toluene = 50,87^
^^C-toluene + 1 ml, methanol = 30.54^
14C-toluene + 2 ml. methanol = 20.
(b) Unquenched ^H-labelled toluene = 18.26^ 
^H-toluene + 1 ml. methanol = 15.13%
^H-toluene t 2 ml. methanol — X2 , 5 7 %
It may be seen from the results given above that 
the addition of 1 ml. or 2 ml, methanol reduces the 
counting efficiency of, the -toluene by 20^ and 
30^ respectively. The efficiency of counting of
o
the H-toluene was similarly reduced by 3 and 6% 
respectively.
ZZ3
o
Results using DHA sulphate.
Radioactivity (dpm) as determined by comparison 
with the appropriate preparation of radioactive toluene.
(1) 939,180
(2) 1,861,820
(3) 1,864,980
(4) 1,913,630
(5) 1,959,080.
These data show the increased counting efficiency 
of 7a-^H DHA sulphate by liquid scintillation 
spectrometry of approximately 100^ by the addition of 
1 or 2 ml. methanol to the samples. The addition of 
unlabelled steroid (vial 4) shows little effect on the 
measurement of the contained radioactivity and indicates 
that **glass-sticking" is not of importance at the 0.2 pg. 
level.
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Appendix 10.
Investigation of the loss of radioactivity when 
7a,- H androst-5-ene-diol is subjected to an 
oxidation reaction.
A solution containing 50 pg. unlabelled DHA
0
and approximately 0.3 pC 7a- H DHA was prepared
and chromatographed on a silica gel-coated plate
in solvent system A (Table 4)• The steroid was
eluted and a specific activity determined. The
remainder was subjected to a reduction reaction
(see Section IV, H iv) and the resulting androst-
-5-ene-diol chromatographed on silica gel, again
0
in system A. This provided the 7a- H androst- 
-5-cne-diol to be investigated. The specific 
activity of this compound was determined and the 
remainder subjected to an oxidation reaction (see 
Section IV, H i). The products of this procedure 
were chromatographed on silica gel in system A and 
6-oxo-androstenedione eluted. Its specific
activity was assessed.
Results.
Steroid Specific activity (dpm/mpniole)
DHA 25,649
androst-5*'ene-diol 23, 877
6-oxo-androstenedione 2,848
It may be seen from the results given above 
that oxidation using Kiliani ? s reagent causes loss 
of 7a-tritium from androst-5-ene-diol. It is 
assumed that this is due to énolisation at the 
6,7 position. This procedure was therefore only 
used in the examination of carbon-labelled androst- 
-5-cne-diol.
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